Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3003181	u-na	mmol/l (mmol/l)	5186	7292	1.63%
3003181	u-na	— (—)	1758	2140	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1751

4217

2.88

323.31

1.6

1.4

61.56

64.70

mmol/l

1.96

1354

3358

Influenza and pneumonia

1793

4081

2.84

316.31

1.6

1.4

62.01

64.90

mmol/l

1.69

1385

3249

Heart failure, not strict

1470

3268

3.13

310.00

1.4

1.3

58.44

65.10

mmol/l

6.56

1126

2612

Alcohol use disorder, ICD-based

873

2189

4.11

308.48

1.5

1.3

53.56

65.64

mmol/l

11.81

611

1755

Benzodiazepine use

1776

4476

2.78

308.01

1.4

57.94

64.71

mmol/l

8.16

1328

3600

Anaemias

473

145

21.99

307.65

1.8

61.15

73.24

mmol/l

1.68

354

121

Other bacterial diseases

1883

4040

3.20

307.65

1.6

1.4

60.42

64.32

mmol/l

3.04

1448

3218

All kidney diseases

1745

4189

2.90

307.65

1.5

1.4

57.54

66.15

mmol/l

12.40

1348

3344

Renal tubulo-interstitial diseases

1753

4114

3.25

307.65

1.5

1.4

56.53

66.06

mmol/l

15.58

1351

3292

Mental and behavioural disorders due to alcohol

1036

2612

3.92

307.65

1.5

1.3

54.58

65.85

mmol/l

12.23

728

2106

Substance abuse, excluding more controls

1156

2178

4.65

307.65

1.5

1.3

54.71

66.63

mmol/l

13.42

816

1752

1177

2851

3.83

307.65

1.5

1.3

55.10

65.86

mmol/l

12.46

824

2310

Malaise and fatigue

1301

2052

5.29

307.65

1.6

1.3

59.69

65.06

mmol/l

3.84

1057

1607

General symptoms and signs

1703

2619

3.31

307.65

1.5

1.4

61.99

65.89

mmol/l

2.33

1356

2041

All pneumoniae

1778

4183

2.89

307.65

1.6

1.4

61.54

64.89

mmol/l

2.19

1372

3333

Endocrine, nutritional and metabolic diseases

1145

1063

5.54

307.65

1.5

1.3

64.17

73.74

mmol/l

5.15

897

845

Bacterial Sepsis

1131

2624

3.81

307.65

1.6

1.3

57.99

64.75

mmol/l

5.65

875

2097

Pneumonias (Asthma/COPD co-morbidities)

1778

4175

2.91

307.65

1.6

1.4

61.58

64.88

mmol/l

2.14

1376

3323

Hypo-osmolality and hyponatraemia

3078

647

75.53

307.65

1.6

1.1

56.38

67.16

mmol/l

7.88

2418

490

Mental and behavioural disorders due to psychoactive substance use

1183

3003

3.74

307.65

1.5

1.3

54.96

65.62

mmol/l

12.31

836

2415

Condition for Implicit Sepsis (Organ dysfunction codes)

1718

3602

3.45

307.65

1.5

1.4

60.41

64.62

mmol/l

3.20

1333

2852

Alcohol use disorder, Swedish definition

1137

2752

3.89

307.65

1.5

1.3

54.29

65.94

mmol/l

14.23

791

2242

Mental and behavioural disorders due to alcohol, excluding acute intoxication

952

2360

4.14

307.65

1.5

1.3

53.66

65.65

mmol/l

12.82

666

1895

Hypokalaemia

518

384

14.82

307.65

1.8

1.2

61.65

69.83

mmol/l

2.21

419

288

1201

2924

3.71

307.65

1.5

1.3

54.95

65.82

mmol/l

12.95

838

2375

Metabolic disorders

2577

2096

7.80

307.65

1.6

1.3

59.83

70.15

mmol/l

14.01

2004

1650

Bacterial infection, other or unspecified

1297

3246

3.48

307.65

1.6

1.3

59.88

64.41

mmol/l

3.20

1006

2609

Implicit bacterial Sepsis

1121

2564

3.91

307.65

1.6

1.3

57.86

64.34

mmol/l

5.24

871

2053

Other bacterial diseases

1839

3945

3.01

307.65

1.6

1.4

60.90

65.07

mmol/l

3.22

1412

3145

Condition for Implicit Sepsis (Organ dysfunction codes)

1734

3537

3.46

307.65

1.5

1.4

60.70

64.92

mmol/l

3.14

1350

2799

Other disorders of fluid, electrolyte and acid-base balance

3431

1137

36.53

307.65

1.6

1.2

57.98

68.94

mmol/l

12.21

2711

871

Pneumonia, organism unspecified

1670

3958

3.02

307.65

1.6

1.4

61.59

64.49

mmol/l

1.65

1281

3147

Substance abuse

1156

2962

3.76

307.65

1.5

1.3

54.71

65.67

mmol/l

12.73

816

2384

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1866

4284

3.07

307.65

1.5

1.4

60.01

64.46

mmol/l

3.97

1446

3415

Implicit Sepsis

1749

3595

3.65

307.65

1.5

1.3

60.31

64.33

mmol/l

3.01

1356

2846

Bacterial infection, other or unspecified

1228

3134

3.51

307.65

1.6

1.3

60.30

64.24

mmol/l

2.40

952

2524

Convulsions, not elsewhere classified

604

895

6.94

307.65

1.6

1.5

66.90

67.13

mmol/l

0.03

475

707

Implicit bacterial Sepsis

1043

2408

3.98

307.65

1.6

1.3

57.91

64.21

mmol/l

4.68

811

1929

Implicit Sepsis

1702

3524

3.75

307.65

1.5

1.3

59.11

64.57

mmol/l

5.06

1326

2786

Cerebrovascular diseases (FINNGEN)

602

694

6.32

304.65

1.4

70.76

66.62

mmol/l

0.86

486

539

1586

3248

3.01

304.33

1.6

1.3

61.73

64.28

mmol/l

1.23

1229

2568

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1586

3248

3.01

304.33

1.6

1.3

61.73

64.28

mmol/l

1.23

1229

2568

Fever of other and unknown origin

963

2321

3.77

294.19

1.7

1.4

62.22

65.39

mmol/l

1.29

788

1812

Exclusions for E4_PCOS_BROAD

537

943

6.03

293.09

1.9

1.5

75.02

65.33

mmol/l

3.86

468

765

Explicit Sepsis

976

2607

3.60

279.90

1.7

1.4

59.11

65.23

mmol/l

4.08

757

2095

Heart failure and antihypertensive medication

520

527

6.68

265.61

1.5

1.3

57.01

67.71

mmol/l

3.90

402

406

Persons encountering health services for specific procedures and health care

1733

4049

2.61

256.06

1.6

1.4

63.81

64.21

mmol/l

0.12

1400

3173

Other septicaemia

888

2454

3.60

255.38

1.7

1.3

58.54

64.66

mmol/l

3.87

693

1993

Septicaemia

959

2699

3.43

254.69

1.7

1.4

58.58

64.60

mmol/l

4.05

744

2200

Hyperkalaemia

230

167

15.13

253.00

1.7

1.2

57.70

67.32

mmol/l

1.91

183

122

Nausea and vomiting

682

1626

4.26

250.11

1.9

1.4

63.01

64.74

mmol/l

0.42

556

1304

Constipation

1572

4205

2.64

246.50

1.5

1.4

60.03

64.58

mmol/l

3.72

1228

3367

Any death

1289

3324

2.85

234.75

1.4

1.3

59.51

63.19

mmol/l

2.03

953

2701

Volume depletion

283

313

9.60

234.31

2.2

1.2

61.36

68.42

mmol/l

1.30

224

228

Disorders of lipoprotein metabolism and other lipidaemias

1010

1908

3.33

230.04

1.4

1.2

59.42

69.34

mmol/l

9.00

813

1490

Bleeding

1506

4212

2.59

230.04

1.6

1.4

67.23

61.31

mmol/l

4.67

1179

3338

Acute tubulo-interstitial nephritis

1156

3528

2.89

227.46

1.5

1.4

58.09

65.94

mmol/l

8.20

914

2834

Aplastic and other anaemias

1032

3247

3.05

226.13

1.6

1.4

57.52

63.39

mmol/l

4.62

816

2615

Renal failure

1047

3129

3.05

226.03

1.5

1.3

52.94

64.13

mmol/l

16.39

817

2516

Pure hypercholesterolaemia

935

1817

3.41

225.04

1.3

1.2

60.08

69.36

mmol/l

7.43

753

1417

Syncope and collapse

802

1959

3.58

224.77

1.5

1.3

61.50

64.68

mmol/l

1.24

656

1534

Oxycodone

825

2205

3.48

223.34

1.4

1.3

59.70

63.33

mmol/l

1.52

627

1767

Any mental disorder

1670

3336

2.54

222.56

1.5

1.4

61.85

65.35

mmol/l

2.10

1283

2706

Hypertensive diseases (excluding secondary)

688

934

4.35

218.84

1.5

63.36

68.42

mmol/l

1.45

547

712

Mood disorders, excluding more controls

1417

3222

2.66

218.60

1.5

1.4

58.55

65.26

mmol/l

6.22

1074

2612

Other anaemias

968

3099

3.06

214.06

1.6

1.4

56.81

63.42

mmol/l

5.49

759

2491

Intracranial trauma

893

1909

3.34

213.50

1.5

65.81

62.14

mmol/l

1.32

710

1472

Other and unspecified anaemias

961

3083

3.06

212.83

1.6

1.4

56.56

63.39

mmol/l

5.82

755

2479

Alcohol dependence

568

1385

4.24

208.95

1.5

1.3

53.12

65.75

mmol/l

8.55

389

1127

Hypertension, essential

1079

2027

3.06

208.83

1.4

61.29

66.16

mmol/l

2.45

849

1561

Epilepsy

681

1899

3.68

205.85

1.5

68.25

64.00

mmol/l

1.49

564

1493

Other antidepressants

1583

3296

2.49

204.87

1.5

1.4

61.63

64.86

mmol/l

1.87

1222

2667

STROKE

958

2142

3.10

200.46

1.4

1.3

68.59

62.87

mmol/l

2.77

781

1640

Asthma, unspecified (mode), excluding more controls

792

1764

3.42

199.61

1.4

1.3

63.05

65.83

mmol/l

0.88

627

1397

Symptoms and signs involving cognition, perception, emotional state and behaviour

1515

4362

2.40

196.47

1.5

1.4

63.55

62.94

mmol/l

0.21

1231

3408

Other heart diseases

609

967

4.18

193.49

1.6

61.33

69.46

mmol/l

3.12

479

747

Disorders of other endocrine glands

876

2925

3.02

192.12

1.8

1.5

69.19

62.23

mmol/l

4.26

738

2306

Symptoms and signs involving the urinary system

1335

4152

2.49

192.06

1.4

59.92

63.44

mmol/l

2.20

1052

3291

Acute renal failure

578

1523

3.97

192.03

1.5

1.3

51.45

64.40

mmol/l

11.26

429

1214

All chronic kidney diseases

1017

3019

2.82

188.48

1.5

1.4

54.44

65.83

mmol/l

15.98

820

2425

Heart failure,strict

1015

2547

2.88

188.17

1.5

1.3

56.74

65.25

mmol/l

8.46

804

2050

Hypertension

1055

2088

2.89

185.91

1.4

61.76

66.63

mmol/l

2.37

822

1611

Other CVD (FINNGEN)

292

299

7.94

185.88

1.5

1.2

58.75

69.98

mmol/l

2.99

224

234

Injuries to the head

1684

4638

2.26

185.87

1.5

1.4

63.03

63.97

mmol/l

0.35

1317

3682

Hypertensive diseases

1055

2092

2.89

185.36

1.4

61.78

66.72

mmol/l

2.42

822

1615

Oedema, not elsewhere classified

590

1604

3.72

181.56

1.4

1.3

57.62

64.76

mmol/l

3.47

449

1249

Headache

867

2355

2.98

178.83

1.6

1.4

62.05

66.22

mmol/l

1.84

726

1835

Anxiety disorders, excluding more controls

1170

2955

2.61

178.49

1.5

1.4

59.41

65.41

mmol/l

4.15

909

2387

Asthma, unspecified (mode)

828

2051

3.09

178.28

1.4

1.3

62.93

64.05

mmol/l

0.28

660

1624

Tramadol

1183

2819

2.62

177.95

1.5

1.3

60.17

63.77

mmol/l

1.83

915

2246

Hypothyroidism (congenital or acquired)

264

136

11.11

177.77

2.1

1.6

73.05

76.00

mmol/l

0.20

216

114

Diseases of arteries, arterioles and capillaries (FINNGEN)

415

553

5.33

176.89

1.4

1.3

56.55

66.74

mmol/l

3.41

323

436

Cardiovascular diseases (excluding rheumatic etc)

693

1122

3.59

172.72

1.6

1.7

68.05

70.31

mmol/l

0.44

557

871

Schizophrenia or delusion, excluding more controls

492

1224

4.07

172.62

1.4

1.3

54.85

65.71

mmol/l

5.75

358

981

Hypothyroidism, levothyroxine purchases

258

136

10.87

171.77

1.8

1.6

72.78

76.00

mmol/l

0.22

213

114

Hypothyroidism and >3 levothyroxin purchases

258

136

10.87

171.77

1.8

1.6

72.78

76.00

mmol/l

0.22

213

114

Implicit viral Sepsis

611

1795

3.51

171.61

1.6

1.3

62.09

64.90

mmol/l

0.81

495

1444

Psychiatric diseases

1404

2933

2.43

170.96

1.5

1.4

62.45

64.72

mmol/l

0.94

1098

2381

Other functional intestinal disorders

850

2787

2.89

170.80

1.7

1.4

60.47

65.27

mmol/l

2.56

684

2244

First line medication for Crohn's disease

1581

3808

2.27

170.37

1.5

1.4

64.37

63.78

mmol/l

0.18

1244

3006

Fall on same level

1610

3972

2.24

168.49

1.5

62.09

64.89

mmol/l

1.55

1250

3167

Osteopathies and chondropathies

1019

3739

2.59

165.80

1.5

1.4

61.23

62.48

mmol/l

0.42

795

2978

Retention of urine

692

1785

3.27

165.60

1.5

1.3

57.36

65.04

mmol/l

5.21

547

1445

Complications of surgical and medical care, not elsewhere classified

1516

4736

2.22

164.96

1.5

1.4

63.10

62.86

mmol/l

0.07

1206

3729

Depression medications

280

143

9.96

164.61

1.6

1.4

62.88

78.57

mmol/l

2.20

224

121

Hyperosmolality and hypernatraemia

107

35.06

163.37

2.0

1.4

67.61

66.53

mmol/l

0.05

Use of hypnotics and sedatives

1552

4050

2.23

162.64

1.4

59.80

64.85

mmol/l

4.38

1202

3219

Viral Sepsis

466

1189

4.07

161.58

1.7

1.3

63.59

64.57

mmol/l

0.17

378

953

Implicit viral Sepsis

465

1187

4.06

161.13

1.7

1.3

63.53

64.56

mmol/l

0.18

377

951

Dyspnoea

1398

4641

2.26

160.76

1.4

60.84

63.17

mmol/l

1.25

1118

3646

GASTRO-related operations

1023

1880

2.76

160.11

1.6

1.3

66.22

66.71

mmol/l

0.10

791

1534

Any gastric operation

1023

1880

2.76

160.11

1.6

1.3

66.22

66.71

mmol/l

0.10

791

1534

Infections, IBD-co-morbidities

299

330

6.65

159.66

1.9

1.4

57.81

62.66

mmol/l

0.74

248

238

Other medical care

860

2869

2.76

156.74

1.4

1.3

61.16

63.60

mmol/l

0.87

674

2274

Focal epilepsy

479

1276

3.89

156.12

1.5

71.07

64.67

mmol/l

2.10

395

1031

Diseases of oesophagus, stomach and duodenum

1546

4292

2.18

155.68

1.5

1.4

61.36

63.75

mmol/l

1.23

1193

3393

Symptoms and signs concerning food and fluid intake

266

440

6.33

154.02

1.6

1.5

62.74

68.53

mmol/l

0.92

203

350

Anxiety (asthma-related co-morbidities)

799

2178

2.88

153.57

1.5

56.65

68.32

mmol/l

9.76

609

1760

Concussion

702

1899

3.06

152.47

1.5

63.80

62.04

mmol/l

0.44

564

1464

Diseases of liver

664

2206

3.09

152.22

1.5

1.4

55.96

64.42

mmol/l

5.44

480

1777

Heart failure, strict

1102

3224

2.46

151.08

1.5

1.3

57.23

63.75

mmol/l

6.13

876

2585

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

380

875

4.41

149.11

1.6

1.3

56.57

66.35

mmol/l

3.05

268

699

All-cause Heart Failure

1084

3188

2.45

147.27

1.4

1.3

57.28

63.91

mmol/l

6.14

858

2553

Depression or dysthymia

935

1935

2.70

145.21

1.5

1.3

60.62

64.92

mmol/l

1.99

724

1586

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

374

886

4.43

143.95

1.5

1.4

51.67

64.50

mmol/l

6.38

236

717

Alcoholic liver disease

285

540

5.59

143.85

1.5

1.3

52.58

64.28

mmol/l

3.84

174

439

Osteoporosis

652

2076

3.05

141.62

1.5

1.4

60.52

60.98

mmol/l

0.10

505

1667

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1382

4196

2.17

140.71

1.6

1.4

63.59

63.78

mmol/l

0.05

1094

3315

Mood disorders

1471

4547

2.12

140.67

1.5

1.4

58.91

64.68

mmol/l

5.18

1117

3622

Mood [affective] disorders

1467

4539

2.12

140.58

1.5

1.4

58.86

64.73

mmol/l

5.32

1115

3615

Certain infectious and parasitic diseases

1285

2829

2.30

139.68

1.4

61.41

66.13

mmol/l

2.82

997

2254

Covid-19 confirmed case

697

2499

2.86

139.11

1.5

1.4

60.51

63.20

mmol/l

0.90

570

1997

Focal epilepsy, strict definition

441

1203

3.80

139.01

1.5

71.42

64.78

mmol/l

2.12

365

973

Other disorders of urethra and urinary system

1028

3099

2.43

138.88

1.5

1.4

62.93

64.34

mmol/l

0.47

835

2463

Non-invasive ventilation

346

686

4.60

138.09

1.5

1.4

65.69

66.26

mmol/l

0.07

286

537

Persons encountering health services in other circumstances

660

2292

2.92

137.82

1.4

60.87

65.31

mmol/l

1.67

506

1813

Transplanted organ and tissue status

263

487

5.70

135.96

1.6

1.5

57.65

66.00

mmol/l

1.99

225

392

Nutritional anaemias

902

3569

2.49

135.63

1.6

1.4

59.19

63.07

mmol/l

2.11

700

2874

Any reimbursement code in KELA

594

859

3.50

135.63

1.5

1.4

64.75

70.02

mmol/l

1.30

466

664

Cerebrovascular diseases

1236

3970

2.22

135.27

1.4

66.97

61.29

mmol/l

4.03

1009

3132

Atrial fibrillation and flutter

419

660

4.19

133.37

1.4

1.3

59.88

65.19

mmol/l

1.34

327

510

Dental caries

468

1301

3.55

133.25

1.6

1.4

63.34

63.43

mmol/l

0.01

359

1013

Intracranial injury

923

3643

2.43

132.93

1.5

1.4

65.25

63.76

mmol/l

0.44

734

2909

COPD (mode)

561

1388

3.25

132.14

1.4

1.3

55.09

63.52

mmol/l

4.59

415

1098

ILD medications: prednisolone, methylprednisolone, prednisone

1505

4102

2.07

131.71

1.5

1.4

61.83

64.25

mmol/l

1.26

1174

3241

Provisional assignment of new diseases of uncertain etiology

848

3440

2.50

131.03

1.5

1.4

61.29

63.43

mmol/l

0.73

687

2720

Codes for special purposes

848

3444

2.50

130.71

1.5

1.4

61.29

63.44

mmol/l

0.74

687

2724

Depression

1326

4271

2.13

129.94

1.5

1.4

59.16

64.65

mmol/l

4.32

1016

3393

Diarrhoea and gastroenteritis of presumed infectious origin

1055

4225

2.28

129.86

1.8

1.4

61.34

64.78

mmol/l

1.60

836

3334

Alcohol abuse, main dg, excluding more controls

266

521

5.26

128.33

1.4

1.3

57.90

66.85

mmol/l

2.04

196

425

Focal epilepsy, mode (most common among epilepsy diagnosis)

407

1113

3.78

127.83

1.5

72.72

64.21

mmol/l

2.86

338

901

Asthma, excluding more controls

903

1838

2.59

127.49

1.5

1.3

65.10

66.49

mmol/l

0.35

710

1451

Other symptoms and signs involving cognitive functions and awareness

812

2959

2.55

127.41

1.5

1.3

61.36

61.96

mmol/l

0.16

651

2335

Caries of dentine

423

1151

3.67

127.17

1.5

1.4

63.69

63.51

mmol/l

0.02

323

892

Personality disorders, excluding more controls

332

786

4.30

126.50

1.5

1.3

54.80

67.14

mmol/l

5.11

244

633

Cardiovascular diseases

586

971

3.28

124.97

1.6

1.8

69.21

71.01

mmol/l

0.30

484

761

Parasetamol

886

1749

2.59

124.26

1.4

64.29

65.75

mmol/l

0.36

706

1349

Iron deficiency anaemia

780

3081

2.55

124.11

1.5

1.4

59.01

63.10

mmol/l

2.02

598

2479

Intestinal infectious diseases

1338

4996

2.06

122.77

1.6

1.4

60.41

64.39

mmol/l

2.51

1060

3948

Persons encountering health services in other circumstances, wide

1617

4241

1.98

122.75

1.5

1.4

61.86

64.06

mmol/l

1.11

1263

3352

Other disorders of adrenal gland

170

229

8.09

120.75

1.8

1.4

70.77

62.42

mmol/l

1.27

150

188

Disorders of mineral metabolism

175

241

7.58

120.72

2.2

1.3

60.93

70.24

mmol/l

1.54

150

186

Antihypertensive medication - note that there are other indications

578

958

3.23

120.03

1.5

1.8

66.40

73.80

mmol/l

2.27

476

741

Abnormalities of breathing

1163

3097

2.20

119.89

1.5

64.02

64.84

mmol/l

0.23

909

2447

Opioids

1220

2927

2.19

119.58

1.4

1.3

63.08

64.66

mmol/l

0.54

957

2335

COPD/asthma related infections

1352

3248

2.11

119.45

1.5

1.3

62.26

64.28

mmol/l

0.84

1075

2568

COPD/asthma/ILD related infections

1352

3248

2.11

119.45

1.5

1.3

62.26

64.28

mmol/l

0.84

1075

2568

General examination and investigation of persons without complaint and reported diagnosis

918

1953

2.48

119.10

1.5

1.4

63.32

62.94

mmol/l

0.08

712

1519

All anxiety disorders

804

2570

2.50

118.86

1.6

1.4

56.71

66.26

mmol/l

7.18

614

2029

Pain, not elsewhere classified

409

1175

3.55

118.61

1.6

1.4

61.72

66.20

mmol/l

1.16

321

923

Erysipelas

1033

3570

2.24

117.71

1.4

1.3

58.70

63.48

mmol/l

3.07

815

2843

Other diseases of urinary system

1331

3634

2.08

117.67

1.5

1.4

61.61

64.53

mmol/l

1.58

1059

2880

Other diseases of intestines

1364

3814

2.05

117.10

1.7

1.4

61.78

65.73

mmol/l

2.39

1059

3019

Dizziness and giddiness

1084

3993

2.18

116.76

1.4

64.27

62.79

mmol/l

0.52

883

3127

Asthma (only as main-diagnosis), excluding more controls

816

1838

2.57

116.53

1.4

1.3

64.48

66.49

mmol/l

0.57

649

1451

Secondary hypertension

168

226

7.64

116.33

1.5

1.3

62.36

76.09

mmol/l

2.78

146

182

Dialysis, with operation codes

306

732

4.37

116.31

1.6

1.4

53.74

67.54

mmol/l

6.64

254

587

Early onset COPD, excluding more controls

343

889

3.96

115.90

1.5

1.3

53.18

66.00

mmol/l

5.73

241

712

Other disorders of electrolyte and fluid balance, not elsewhere classified

41.16

115.07

2.2

1.1

62.33

63.07

mmol/l

0.03

ILD medications

1497

4139

1.98

114.90

1.5

1.4

62.30

64.63

mmol/l

1.15

1174

3277

Other heart diseases, wide

1151

3311

2.15

112.90

1.5

61.66

65.57

mmol/l

2.06

915

2581

Open wound of head

839

3490

2.35

112.55

1.5

1.4

62.25

63.56

mmol/l

0.36

641

2775

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

381

451

4.28

112.44

1.4

1.6

64.82

69.67

mmol/l

0.86

317

358

Adrenocortical insufficiency

149

188

8.75

112.18

1.7

1.4

70.46

64.67

mmol/l

0.66

132

155

Substance use, excluding alcohol

328

848

3.97

111.37

1.6

1.4

54.11

65.34

mmol/l

3.81

231

685

Complications of medical and surgical care

1095

4841

2.11

111.34

1.5

1.4

62.66

62.96

mmol/l

0.08

880

3820

Oral corticosteroids

1439

4380

1.97

111.22

1.5

1.4

62.15

63.36

mmol/l

0.46

1111

3466

Stroke, including SAH

1048

3538

2.19

110.76

1.4

68.96

61.18

mmol/l

5.81

846

2803

Other anxiety disorders

594

1876

2.78

110.69

1.6

1.4

54.10

65.39

mmol/l

8.31

465

1473

Paralytic ileus and intestinal obstruction

498

1685

3.03

110.59

2.0

1.3

59.18

64.18

mmol/l

1.57

368

1358

Neurotic, stress-related and somatoform disorders

1188

4044

2.08

110.46

1.5

1.4

59.62

64.81

mmol/l

3.40

921

3193

Acute alcohol intoxication

426

1319

3.31

110.01

1.5

1.3

55.90

65.48

mmol/l

4.09

303

1079

Anxiety disorders

1202

4099

2.07

109.96

1.5

1.4

59.78

64.69

mmol/l

3.15

933

3236

Asthma

946

2133

2.35

109.66

1.5

1.3

65.17

64.63

mmol/l

0.12

743

1684

Chronic kidney disease

606

2241

2.72

109.59

1.5

1.3

51.88

64.47

mmol/l

15.59

495

1784

Cystitis

1145

3227

2.13

109.52

1.5

1.4

60.85

64.34

mmol/l

1.83

908

2565

Excluding asthma or asthma-COPD overlap

985

2154

2.31

108.95

1.4

1.3

60.89

64.59

mmol/l

1.59

791

1703

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

454

851

3.41

108.76

1.4

1.3

62.79

67.40

mmol/l

1.04

341

651

Unspecified mental disorder

592

2214

2.72

108.59

1.4

54.15

64.76

mmol/l

7.75

429

1750

Cardiac arrhythmias

666

1627

2.69

108.25

1.4

63.61

64.88

mmol/l

0.26

529

1257

Symptoms and signs involving the digestive system and abdomen

1312

3241

2.05

108.10

1.4

62.95

64.74

mmol/l

0.66

1035

2581

Complications of procedures, not elsewhere classified

1142

4636

2.06

107.78

1.5

1.4

62.41

62.77

mmol/l

0.10

903

3657

Atrial fibrillation and flutter with reimbursement

352

560

4.08

107.42

1.4

1.3

59.55

66.14

mmol/l

1.69

276

441

Hyperlipidaemia, other/unspecified

467

1406

3.11

107.42

1.4

1.2

56.97

68.49

mmol/l

7.93

385

1102

Poisoning by drugs, medicaments and biological substances

381

1117

3.49

107.33

1.6

1.4

55.80

65.80

mmol/l

3.52

273

877

COPD differential diagnosis

980

2154

2.30

107.18

1.4

1.3

60.64

64.77

mmol/l

1.91

789

1698

ILD differential diagnosis

979

2154

2.30

106.82

1.4

1.3

60.68

64.77

mmol/l

1.88

788

1698

Schizophrenia, schizotypal and delusional disorders

495

1702

2.97

106.62

1.4

54.69

63.99

mmol/l

4.77

360

1341

Other pulmonary diagnosis

978

2154

2.30

106.47

1.5

1.3

60.44

64.59

mmol/l

1.93

787

1703

Schizophrenia or delusion

492

1693

2.96

105.83

1.4

54.85

63.87

mmol/l

4.49

358

1331

Kela-code for severe mental illness

550

2010

2.79

105.68

1.4

53.88

64.57

mmol/l

7.29

398

1582

Hypopituitarism

194

343

5.98

105.51

2.1

1.6

78.36

69.93

mmol/l

1.17

170

285

Kidney transplant status

164

246

7.16

105.44

1.6

1.5

54.55

69.26

mmol/l

3.30

145

205

L04AD Calcineurin inhibitors

253

564

4.69

105.27

1.6

57.85

67.68

mmol/l

2.51

212

449

Asthma (only as main-diagnosis)

864

2133

2.37

105.06

1.4

1.3

64.19

64.63

mmol/l

0.10

692

1684

Codeine

1124

2894

2.13

104.89

1.4

1.3

63.01

64.31

mmol/l

0.40

875

2308

Poisoning by medicine

351

993

3.62

104.51

1.5

1.4

56.15

65.04

mmol/l

2.66

249

779

Hyperfunction of pituitary gland

142

184

8.21

103.75

2.4

1.3

77.72

64.81

mmol/l

1.89

124

160

Hypertensive heart and/or renal disease

437

1015

3.29

103.45

1.4

1.3

55.31

65.69

mmol/l

5.62

350

806

Pain in throat and chest

1068

3030

2.14

103.24

1.4

63.93

64.23

mmol/l

0.07

840

2387

Used for control exclusion in common control thyroid runs

1321

3378

1.99

101.63

1.6

1.4

65.20

63.78

mmol/l

0.48

1070

2641

ILD medications: immunosuppressive drugs

859

3624

2.23

101.20

1.5

1.4

61.42

64.74

mmol/l

1.39

691

2866

Alcohol withdrawal state with delirium

193

354

5.79

101.14

1.5

1.3

51.02

65.24

mmol/l

3.94

131

290

Inflammatory bowel disease treatment related agents

1490

4465

1.88

99.94

1.5

1.4

62.76

63.97

mmol/l

0.47

1145

3545

Nephropathy related operations

284

722

4.11

99.52

1.6

1.4

54.39

65.86

mmol/l

4.51

237

582

Ascites

206

408

5.33

99.04

1.4

1.3

48.57

62.68

mmol/l

4.58

121

325

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1017

4445

2.08

98.90

1.4

62.33

62.75

mmol/l

0.11

822

3525

Autoimmune diseases excluding thyroid diseases

1329

3751

1.95

98.28

1.6

1.4

63.03

64.53

mmol/l

0.54

1057

2956

Acute alcohol intoxication, ICD10

342

997

3.52

97.41

1.4

57.40

65.37

mmol/l

2.24

240

807

Asthma (mode)

901

2154

2.26

96.71

1.4

1.3

66.02

64.77

mmol/l

0.32

718

1698

Non-ischemic cardiomyopathy

575

1771

2.68

96.62

1.4

1.3

57.93

64.06

mmol/l

3.08

449

1420

Asthma-related pneumonia

646

2668

2.47

96.40

1.5

1.4

62.72

63.34

mmol/l

0.13

515

2114

Asthma, hospital admissions 3, pneumonia

646

2674

2.46

95.91

1.5

1.4

62.72

63.32

mmol/l

0.13

515

2119

Asthma-related pneumonia or sepsis

646

2674

2.46

95.91

1.5

1.4

62.72

63.32

mmol/l

0.13

515

2119

Type 2 diabetes, wide definition

1149

3708

2.01

95.34

1.4

58.16

63.38

mmol/l

4.07

885

2948

Care involving use of rehabilitation procedures

875

3771

2.16

95.17

1.5

1.4

65.29

63.61

mmol/l

0.51

738

2967

Diseases of the digestive system

767

3425

2.27

94.75

2.0

1.3

61.80

63.32

mmol/l

0.43

600

2739

Care involving dialysis

191

368

5.45

94.57

1.5

1.4

55.07

66.10

mmol/l

2.90

166

296

Erysipelas

813

3277

2.23

94.37

1.4

1.3

58.43

63.87

mmol/l

3.28

645

2612

Selective serotonin reuptake inhibitors

1246

3327

1.97

94.03

1.4

60.73

65.17

mmol/l

2.69

940

2697

Delirium, not induced by alcohol and other psychoactive substances

303

838

3.77

93.89

1.5

1.3

58.49

60.85

mmol/l

0.45

240

668

Other and unspecified iron deficiency

591

2386

2.53

93.01

1.5

1.4

58.98

63.35

mmol/l

1.82

455

1922

Exposure to unspecified factor

1323

5120

1.88

92.96

1.5

1.4

59.77

64.48

mmol/l

3.60

1021

4076

Low back pain

1004

3529

2.06

92.52

1.4

61.74

63.05

mmol/l

0.41

806

2761

Examination and observation for other reasons

777

1938

2.35

92.48

1.6

1.4

63.78

62.92

mmol/l

0.19

619

1507

Hypertensive Heart Disease

392

967

3.25

92.41

1.4

1.3

55.05

66.37

mmol/l

5.97

311

764

Falls/tendency to fall

1299

3384

1.94

92.32

1.4

1.5

61.84

64.84

mmol/l

1.50

1013

2707

Traumatic subdural haemorrhage

272

672

4.01

92.20

1.5

1.3

69.41

62.50

mmol/l

1.35

216

530

Hard cardiovascular diseases

1139

3450

1.99

90.98

1.5

1.4

64.84

62.66

mmol/l

0.81

912

2687

Autoimmune diseases excluding thyroid diseases, strict definition

1255

3584

1.93

90.78

1.6

1.4

62.15

63.98

mmol/l

0.70

999

2813

Asthma, hospital admission 2, infections

861

4020

2.13

90.71

1.5

1.4

63.03

63.43

mmol/l

0.10

691

3179

Asthma-related infections

861

4020

2.13

90.71

1.5

1.4

63.03

63.43

mmol/l

0.10

691

3179

COPD

751

2740

2.28

90.54

1.4

1.3

56.35

63.45

mmol/l

4.89

565

2180

Medical observation and evaluation for suspected diseases and conditions

852

1962

2.24

88.58

1.5

1.4

62.72

62.89

mmol/l

0.03

654

1525

Other neurological diseases

1080

4386

1.96

87.47

1.5

1.4

67.34

61.50

mmol/l

4.04

880

3462

Other chronic obstructive pulmonary disease

724

2666

2.28

87.23

1.4

1.3

56.36

63.49

mmol/l

4.77

547

2122

Stroke, excluding SAH

952

3446

2.05

85.55

1.4

66.43

61.61

mmol/l

2.52

762

2740

Intestinal infectious diseases

1487

4810

1.78

84.12

1.5

1.4

60.22

64.38

mmol/l

3.01

1179

3804

Other diseases of pleura

750

3047

2.20

83.67

1.5

1.3

58.85

63.59

mmol/l

2.33

567

2465

Other and unspecified nonorganic psychotic disorders

286

821

3.56

83.35

1.4

54.35

64.80

mmol/l

3.11

208

652

Injuries to the abdomen, lower back, lumbar spine and pelvis

644

2804

2.31

83.32

1.5

1.4

62.11

62.49

mmol/l

0.08

515

2232

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

380

1296

2.98

83.08

1.6

1.4

56.57

65.33

mmol/l

2.71

268

1025

Haemorrhage from respiratory passages

553

2039

2.49

82.89

1.5

1.4

61.46

63.84

mmol/l

0.64

428

1644

Autoimmune diseases

1355

3776

1.84

82.84

1.6

1.4

63.60

64.60

mmol/l

0.32

1073

2975

Asthma (diagnoses ohter than nonallergic)

1149

5136

1.87

82.59

1.4

1.5

63.30

63.81

mmol/l

0.15

924

4062

Other or unspecified ileus, impaction or obstruction

358

1194

3.08

81.85

2.1

1.3

60.20

63.82

mmol/l

0.72

260

965

Intestinal stricture

554

2307

2.46

81.83

2.2

1.3

59.74

62.68

mmol/l

0.80

408

1856

Other chronic obstructive pulmonary disease, including avohilmo

845

3406

2.08

81.53

1.4

1.3

56.84

64.05

mmol/l

5.42

637

2725

Abdominal and pelvic pain

1212

3239

1.89

80.86

1.4

62.39

64.72

mmol/l

0.95

965

2579

Diabetes, varying definitions

1289

4158

1.83

80.68

1.5

1.4

59.93

64.92

mmol/l

3.83

1013

3290

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1383

4211

1.80

80.12

1.5

1.4

61.76

64.11

mmol/l

1.15

1109

3334

Implicit fungal Sepsis

176

366

5.07

80.02

1.6

1.3

59.24

62.51

mmol/l

0.43

147

296

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

253

689

3.76

79.88

1.5

1.4

54.63

63.71

mmol/l

1.93

171

547

Suicide or other Intentional self-harm

354

1188

3.04

79.81

1.5

1.4

55.11

64.27

mmol/l

2.95

245

940

Diabetes mellitus

1290

4165

1.83

79.69

1.5

1.4

59.99

64.87

mmol/l

3.69

1015

3294

Certain infectious and parasitic diseases

889

2130

2.11

79.37

1.4

61.41

66.69

mmol/l

2.51

700

1687

Insulin, fast-acting

561

2381

2.40

79.06

1.6

1.4

56.60

65.13

mmol/l

5.80

452

1877

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

871

4336

2.01

78.94

1.6

1.3

63.85

63.01

mmol/l

0.22

700

3436

Hypotension

371

1297

2.95

78.31

1.5

1.3

60.09

62.18

mmol/l

0.48

287

1032

Polyuria

377

1329

2.91

78.02

1.4

1.3

62.53

64.77

mmol/l

0.44

303

1070

Alcohol abuse, main dg

266

764

3.58

77.71

1.4

57.90

65.11

mmol/l

1.57

196

619

Other disorders of skin and subcutaneous tissue

986

4627

1.92

76.62

1.5

1.3

58.86

63.17

mmol/l

2.72

800

3660

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1224

4070

1.83

76.42

1.5

1.4

58.47

64.61

mmol/l

5.52

949

3220

Disorders of calcium metabolism

121

184

6.85

76.30

2.3

1.3

60.85

69.85

mmol/l

1.11

103

137

COPD, early/later onset

730

2927

2.14

75.64

1.4

1.3

56.46

64.01

mmol/l

5.43

553

2347

Heart failure and bmi 25plus

545

1515

2.48

75.43

1.4

1.3

57.70

63.83

mmol/l

2.75

411

1191

Neurological diseases, wide definition

312

437

3.62

75.03

1.4

1.7

67.81

67.39

mmol/l

0.04

268

330

Insulin, fast-acting or short human

565

2461

2.33

75.03

1.6

1.4

56.51

64.86

mmol/l

5.64

456

1935

Other reaction to severe stress, and adjustment disorders

429

1645

2.64

74.99

1.6

1.4

64.80

mmol/l

0.00

334

1284

Status epilepticus

114

168

7.26

74.54

1.6

1.4

71.05

70.85

mmol/l

0.01

131

Lower back pain or/and sciatica

1327

4966

1.76

74.38

1.4

62.42

62.90

mmol/l

0.15

1065

3899

Non-selective monoamine reuptake inhibitors

547

2271

2.36

74.03

1.5

1.3

58.05

63.34

mmol/l

2.35

421

1845

Diabetes medication

1303

4391

1.77

73.57

1.4

59.43

64.43

mmol/l

3.91

1024

3469

Nonorganic sleeping disorders, excluding more controls

246

695

3.60

73.42

1.6

1.3

59.23

66.26

mmol/l

1.69

194

556

Injuries to the thorax

673

3178

2.15

73.21

1.4

1.3

60.90

62.71

mmol/l

0.49

509

2527

Other diseases of the digestive system

550

2403

2.33

72.80

1.7

1.3

59.79

63.05

mmol/l

1.06

422

1914

Fracture of lumbar spine and pelvis

434

1703

2.61

72.78

1.5

1.3

61.60

61.73

mmol/l

0.02

343

1346

Dialysis

121

195

6.65

72.72

1.6

1.4

56.80

71.78

mmol/l

2.83

109

162

Neurological diseases

977

2516

1.97

72.66

1.4

1.5

65.15

62.82

mmol/l

0.75

799

1954

COPD, hospital admissions

716

2909

2.12

72.33

1.4

1.3

56.28

64.06

mmol/l

5.70

542

2336

COPD related to multimorbidity

647

2528

2.20

72.12

1.5

1.3

56.64

63.63

mmol/l

4.32

492

2042

Disorders of lens

894

2842

1.99

71.90

1.4

60.05

62.84

mmol/l

1.15

707

2239

Diabetes, insulin treatment (Kela reimbursement)

1304

4516

1.76

71.83

1.4

58.75

64.21

mmol/l

4.85

1010

3581

Heart failure and coronary heart disease

722

2449

2.13

71.07

1.4

1.3

57.62

62.21

mmol/l

2.45

591

1950

Diarrhoea and gastroenteritis of presumed infectious origin

1271

4810

1.76

70.94

1.7

1.4

61.82

64.29

mmol/l

1.12

1011

3800

GI-bleeding

547

2411

2.31

70.91

1.8

1.3

59.64

63.02

mmol/l

1.13

422

1916

Abnormal findings on diagnostic imaging of lung

744

3544

2.04

70.23

1.4

1.3

61.26

62.97

mmol/l

0.55

596

2822

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

517

2234

2.36

70.17

1.7

1.4

70.43

62.27

mmol/l

3.28

430

1778

Unspecified fall

742

3641

2.04

69.84

1.5

61.73

63.75

mmol/l

0.64

577

2898

Other CVD

394

1509

2.68

69.75

1.5

1.3

60.59

62.53

mmol/l

0.44

305

1205

Gastro-oesophageal reflux disease

881

3984

1.93

69.66

1.5

1.4

63.81

63.42

mmol/l

0.09

700

3162

Disorders of adult personality and behaviour

348

1247

2.83

69.56

1.5

1.4

54.32

64.88

mmol/l

4.64

258

968

Bipolar affective disorders

251

747

3.42

69.20

1.4

1.3

53.26

67.71

mmol/l

5.26

189

591

Fracture of rib(s), sternum and thoracic spine

491

2090

2.40

69.07

1.4

1.3

61.39

62.61

mmol/l

0.24

367

1670

Hypothyroidism, drug reimbursement

110

8.01

68.81

1.3

1.2

63.70

73.94

mmol/l

0.84

Codeine or tramadol medication

1377

4414

1.72

68.67

1.4

1.3

62.48

63.05

mmol/l

0.18

1066

3486

Insulin medication

841

3665

1.95

68.61

1.5

1.4

57.40

64.00

mmol/l

5.02

673

2903

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

804

4146

1.96

68.36

1.5

1.4

64.19

62.73

mmol/l

0.41

640

3293

Dysphagia

388

1487

2.66

68.28

1.5

1.3

59.99

65.85

mmol/l

1.83

305

1187

Pain in limb

1036

3794

1.84

68.05

1.4

61.87

63.57

mmol/l

0.62

848

2959

Episodal and paroxysmal disorders

1320

3879

1.74

68.03

1.5

64.85

62.47

mmol/l

1.06

1064

3027

Osteoporosis with pathological fracture (FG)

213

583

3.86

67.83

1.5

1.3

61.04

58.15

mmol/l

0.41

165

446

Symptoms and signs involving the nervous and musculoskeletal systems

802

4149

1.96

67.71

1.5

1.4

63.50

63.15

mmol/l

0.08

656

3284

Problems related to lifestyle

177

421

4.32

67.61

1.5

1.4

52.58

64.94

mmol/l

2.32

124

334

Personality disorders

332

1182

2.85

67.21

1.5

1.4

54.80

64.59

mmol/l

3.83

244

930

COPD, hospital admission 2, with asthma infections

533

2014

2.31

67.10

1.5

1.3

56.04

63.84

mmol/l

4.48

409

1617

Type 2 diabetes

1207

4032

1.76

66.61

1.4

59.67

64.15

mmol/l

3.06

948

3179

Type 1 diabetes

359

1339

2.72

66.37

1.7

1.5

56.76

66.99

mmol/l

5.06

299

1082

Gastrointestinal diseases

626

1402

2.25

65.88

1.5

1.4

64.24

68.02

mmol/l

1.04

496

1124

Symptoms and signs involving the circulatory and respiratory systems

1117

3100

1.82

65.83

1.4

1.5

64.78

64.82

mmol/l

0.01

879

2450

Recurrent or chronic depression

416

1134

2.61

65.43

1.5

1.3

59.25

65.85

mmol/l

2.14

308

922

Other acute lower respiratory infections

729

3535

1.99

64.13

1.7

1.5

61.55

63.92

mmol/l

0.91

589

2794

Type 1 diabetes, wide definition, subgroup 1

295

1015

2.96

63.60

1.7

1.5

56.51

67.18

mmol/l

4.82

250

828

Fungal Sepsis

114

198

6.13

63.48

2.0

1.3

60.77

60.50

mmol/l

0.02

165

Use of disulfiram, acamprosate or naltrexone

167

400

4.32

63.42

1.4

1.3

52.72

64.36

mmol/l

2.22

110

327

Accidents

940

2502

1.90

63.06

1.4

1.5

62.35

65.23

mmol/l

1.06

744

2001

Organic, including symptomatic, mental disorders

818

3050

1.94

62.84

1.4

1.3

62.47

61.69

mmol/l

0.21

650

2447

Hernia of abdominal wall, postoperative

246

768

3.26

62.84

2.1

1.3

56.69

65.36

mmol/l

2.52

179

632

Chronic lower respiratory diseases

1435

4630

1.66

62.84

1.4

1.5

62.55

64.35

mmol/l

0.77

1118

3665

Alcohol-induced chronic pancreatitis

145

314

4.84

62.80

1.6

1.3

51.29

65.26

mmol/l

3.00

109

251

Chronic pancreatitis

235

718

3.38

62.61

1.6

1.3

56.54

62.94

mmol/l

1.26

180

581

Other special examinations and investigations of persons without complaint or reported diagnosis

777

1962

2.02

62.60

1.4

66.53

62.89

mmol/l

1.21

615

1525

Other external causes of accidental injury

938

2502

1.89

62.53

1.4

1.5

61.99

65.23

mmol/l

1.28

737

2001

Vocal cord dysfunction

155

308

4.59

62.39

1.4

1.3

63.42

68.83

mmol/l

0.65

126

249

Insulin, intermediate and long-acting

771

3930

1.93

62.30

1.5

1.4

57.15

64.21

mmol/l

5.36

614

3112

Later onset COPD, excluding more controls

358

1039

2.72

61.96

1.4

1.3

58.92

63.14

mmol/l

1.17

288

817

Valvular heart disease excluding rheumatic fever

649

2276

2.09

61.63

1.4

61.28

65.26

mmol/l

1.64

535

1812

Non-rheumatic valve diseases

645

2257

2.09

61.49

1.4

61.12

65.15

mmol/l

1.70

531

1794

Continuous positive airway pressure

235

594

3.39

61.10

1.5

1.6

68.86

66.34

mmol/l

0.29

180

468

Insulin, combination of fast acting with intermediate-acting or long-acting

845

4202

1.86

60.27

1.5

1.4

57.42

63.96

mmol/l

5.09

675

3333

Other dialysis

100

162

6.68

60.00

1.6

1.3

56.92

69.86

mmol/l

1.97

137

External causes of morbidity and mortality

738

1836

2.03

60.00

1.4

1.5

65.60

65.41

mmol/l

0.04

593

1464

Senile cataract

819

2638

1.92

59.99

1.4

1.3

60.46

62.64

mmol/l

0.77

647

2090

Gastroduodenal ulcer

421

1783

2.40

59.56

1.6

1.3

58.88

62.30

mmol/l

0.98

310

1436

Other soft tissue disorders, not elsewhere classified

1135

3862

1.74

59.54

1.4

1.5

62.62

64.04

mmol/l

0.50

925

3009

Nontraumatic intracranial haemmorrhage

368

1472

2.56

59.54

1.5

1.3

82.79

61.30

mmol/l

11.14

304

1163

Glomerular diseases

306

1124

2.79

58.82

1.6

1.4

51.65

65.13

mmol/l

8.20

257

905

Schizophrenia

241

778

3.17

58.38

1.4

53.73

64.31

mmol/l

3.27

168

616

Panhypopituitarism

9.60

58.38

2.3

1.4

82.91

67.37

mmol/l

1.34

COPD, hospital admissions 3, with asthma pneumonia sepsis

454

1696

2.33

58.32

1.5

1.3

56.41

63.75

mmol/l

3.44

356

1365

Presence of other functional implants

845

3173

1.87

58.28

1.4

1.3

62.39

62.64

mmol/l

0.06

687

2527

Ischaemic Stroke, excluding all haemorrhages

834

3364

1.87

58.22

1.3

63.45

61.82

mmol/l

0.50

659

2692

Superficial injury of head

371

1507

2.51

57.91

1.4

61.39

62.93

mmol/l

0.27

290

1174

Invasive ventilation

163

412

4.13

57.83

1.7

1.5

60.64

64.32

mmol/l

0.40

121

336

Implicit fungal Sepsis

104

181

6.11

57.82

1.7

1.3

58.22

60.61

mmol/l

0.21

149

Supplementary factors related to causes of morbidity and mortality classified elsewhere

449

1986

2.30

57.76

1.6

1.4

62.83

63.36

mmol/l

0.08

347

1576

Injuries to the hip and thigh

713

3378

1.94

57.53

1.5

1.4

58.87

63.21

mmol/l

2.32

559

2700

574

2776

2.08

57.39

1.5

62.77

64.73

mmol/l

0.54

466

2188

1364

4311

1.65

57.25

1.5

1.4

62.62

63.29

mmol/l

0.23

1111

3384

Ischemic heart diseases

1058

3673

1.75

56.82

1.4

62.16

63.30

mmol/l

0.36

840

2874

Other arrhythmias

731

2885

1.93

56.74

1.4

62.95

64.62

mmol/l

0.46

605

2264

Diseases of arteries, arterioles and capillaries

955

4016

1.78

56.57

1.4

58.97

62.83

mmol/l

2.14

738

3211

Fracture of skull and facial bones

301

1118

2.74

56.42

1.5

1.3

62.31

64.25

mmol/l

0.29

230

878

Dermatitis

789

4295

1.85

56.37

1.4

61.52

63.72

mmol/l

0.70

608

3421

Early onset COPD

343

1362

2.57

56.32

1.5

1.3

53.18

65.69

mmol/l

6.05

241

1085

Any event in cancer register

1071

3672

1.73

55.72

1.4

63.26

63.92

mmol/l

0.17

845

2887

Diseases of the myoneural junction and muscle

240

798

3.10

55.60

1.5

1.4

57.21

64.19

mmol/l

1.63

176

642

Type 1 diabetes, wide definition

303

1137

2.71

55.51

1.7

1.5

56.58

66.57

mmol/l

4.53

255

918

Diseases of the respiratory system

743

1909

1.97

55.40

1.5

1.3

63.19

64.71

mmol/l

0.38

594

1509

Other and unspecified myopathies

192

561

3.56

55.15

1.5

1.3

53.78

63.35

mmol/l

2.24

134

449

Diverticular disease of intestine

908

3246

1.80

55.10

1.4

1.3

60.07

63.31

mmol/l

1.54

712

2579

Sequelae of cerebrovascular disease

564

2378

2.08

54.89

1.4

1.3

71.01

61.48

mmol/l

4.81

447

1910

Type of accident

419

1841

2.31

54.81

1.6

1.4

63.67

63.63

mmol/l

0.01

323

1461

Polyneuropathies and other disorders of the peripheral nervous system

359

1477

2.49

54.74

1.5

1.3

59.30

63.85

mmol/l

1.40

293

1183

Specific personality disorders

279

1015

2.79

54.36

1.5

1.4

55.92

64.94

mmol/l

2.79

206

793

Bronchitis

1282

4993

1.63

53.90

1.5

1.4

61.21

63.71

mmol/l

1.32

1025

3935

severe traumatic brain injury, does not include concussion

374

1580

2.42

53.74

1.5

1.3

69.69

61.86

mmol/l

2.36

298

1262

Genitourinary diseases

629

1538

2.07

53.72

1.6

1.5

63.27

69.50

mmol/l

2.29

501

1217

Other degenerative diseases of the nervous system

378

1165

2.46

53.41

1.5

1.3

61.16

61.21

mmol/l

0.01

299

916

Hypothyreosis and Thyroxine purchase for inclusion criteria

1108

4352

1.68

53.32

1.5

1.4

65.72

62.73

mmol/l

1.37

892

3450

Hypothyroidism, other/unspecified

1066

4156

1.70

53.27

1.5

1.4

65.46

62.75

mmol/l

1.15

860

3294

Aneurysms, operations, SAH

281

1041

2.77

53.21

1.5

1.3

83.28

62.26

mmol/l

7.86

232

825

Dorsalgia

1128

3594

1.69

53.13

1.4

64.59

63.45

mmol/l

0.35

916

2814

All influenza

351

1446

2.47

53.11

1.8

1.3

63.99

64.89

mmol/l

0.15

281

1160

Benign neoplasm: Pituitary gland, craniopharyngeal duct

124

272

4.78

52.98

1.7

1.3

82.29

63.76

mmol/l

2.98

111

223

Neuromuscular dysfunction of bladder

166

452

3.79

52.84

1.6

1.3

60.09

64.02

mmol/l

0.57

132

369

Exclusions for E4_PCOS_CONSORTIUM

875

3070

1.80

52.79

1.7

1.4

67.12

62.51

mmol/l

1.97

705

2412

Infections of the skin and subcutaneous tissue

692

3667

1.89

52.77

1.7

1.4

60.41

65.21

mmol/l

2.16

524

2886

Hypothyroidism, strict autoimmune

835

3047

1.82

52.48

1.5

1.3

62.17

63.19

mmol/l

0.28

671

2412

Factors influencing health status and contact with health services

338

632

2.71

51.88

1.4

1.3

64.35

63.93

mmol/l

0.05

276

494

Generalized anxiety disorder

182

533

3.47

51.56

1.7

1.3

62.01

65.91

mmol/l

0.49

139

422

Spondylopathies

970

3361

1.74

51.45

1.4

60.68

62.34

mmol/l

0.60

775

2622

Cough

516

2379

2.08

51.31

1.4

1.5

61.37

63.77

mmol/l

0.66

403

1902

Lung cancer and mesothelioma

284

907

2.73

51.13

1.3

64.77

63.25

mmol/l

0.22

218

730

Pleural effusion

274

1026

2.74

50.89

1.5

1.3

57.38

62.90

mmol/l

1.52

205

835

Glomerular disorders in diseases classified elsewhere

211

686

3.17

50.81

1.6

1.4

49.42

65.94

mmol/l

8.79

177

548

L04AA Selective immunosuppressants

324

1317

2.51

50.63

1.6

1.4

58.35

64.96

mmol/l

2.00

268

1055

Disorders of thyroid, IBD co-morbidities

178

341

3.71

50.40

1.4

1.3

66.97

63.51

mmol/l

0.39

147

253

Persons encountering health services for examination and investigation

739

1962

1.90

50.30

1.4

64.75

62.89

mmol/l

0.49

592

1525

Candidiasis

396

1765

2.28

50.12

1.7

1.4

61.46

63.38

mmol/l

0.37

316

1413

Acute bronchitis

568

2841

1.98

50.07

1.6

1.4

61.57

63.65

mmol/l

0.64

444

2250

Spinal stenosis

711

2923

1.87

50.05

1.4

1.3

59.30

61.32

mmol/l

0.72

573

2302

Bacterial pneumoniae

529

2305

2.05

50.01

1.5

1.3

60.10

64.09

mmol/l

1.40

419

1850

Other and unspecified dermatitis

665

3582

1.88

49.88

1.4

61.31

63.98

mmol/l

0.84

522

2848

Unspecified haematuria

553

2299

2.02

49.69

1.5

1.3

57.09

64.63

mmol/l

4.43

437

1849

Abnormalities of heart beat

450

2072

2.15

49.67

1.4

1.3

62.55

63.66

mmol/l

0.21

367

1649

Mental and behavioural disorders due to sedatives or hypnotics

127

298

4.41

49.64

1.8

1.3

48.11

62.10

mmol/l

2.78

244

Liquid cancers, helper endpoint

549

2409

2.02

49.45

1.3

1.4

59.53

64.30

mmol/l

1.94

446

1926

Other symptoms and signs involving the urinary system

184

560

3.38

49.40

1.3

60.38

65.59

mmol/l

1.00

148

459

Postmenopausal osteoporosis with pathological fracture

178

535

3.51

49.37

1.6

1.3

58.46

58.69

mmol/l

0.02

138

426

Other and unspecified polyneuropathies, also in other diseases

316

1291

2.50

49.03

1.5

1.3

56.71

64.08

mmol/l

3.18

255

1038

Disorders of gallbladder, biliary tract and pancreas

1197

4703

1.62

48.94

1.5

1.4

61.72

62.99

mmol/l

0.45

921

3731

Diseases of the skin and subcutaneous tissue

1151

3522

1.65

48.59

1.4

60.57

65.22

mmol/l

2.90

889

2810

Fracture of femur

472

2060

2.12

48.52

1.5

1.3

57.29

62.14

mmol/l

2.11

372

1650

Malignant neoplasm, wide definition for exclusion

1012

3537

1.69

48.44

1.4

62.99

63.95

mmol/l

0.25

781

2795

Disorders of the thyroid gland

1100

4393

1.64

48.23

1.5

1.4

66.28

62.89

mmol/l

1.66

889

3467

Polyarthropathies

826

3062

1.78

48.21

1.4

63.20

62.91

mmol/l

0.06

644

2392

Cirrhosis of liver, NAS

126

302

4.38

48.20

1.4

1.3

47.31

63.06

mmol/l

4.34

250

Percutaneous Coronary Intervention

986

3597

1.70

48.02

1.4

61.39

63.22

mmol/l

0.66

789

2817

Bacterial pneumonia, not elsewhere classified

505

2194

2.05

48.01

1.4

1.3

60.00

64.21

mmol/l

1.45

399

1760

Pneumonitis due to solids and liquids

170

502

3.50

48.01

1.7

1.3

65.66

62.94

mmol/l

0.29

134

399

Gastric ulcer

296

1185

2.55

47.90

1.6

1.3

58.35

62.38

mmol/l

0.98

217

949

Missing teeth due to accident, extraction or parodontitis

798

4322

1.76

47.80

1.4

1.3

61.87

62.20

mmol/l

0.08

601

3456

Peripheral artery disease

670

2888

1.87

47.74

1.4

1.3

55.92

62.51

mmol/l

4.19

516

2324

Major coronary heart disease event

1062

3910

1.65

46.96

1.4

61.56

63.09

mmol/l

0.54

846

3057

Sequelae of external causes of morbidity and mortality

387

1759

2.24

46.85

1.7

1.4

61.26

63.22

mmol/l

0.38

316

1400

Paroxysmal tachycardia

214

600

3.02

46.41

1.5

58.70

70.28

mmol/l

3.20

173

469

Type 2 diabetes, definitions combined

1097

3965

1.64

46.41

1.4

60.65

63.86

mmol/l

1.64

849

3131

Ulcer of lower limb, not elsewhere classified

258

986

2.69

46.11

1.3

56.75

63.06

mmol/l

1.75

212

782

Transient ischemic attack

738

3371

1.79

46.02

1.4

62.33

61.89

mmol/l

0.11

601

2707

Other metabolic disorders

139

367

3.85

46.02

1.5

1.2

61.68

71.51

mmol/l

1.85

122

282

Malignant neoplasm

984

3496

1.68

45.94

1.4

61.89

63.98

mmol/l

0.70

769

2761

Nerve, nerve root and plexus disorders

1246

4871

1.58

45.82

1.4

62.02

62.84

mmol/l

0.27

1000

3821

Coronary revascularization (ANGIO or CABG)

977

3598

1.68

45.75

1.4

61.59

63.22

mmol/l

0.57

782

2818

Asthma/COPD (KELA code 203)

1084

4623

1.62

45.38

1.4

1.5

62.55

64.40

mmol/l

0.72

883

3658

Iron deficiency anaemia secondary to blood loss (chronic)

274

1086

2.58

45.38

1.7

1.3

59.70

62.71

mmol/l

0.59

211

880

Type 2 diabetes, strict (exclude DM1)

1099

4002

1.62

45.16

1.4

60.65

63.73

mmol/l

1.55

851

3161

Other dorsopathies, not elsewhere classified

1115

3608

1.63

45.15

1.4

64.53

63.60

mmol/l

0.27

904

2826

Fibrosis and cirrhosis of liver

160

475

3.50

44.94

1.4

51.76

61.71

mmol/l

2.31

110

386

Dermatitis and eczema

1283

5140

1.56

44.76

1.4

61.96

63.95

mmol/l

0.86

991

4087

Neoplasms

745

2189

1.81

44.65

1.5

1.6

68.01

66.41

mmol/l

0.35

591

1719

Pain (limb, back, neck, head abdominally)

817

2329

1.77

44.38

1.4

1.5

64.08

65.51

mmol/l

0.36

661

1822

Emergency coronary revascularization (for ACS)

1086

4121

1.62

43.94

1.4

61.64

62.85

mmol/l

0.42

869

3215

Subarachnoid haemorrhage

190

634

3.09

43.83

1.7

1.3

91.34

62.57

mmol/l

8.70

155

509

Acidosis

9.56

43.81

1.9

1.2

69.32

71.55

mmol/l

0.09

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

354

1576

2.26

43.69

1.3

61.18

65.13

mmol/l

0.95

265

1261

Postprocedural disorders of digestive system, not elsewhere classified

178

5.37

43.64

5.7

1.3

77.97

63.55

mmol/l

1.66

149

Unspecified kidney failure

194

659

3.03

43.40

1.6

1.4

53.94

63.76

mmol/l

2.64

157

522

Other cataract

564

2247

1.92

43.34

1.5

1.4

58.89

62.78

mmol/l

1.48

467

1791

Mycoses

371

1713

2.20

43.19

1.6

1.4

62.36

64.35

mmol/l

0.37

296

1370

Type 2 diabetes, definitions combined, including avohilmo

1085

3949

1.61

43.17

1.4

60.87

63.80

mmol/l

1.40

831

3130

Ischaemic heart disease, wide definition

969

3668

1.65

42.88

1.4

1.3

59.79

62.62

mmol/l

1.28

776

2861

Viral hepatitis, IBD co-morbidity

7.06

42.84

1.6

1.2

49.50

66.20

mmol/l

1.22

Emotionally unstable personality disorder

137

377

3.70

42.76

1.6

1.4

56.38

65.78

mmol/l

1.45

100

310

Other bacterial intestinal infections

329

1461

2.29

42.16

1.8

1.3

59.54

63.90

mmol/l

1.11

266

1144

Total colectomy operation

196

4.97

41.76

3.3

1.3

60.47

63.40

mmol/l

0.14

168

Total colectomy

196

4.97

41.76

3.3

1.3

60.47

63.40

mmol/l

0.14

168

Other headache syndromes

484

2489

1.96

41.75

1.5

1.4

63.30

62.35

mmol/l

0.20

411

1929

Postprocedural endocrine and metabolic disorders, not elsewhere classified

127

338

3.82

41.62

1.5

1.2

61.31

70.86

mmol/l

1.66

111

261

Other bacterial intestinal infections

280

1168

2.44

41.52

1.9

1.3

58.96

63.80

mmol/l

1.13

229

918

Coronary atherosclerosis

834

3133

1.70

41.43

1.4

1.3

58.70

62.52

mmol/l

1.98

669

2449

Persons encountering health services for specific procedures, not carried out

126

336

3.84

41.33

2.1

1.4

64.88

65.38

mmol/l

0.03

265

Other symptoms and signs involving the nervous and musculoskeletal systems

514

2713

1.92

41.19

1.4

64.52

63.49

mmol/l

0.21

420

2131

Disorders of choroid and retina

1014

4535

1.60

40.93

1.4

60.92

62.58

mmol/l

0.65

832

3563

Other diseases of the respiratory system

322

1439

2.28

40.76

1.5

1.4

62.48

62.63

mmol/l

0.02

244

1161

Other respiratory disorders and diseases

322

1439

2.28

40.76

1.5

1.4

62.48

62.63

mmol/l

0.02

244

1161

Follow-up examination after treatment for conditions other than malignant neoplasms

491

1649

1.99

40.69

1.5

1.3

59.23

62.93

mmol/l

1.23

404

1287

Autoimmune diseases related-to ILD

971

5227

1.60

40.36

1.6

1.4

61.31

63.44

mmol/l

0.81

734

4142

Respiratory insufficiency

134

379

3.62

40.16

1.7

1.3

64.17

63.37

mmol/l

0.06

310

Other gastritis (incl. Duodenitis)

321

1441

2.26

40.13

1.5

1.3

55.36

63.94

mmol/l

3.28

240

1149

Acute and transient psychotic disorders

171

568

3.08

39.66

1.4

57.07

65.95

mmol/l

1.58

117

447

Leisure time condition

269

1127

2.43

39.53

1.6

1.4

64.36

64.24

mmol/l

0.01

206

914

Atherosclerosis, excluding cerebral and coronary sclerosis

612

2710

1.81

39.37

1.4

1.3

55.86

62.28

mmol/l

3.68

472

2182

Other noninfective gastroenteritis and colitis

346

1613

2.18

39.28

2.1

1.4

62.00

64.84

mmol/l

0.57

274

1294

Other (not insulin) diabetes medications

1108

4229

1.56

39.24

1.3

1.4

59.91

63.63

mmol/l

2.11

861

3337

Diseases of the eye and adnexa

778

2268

1.73

39.16

1.5

65.40

65.05

mmol/l

0.07

636

1760

Other diseases of blood and blood-forming organs, wide

322

1465

2.24

39.02

1.6

1.4

63.92

64.32

mmol/l

0.06

253

1181

Disorder of lipoprotein metabolism, unspecified

146

445

3.34

39.01

1.5

1.2

55.73

68.98

mmol/l

3.88

121

338

Benign neoplasm of other and unspecified endocrine glands

216

823

2.69

38.91

1.6

1.3

72.77

62.93

mmol/l

2.17

190

669

Diabetic nephropathy, excluding more controls

230

728

2.66

38.89

1.5

1.3

50.25

62.27

mmol/l

5.55

192

566

Bacterial pneumonia (organism specified)

579

2919

1.82

38.77

1.5

1.4

60.68

63.39

mmol/l

0.86

463

2319

Artificial opening status

116

307

3.94

38.76

3.2

1.4

69.71

63.07

mmol/l

0.58

246

Noninfective enteritis and colitis

556

3067

1.83

38.61

2.0

1.4

63.27

64.00

mmol/l

0.14

412

2450

Preparatory care for dialysis

102

247

4.34

38.60

1.5

1.3

55.45

64.51

mmol/l

1.63

204

Undetermined asthma, excluding more controls

158

509

3.16

38.48

1.4

1.3

64.47

67.89

mmol/l

0.46

121

404

Viral pneumonia

183

643

2.90

38.38

2.4

1.3

61.85

65.03

mmol/l

0.44

152

524

COPD, hospital admissions 1, only main diagnosis

493

2234

1.92

38.35

1.4

1.3

56.50

63.66

mmol/l

3.72

377

1790

Sequelae with surgical and medical care as external cause

305

1372

2.27

38.05

1.6

1.3

60.96

63.39

mmol/l

0.45

251

1093

Attention to artificial openings

204

4.67

37.95

3.3

1.3

64.90

mmol/l

0.00

164

Sub-endpoint used in defining T1D endpoints

375

1801

2.07

37.60

1.7

1.4

56.82

64.97

mmol/l

3.87

314

1424

Acute pancreatitis

281

1228

2.33

37.51

1.5

1.3

60.55

63.54

mmol/l

0.48

202

989

Asthma, hospital admissions , main diagnosis only

932

5222

1.58

37.47

1.4

1.5

63.74

63.66

mmol/l

0.02

752

4121

Extracorporeal dialysis

121

338

3.72

37.38

1.5

1.4

59.79

65.18

mmol/l

0.77

103

276

Intracerebral haemorrhage

216

841

2.63

37.23

1.5

1.3

79.40

61.31

mmol/l

5.36

178

665

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

151

485

3.20

37.23

1.6

1.4

56.79

63.61

mmol/l

1.30

121

387

Candidiasis

210

809

2.65

36.97

1.9

1.3

60.61

64.23

mmol/l

0.56

170

651

Panic disorder

156

511

3.10

36.94

1.6

1.3

59.34

64.34

mmol/l

0.60

115

407

Fracture of shoulder and upper arm

502

2726

1.86

36.85

1.6

1.4

57.98

63.79

mmol/l

2.73

402

2159

Injury, poisoning and certain other consequences of external causes

559

1503

1.88

36.79

1.4

1.5

64.20

66.09

mmol/l

0.41

454

1199

Nonorganic sleeping disorders

246

1022

2.44

36.76

1.6

1.4

59.23

65.36

mmol/l

1.45

194

818

COPD-related respiratory insufficiency

201

762

2.71

36.64

1.5

1.3

55.08

63.41

mmol/l

1.93

152

614

Asthma, including avohilmo

1318

5005

1.49

36.62

1.4

1.5

63.93

63.63

mmol/l

0.09

1044

3951

Solid cancers, helper endpoint

931

3461

1.60

36.18

1.4

60.99

63.86

mmol/l

1.10

725

2727

Other symptoms and signs involving the digestive system and abdomen

228

923

2.51

36.10

1.6

1.4

59.70

65.33

mmol/l

1.06

179

734

Benign neoplasms

1034

3668

1.56

36.01

1.4

65.00

64.05

mmol/l

0.27

817

2873

Familial hypercholesterolemia

161

546

3.00

35.94

1.3

1.2

64.78

66.86

mmol/l

0.27

137

411

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

275

1216

2.31

35.81

1.3

61.21

64.15

mmol/l

0.46

189

972

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

234

4.20

35.69

1.6

1.3

47.66

64.30

mmol/l

2.53

198

Hypothyroidism, strict autoimmune, 3 medication purchases required

947

4094

1.57

35.25

1.4

61.92

62.42

mmol/l

0.13

760

3243

KRA_PSY_EATING, excluding more controls

147

5.08

35.02

2.3

1.7

63.15

73.28

mmol/l

0.74

131

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

133

273

3.51

34.85

1.5

1.3

64.69

64.08

mmol/l

0.05

118

201

Other retinal disorders

821

4000

1.61

34.75

1.4

1.3

60.88

62.90

mmol/l

0.74

673

3159

Schizoaffective disorder

114

321

3.64

34.63

1.4

49.93

64.14

mmol/l

3.44

266

Malnutrition

126

5.72

34.56

1.6

64.69

66.32

mmol/l

0.10

104

Mental and behavioural disorders due to tobacco

139

445

3.21

34.50

1.6

1.4

53.76

66.09

mmol/l

2.72

366

Spondylosis

651

3140

1.70

34.46

1.4

1.3

62.18

61.97

mmol/l

0.05

533

2459

Disorders of eyelid, lacrimal system and orbit

990

4912

1.54

34.38

1.4

62.26

63.21

mmol/l

0.30

814

3874

Other pleural conditions

179

663

2.77

34.20

1.6

1.4

54.85

62.79

mmol/l

2.01

139

529

Hepatic failure, not elsewhere classified

209

4.42

34.19

1.5

1.3

50.51

63.56

mmol/l

2.03

171

Lung diseases due to external agents

222

915

2.48

33.96

1.6

1.3

63.99

63.04

mmol/l

0.11

173

732

Smoking dependency

139

450

3.17

33.87

1.6

1.4

53.76

66.30

mmol/l

2.80

370

Dipeptidyl peptidase 4 (DPP-4) inhibitors

734

3606

1.65

33.81

1.3

1.4

58.21

62.58

mmol/l

2.30

571

2880

Acute pancreatitis (for exclusion)

281

1286

2.22

33.64

1.5

1.3

60.55

63.74

mmol/l

0.52

202

1031

Bacterial intestinal infections, IBD co-morbidities

276

1258

2.23

33.41

1.9

1.4

58.06

63.85

mmol/l

1.52

226

994

Intestinal adhesions without obstruction

144

481

3.08

33.27

1.9

1.3

58.08

62.89

mmol/l

0.53

107

403

Vascular disorders of the intestines

127

396

3.31

33.00

1.5

1.3

61.02

62.31

mmol/l

0.13

100

320

Other disorders of glucose regulation and pancreatic internal secretion

143

478

3.07

32.99

1.7

1.4

59.53

66.01

mmol/l

0.95

118

387

Other diseases of anus and rectum

384

1981

1.96

32.94

1.5

1.3

59.21

64.67

mmol/l

1.80

295

1596

Symptoms and signs involving the skin and subcutaneous tissue

802

4985

1.59

32.88

1.4

61.62

63.42

mmol/l

0.60

640

3946

Drug-induced adrenocortical insufficiency

6.57

32.75

1.9

1.6

75.31

66.45

mmol/l

0.61

Sciatica+with lumbago

565

3020

1.74

32.62

1.4

62.89

62.53

mmol/l

0.07

455

2353

Peripheral arterial reconstruction

273

1253

2.22

32.56

1.4

1.3

54.08

62.31

mmol/l

2.92

204

1016

Undetermined asthma

158

563

2.85

32.27

1.4

1.3

64.47

65.55

mmol/l

0.12

121

454

Manic episode

101

5.97

32.15

1.4

1.3

56.34

64.81

mmol/l

0.82

141

475

3.05

32.12

1.4

1.3

55.00

65.91

mmol/l

1.93

381

Abnormal findings on examination of blood, without diagnosis

575

3099

1.72

32.06

1.4

59.48

64.08

mmol/l

1.95

467

2465

Enterocolitis due to Clostridium difficile

188

738

2.61

32.01

1.8

1.3

58.39

62.49

mmol/l

0.70

150

583

Chronic gastritis

379

1982

1.94

31.53

1.4

1.3

61.78

62.64

mmol/l

0.15

291

1578

Other and unspecified drugs and medicaments

143

491

2.99

31.51

1.6

1.4

57.10

63.01

mmol/l

1.10

115

389

Other/unspecified dorsalgia

436

2361

1.85

31.49

1.5

1.4

60.71

62.25

mmol/l

0.33

358

1841

Inflammatory diseases of the central nervous system

135

456

3.04

30.61

1.4

1.3

71.08

62.27

mmol/l

1.18

104

361

Explicit bacterial Sepsis

148

526

2.87

30.51

1.6

1.3

58.96

65.94

mmol/l

1.12

110

419

Mixed and other personality disorders

102

291

3.58

30.38

1.5

1.3

53.63

66.77

mmol/l

2.26

241

Other disorders of bladder

161

600

2.74

30.35

1.4

1.3

64.52

64.90

mmol/l

0.04

120

487

Unknown and unspecified causes of morbidity

250

3.80

30.24

1.6

1.3

58.26

62.88

mmol/l

0.54

192

Injuries to the shoulder and upper arm

960

5174

1.50

30.21

1.5

1.4

61.31

63.24

mmol/l

0.73

776

4066

Amputation

170

654

2.66

30.16

1.4

1.3

54.88

63.19

mmol/l

2.04

135

531

Injuries to the elbow and forearm

797

4519

1.56

30.14

1.5

1.4

62.05

63.61

mmol/l

0.49

632

3585

Persistent mood disorders

237

1059

2.27

30.08

1.5

1.3

54.73

63.94

mmol/l

2.96

179

840

Alcohol-induced acute pancreatitis

158

4.68

29.92

1.5

1.3

57.60

62.32

mmol/l

0.29

132

Biguanides

1071

4431

1.48

29.86

1.3

1.4

60.10

63.01

mmol/l

1.39

823

3509

Cellulitis

280

1341

2.12

29.86

1.5

1.4

59.46

64.16

mmol/l

1.01

211

1074

Coagulation defects, purpura and other haemorrhagic conditions

257

1194

2.19

29.69

1.6

1.4

62.43

65.12

mmol/l

0.41

197

967

Other intervertebral disc disorders

879

3449

1.54

29.66

1.4

64.70

62.59

mmol/l

0.69

694

2690

Dorsopathies

1064

3642

1.49

29.65

1.4

1.5

64.19

63.83

mmol/l

0.09

850

2858

Cutaneous abscess, furuncle and carbuncle

298

1464

2.06

29.63

1.6

1.4

61.33

64.80

mmol/l

0.71

218

1163

Mycoses

915

5310

1.51

29.47

1.5

1.4

61.37

63.62

mmol/l

0.86

733

4178

Benign neoplasm of colon, rectum, anus and anal canal

795

4488

1.55

29.07

1.4

1.3

60.37

62.29

mmol/l

0.71

631

3570

Hypoglycaemia, other or unspecified

114

360

3.25

29.04

1.8

1.4

60.95

67.13

mmol/l

0.71

295

Hypocalcemia

109

5.54

28.80

1.6

1.3

64.04

61.10

mmol/l

0.16

Other problems related to primary support group, including family circumstances

133

446

2.95

28.79

2.7

1.8

74.37

66.18

mmol/l

1.00

115

377

Other diseases of liver

234

1061

2.24

28.75

1.5

1.4

58.27

64.60

mmol/l

1.37

182

852

Periodontitis

1071

4919

1.46

28.66

1.3

1.4

64.00

62.34

mmol/l

0.58

842

3879

Volvulus

129

5.04

28.38

1.9

1.2

58.87

61.76

mmol/l

0.19

107

Oesophageal varices

235

3.86

28.38

1.4

1.3

49.78

66.38

mmol/l

3.14

194

Assault

142

513

2.81

28.35

1.6

1.4

62.70

65.82

mmol/l

0.25

414

Suppurative and necrotic conditions of lower respiratory tract

101

301

3.47

28.33

1.6

1.3

54.88

65.54

mmol/l

1.76

245

Visual disturbances and blindness

617

3825

1.63

28.24

1.5

1.4

66.45

62.70

mmol/l

1.28

511

3028

Psychotic depression

213

3.93

28.03

1.4

1.3

52.69

64.39

mmol/l

1.93

175

Chronic periodontitis, including avohilmo

1064

4919

1.46

27.86

1.3

1.4

63.81

62.39

mmol/l

0.47

837

3877

Paralytic ileus

180

4.27

27.83

2.5

1.3

63.32

65.17

mmol/l

0.11

146

Insulin, fast-acting (human)

169

673

2.55

27.82

1.4

55.31

65.80

mmol/l

3.13

141

532

Phobic anxiety disorders

118

389

3.06

27.67

1.6

1.5

58.40

66.81

mmol/l

1.07

324

Traumatic subarachnoid haemorrhage

160

4.47

27.59

1.4

1.2

76.41

63.78

mmol/l

1.15

123

Functional dyspepsia

309

1581

1.98

27.45

1.5

1.3

59.62

63.99

mmol/l

1.06

259

1246

Amyloidosis

7.26

27.35

1.5

1.2

52.52

68.50

mmol/l

1.68

Diagnoses used for exclusion with ILD

335

1767

1.92

27.25

1.5

1.3

64.07

62.94

mmol/l

0.18

268

1400

Mental and behavioural disorders due to opioids

5.50

27.23

2.0

1.3

68.05

69.86

mmol/l

0.06

Noninfectious colitis NAS

191

817

2.38

26.99

2.2

1.4

56.95

64.49

mmol/l

1.41

158

664

Myalgia

270

1325

2.06

26.98

1.3

1.4

64.81

63.15

mmol/l

0.25

222

1028

Colectomy operation

246

1169

2.14

26.95

2.2

1.3

56.89

63.13

mmol/l

1.22

154

955

Degeneration of nervous system due to alcohol

120

5.13

26.86

2.0

1.3

56.20

62.26

mmol/l

0.39

Major coronary heart disease event excluding revascularizations

746

3213

1.56

26.83

1.4

1.3

59.52

62.41

mmol/l

1.13

588

2526

Presence of cardiac and vascular implants and grafts

571

2586

1.66

26.83

1.4

1.3

60.79

62.49

mmol/l

0.49

461

2071

Other mental disorders due to brain damage and dysfunction and to physical disease

191

821

2.38

26.81

1.5

1.3

60.25

60.92

mmol/l

0.07

146

656

Obesity related asthma

381

2103

1.83

26.78

1.4

62.99

63.75

mmol/l

0.13

300

1669

Agranulocytosis

170

695

2.50

26.64

1.8

1.4

66.83

63.82

mmol/l

0.40

125

565

Fall on and from stairs and steps

326

1718

1.92

26.60

1.4

58.65

63.90

mmol/l

1.41

241

1374

Hernia

1037

4815

1.45

26.57

1.6

1.4

61.00

63.04

mmol/l

0.82

812

3801

Degeneration of the brain due to alcohol

122

5.05

26.35

2.0

1.3

56.20

62.32

mmol/l

0.40

101

Speech disturbances, not elsewhere classified

152

593

2.63

26.34

1.6

1.3

67.31

61.37

mmol/l

0.78

122

471

Any dementia, excluding more controls

475

1901

1.74

26.24

1.3

63.51

62.00

mmol/l

0.37

387

1548

Diseases of peritoneum

158

629

2.57

26.21

1.6

1.3

56.46

63.16

mmol/l

1.38

117

507

Cardiomyopathy

218

998

2.22

26.18

1.6

1.3

60.91

65.41

mmol/l

0.80

169

798

Visual disturbances

560

3458

1.63

26.16

1.5

1.4

66.27

63.02

mmol/l

0.97

464

2738

Acute peritonitis

111

368

3.11

26.14

1.8

1.4

54.02

63.29

mmol/l

1.59

293

L04AX Other immunosuppressants

606

3812

1.60

26.13

1.6

1.4

64.98

63.81

mmol/l

0.27

487

3016

Other disorders of skin and subcutaneous tissue, not elsewhere classified

204

911

2.28

26.10

1.6

1.3

53.68

64.80

mmol/l

4.01

158

737

Viral infections characterized by skin and mucous membrane lesions

480

2849

1.70

26.08

1.4

62.59

63.96

mmol/l

0.33

391

2246

Dental operations

742

2446

1.57

26.04

1.4

1.3

63.33

62.72

mmol/l

0.14

617

1927

Other systemic involvement of connective tissue (FG)

336

1776

1.89

26.03

1.5

1.4

61.86

62.06

mmol/l

0.03

280

1388

Migraine

444

2075

1.75

25.92

1.5

66.50

64.18

mmol/l

0.45

359

1609

Peripheral artery operations in Hilmo

190

827

2.34

25.81

1.3

53.83

63.30

mmol/l

2.92

144

667

Disorders resulting from impaired renal tubular function

200

3.97

25.78

1.4

1.3

57.84

65.96

mmol/l

1.03

162

Other complications of surgical and medical care, not elsewhere classified

139

524

2.71

25.72

2.3

1.4

66.32

63.58

mmol/l

0.28

111

427

Fracture of lower leg, including ankle

628

3959

1.58

25.69

1.4

60.18

63.18

mmol/l

1.08

487

3129

Streptococcal septicaemia

128

463

2.83

25.67

1.6

1.4

59.54

65.23

mmol/l

0.73

376

Weight loss

159

644

2.53

25.47

1.6

1.4

65.24

63.90

mmol/l

0.13

126

515

Enlarged lymph nodes

157

630

2.52

25.44

1.4

64.21

66.43

mmol/l

0.26

119

498

Second line medication for Crohn's disease

615

3908

1.58

25.41

1.5

1.4

65.16

63.87

mmol/l

0.31

494

3090

Other general symptoms and signs

164

4.20

25.35

1.7

2.3

67.94

66.14

mmol/l

0.09

133

Abnormal weight loss

150

593

2.59

25.31

1.6

1.4

63.56

62.80

mmol/l

0.07

119

472

Decubitus ulcer and pressure area

116

403

2.97

25.20

1.6

1.3

49.71

61.91

mmol/l

2.97

316

Other and unspecified injuries of head

113

387

3.00

25.10

1.5

1.4

59.13

63.55

mmol/l

0.47

306

Conduction disorders

359

1594

1.84

25.03

1.4

1.3

57.96

65.00

mmol/l

2.59

279

1269

Diseases of oral cavity, salivary glands and jaws

710

2343

1.57

24.98

1.4

64.79

62.03

mmol/l

0.90

586

1850

Non-allergic asthma (mode), excluding more controls

193

849

2.28

24.85

1.5

1.4

66.73

68.55

mmol/l

0.21

160

668

Purpura and other haemorrhagic conditions

188

829

2.31

24.83

1.6

1.4

62.18

64.76

mmol/l

0.32

140

672

Somatoform disorder

186

817

2.31

24.70

1.5

1.3

58.33

64.02

mmol/l

1.10

153

648

Polycystic ovarian syndrome, consortium definition

735

2843

1.54

24.68

1.5

1.4

65.13

61.02

mmol/l

1.59

583

2243

Other specified and unspecified personality disorders

107

358

3.04

24.68

1.6

1.3

54.31

64.54

mmol/l

1.56

293

Sleep disorders (combined)

1211

4553

1.40

24.62

1.4

63.09

62.95

mmol/l

0.04

961

3613

Focal brain injury

267

3.40

24.62

1.5

1.3

72.57

65.61

mmol/l

0.57

211

Other disorders of lacrimal gland

418

2432

1.74

24.61

1.4

62.96

62.55

mmol/l

0.07

347

1913

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

245

1186

2.06

24.54

2.2

1.6

68.37

67.20

mmol/l

0.13

200

937

Alzheimer disease, excluding more controls

213

631

2.25

24.48

1.3

63.88

58.81

mmol/l

1.12

173

505

Sequelae of injuries of head

235

3.59

24.43

1.7

1.2

73.43

64.69

mmol/l

0.75

194

Pain associated with micturition

160

664

2.45

24.27

1.5

1.4

57.93

65.03

mmol/l

1.33

135

542

Open wound of lower leg

204

943

2.20

24.01

1.4

57.06

64.99

mmol/l

2.11

158

759

Amyloidosis, other/unspecified

7.26

23.97

1.5

1.2

51.29

67.46

mmol/l

1.59

Budesonide

167

710

2.39

23.94

1.7

1.3

66.21

64.35

mmol/l

0.18

117

572

152

619

2.49

23.94

1.8

1.3

68.55

67.32

mmol/l

0.10

126

482

Soft tissue disorders

1075

3901

1.42

23.89

1.4

1.5

63.17

64.27

mmol/l

0.34

867

3042

Osteonecrosis

101

335

3.10

23.81

1.4

1.3

58.74

60.44

mmol/l

0.15

269

Acute upper respiratory infections of multiple and unspecified sites

773

3844

1.50

23.79

1.5

1.4

61.71

64.16

mmol/l

0.85

612

3002

Systemic connective tissue disorders

443

2644

1.69

23.78

1.5

1.4

59.78

62.66

mmol/l

0.83

368

2089

Chronic apical periodontitis

1174

4808

1.40

23.75

1.5

1.4

64.96

62.81

mmol/l

0.87

911

3816

Other diseases of intestine

186

833

2.27

23.66

2.2

1.3

59.43

63.75

mmol/l

0.64

139

684

Hypoparathyroidism

227

3.63

23.63

1.6

1.3

63.05

58.64

mmol/l

0.35

183

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1031

4671

1.42

23.45

1.4

63.75

62.64

mmol/l

0.34

807

3680

Zoster [herpes zoster]

257

1312

1.99

23.19

1.4

59.08

62.78

mmol/l

0.88

210

1049

Amenorrhoea

182

3.85

23.10

2.4

1.5

70.60

65.14

mmol/l

0.29

145

Complications of internal orthopaedic prosthetic devices, implants and grafts

312

1702

1.86

23.00

1.4

60.31

62.43

mmol/l

0.45

252

1360

Myocardial infarction

598

2687

1.58

22.99

1.4

1.3

60.06

62.76

mmol/l

0.88

477

2113

Persons with potential health hazards related to communicable diseases

323

1760

1.83

22.98

1.6

67.64

67.11

mmol/l

0.07

250

1408

Failure and rejection of transplanted organs and tissues

6.81

22.96

1.7

1.5

50.10

64.35

mmol/l

1.11

Diabetic nephropathy

232

1133

2.06

22.90

1.5

1.3

50.37

61.12

mmol/l

5.14

193

882

Pain in joint

555

2213

1.61

22.81

1.5

1.4

65.08

64.85

mmol/l

0.04

434

1726

Abnormalities of gait and mobility

175

778

2.29

22.76

1.4

62.17

64.35

mmol/l

0.32

149

625

Dental caries, including avohilmo

854

2978

1.47

22.68

1.5

1.4

64.48

63.27

mmol/l

0.32

696

2360

ILD medications: azathioprine

166

721

2.33

22.68

1.8

1.4

62.87

66.95

mmol/l

0.51

127

573

Viral and other specified intestinal infections

252

1240

1.98

22.48

2.2

1.5

64.89

68.97

mmol/l

0.66

204

991

Haemorrhage, not elsewhere classified

169

3.97

22.37

1.4

1.3

59.86

58.72

mmol/l

0.07

130

Pruritus

148

616

2.45

22.35

1.4

60.40

64.50

mmol/l

0.62

121

499

Behavioural syndromes associated with physiological disturbances and physical factors

944

4719

1.43

22.32

1.5

1.4

61.77

63.75

mmol/l

0.72

729

3730

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

122

4.55

22.31

1.6

1.2

51.27

65.88

mmol/l

2.18

101

Obsessive-compulsive disorder

151

4.10

22.29

1.8

1.4

59.87

72.38

mmol/l

0.84

133

Intestinal malabsorption

231

3.48

22.17

3.7

1.3

57.12

64.11

mmol/l

0.81

188

Benign neoplasm: Colon

662

4212

1.51

22.06

1.4

1.3

60.90

62.14

mmol/l

0.35

526

3363

Angina pectoris

672

2958

1.53

22.05

1.4

1.3

60.79

62.65

mmol/l

0.59

536

2324

Viral and other specified intestinal infections

197

904

2.15

22.03

2.4

1.6

65.70

67.71

mmol/l

0.23

161

727

Heartburn

132

524

2.56

22.02

1.6

1.3

71.16

65.37

mmol/l

0.68

105

416

Oesophagitis

277

3.23

21.99

1.5

1.3

55.61

61.95

mmol/l

0.82

217

Later onset COPD

390

1817

1.73

21.87

1.4

1.3

58.94

63.11

mmol/l

1.37

315

1461

Disorders of lacrimal system

500

3135

1.60

21.82

1.4

62.11

62.59

mmol/l

0.09

414

2474

Cerebral palsy and other paralytic syndromes

152

649

2.38

21.69

2.5

1.5

67.20

65.28

mmol/l

0.18

123

522

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

305

3.08

21.66

1.5

1.3

66.86

65.34

mmol/l

0.09

253

Malignant neoplasm of respiratory system and intrathoracic organs

270

1181

1.93

21.65

1.3

64.11

64.24

mmol/l

0.02

214

950

Other diseases of hard tissues of teeth

678

2307

1.53

21.49

1.4

63.97

62.10

mmol/l

0.51

553

1828

Deforming dorsopathies

315

1759

1.81

21.45

1.3

1.4

62.10

63.49

mmol/l

0.24

250

1388

Viral infections characterized by skin and mucous membrane lesions

892

5389

1.42

21.44

1.4

63.31

63.56

mmol/l

0.06

723

4246

Drug-induced osteoporosis with pathological fracture

5.08

21.43

1.6

1.3

68.86

66.48

mmol/l

0.10

Migraine with aura

213

1044

2.06

21.42

1.4

1.5

58.84

64.72

mmol/l

1.29

173

807

Hyperaldosteronism

144

4.21

21.37

1.4

1.3

68.89

60.84

mmol/l

0.76

118

Parkinson's disease, excluding more controls

147

583

2.41

21.34

1.3

71.59

60.26

mmol/l

2.69

114

476

Other diseases of pancreas

128

510

2.57

21.33

1.6

1.3

59.13

63.81

mmol/l

0.56

100

413

Gingivitis and periodontal diseases

1112

4157

1.39

21.19

1.4

63.62

63.00

mmol/l

0.18

901

3289

Glomerulonephritis

140

584

2.45

21.10

1.7

1.4

55.48

64.95

mmol/l

2.06

119

470

Disorders of continuity of bone

120

465

2.63

21.09

1.5

1.4

60.52

64.87

mmol/l

0.48

382

Type 1 diabetes, definitions combined

100

352

2.87

20.97

2.3

1.8

63.94

74.79

mmol/l

1.61

297

Finngen Rheumatological endpoints

937

3769

1.42

20.94

1.4

63.48

63.65

mmol/l

0.04

753

2919

Type 1 diabetes, strict (exclude DM2)

100

353

2.86

20.87

2.3

1.7

63.94

74.64

mmol/l

1.58

299

Eating disorder

219

3.42

20.84

2.3

1.6

63.15

72.58

mmol/l

0.71

193

Fentanyl

148

636

2.36

20.76

1.7

1.3

57.96

62.23

mmol/l

0.59

119

490

Small cell lung cancer, including Hilmo

109

4.67

20.74

1.4

77.68

63.47

mmol/l

1.45

Small cell lung cancer

109

4.67

20.74

1.4

77.68

63.47

mmol/l

1.45

Injuries to the knee and lower leg

1235

5079

1.35

20.74

1.4

61.57

64.16

mmol/l

1.37

978

4019

Collagenous colitis

135

560

2.46

20.64

2.1

1.3

65.06

62.60

mmol/l

0.30

101

456

Malignant neoplasm of head and neck

115

442

2.66

20.59

1.5

1.4

59.81

62.73

mmol/l

0.26

352

Endovascular or surgical operations to intracerebral aneurysms

353

2.88

20.56

1.6

1.4

91.57

60.53

mmol/l

5.93

281

Unspecified acute lower respiratory infection

182

856

2.16

20.56

1.4

58.95

64.46

mmol/l

1.09

153

681

Azathioprine

166

753

2.23

20.51

1.8

1.4

62.87

66.31

mmol/l

0.41

127

601

Hydrocephalus

125

503

2.55

20.44

1.7

1.4

90.96

62.06

mmol/l

6.79

111

398

Malignant neoplasm of bronchus and lung, including Hilmo

274

1236

1.88

20.40

1.3

63.89

64.16

mmol/l

0.04

212

990

Diseases of the musculoskeletal system and connective tissue

515

1615

1.61

20.15

1.4

1.6

64.28

66.50

mmol/l

0.50

422

1262

Other nutritional deficiencies

629

3978

1.50

20.09

1.4

63.69

64.00

mmol/l

0.06

467

3151

Somnolence, stupor and coma

226

3.37

20.07

1.4

1.3

58.02

64.40

mmol/l

0.62

179

Chronic periodontitis, complicated

599

3960

1.51

20.01

1.4

61.77

62.78

mmol/l

0.22

471

3117

Non-allergic asthma (mode)

193

928

2.08

19.96

1.5

1.4

66.73

66.52

mmol/l

0.02

160

739

Congenital malformations, deformations and chromosomal abnormalities

528

3260

1.55

19.95

1.7

1.4

67.99

64.63

mmol/l

0.82

414

2567

Osteomyelitis

337

2.89

19.91

1.5

1.4

55.81

64.69

mmol/l

1.37

280

Transport accidents

399

2077

1.66

19.82

1.4

1.5

62.59

65.84

mmol/l

0.75

325

1660

Pulmonary heart disease, diseases of pulmonary circulation

411

2526

1.64

19.79

1.4

63.56

62.40

mmol/l

0.23

314

2029

Hypertensive Renal Disease

152

3.93

19.76

1.5

1.3

54.35

64.56

mmol/l

1.27

121

Diseases of pulp and periapical tissues and dental caries

764

2687

1.46

19.69

1.4

64.73

62.86

mmol/l

0.55

631

2136

AV-block

227

1024

1.97

19.59

1.3

55.52

64.19

mmol/l

2.69

174

826

Other systemic involvement of connective tissue

340

1995

1.72

19.58

1.5

1.4

62.12

62.48

mmol/l

0.06

284

1579

Irritable bowel syndrome

271

1490

1.83

19.46

1.6

1.3

62.09

65.62

mmol/l

0.71

222

1182

Secondary parkinsonism, excluding more controls

5.23

19.42

1.3

59.87

60.93

mmol/l

0.05

Sequelae of injuries, of poisoning and of other consequences of external causes

254

1371

1.87

19.39

1.5

1.4

63.41

63.47

mmol/l

0.01

201

1085

Other symptoms and signs involving the circulatory and respiratory systems

331

2.87

19.33

1.4

1.3

54.44

63.92

mmol/l

1.26

263

Venous thromboembolism

637

4186

1.48

19.26

1.4

1.3

63.63

61.93

mmol/l

0.48

494

3332

Myocardial infarction, without ST-elevation

514

3045

1.55

19.24

1.4

1.3

58.75

61.93

mmol/l

1.25

416

2440

Diaphragmatic hernia

448

2834

1.60

19.17

1.5

1.3

58.79

62.93

mmol/l

1.54

364

2269

Disorders of oesophagus in diseases classified elsewhere

104

4.64

19.16

1.4

1.3

54.72

61.94

mmol/l

0.62

Other and unspecified effects of external causes

273

1512

1.82

19.16

1.7

1.5

61.09

64.45

mmol/l

0.61

212

1207

Alzheimer’s disease (Late onset), excluding more controls

179

545

2.18

19.12

1.3

64.96

59.56

mmol/l

1.01

141

440

Caries of dentine, including avohilmo

880

3187

1.42

19.10

1.4

1.5

64.15

63.64

mmol/l

0.12

715

2542

Disorders of parathyroid gland

292

1635

1.79

19.04

1.4

1.3

57.45

60.79

mmol/l

0.83

237

1298

Small cell lung cancer, helper endpoint

117

4.35

19.00

1.4

1.3

77.68

62.53

mmol/l

1.66

101

Other eating disorders

129

4.10

19.00

2.0

1.7

63.54

78.58

mmol/l

0.89

117

Other and unspecified mood [affective] disorders

208

3.37

18.99

1.2

48.22

66.57

mmol/l

3.28

180

Superficial injury of hip and thigh

198

992

2.02

18.93

1.6

1.3

59.05

63.06

mmol/l

0.82

162

797

Pyothorax

240

3.23

18.91

1.5

1.3

54.94

63.45

mmol/l

0.97

197

Pneumonia due to other infectious organisms, not elsewhere classified

148

3.91

18.90

1.5

1.3

68.84

59.25

mmol/l

0.86

122

Migraine without aura

151

683

2.23

18.75

1.6

68.15

67.17

mmol/l

0.08

123

526

Persistent delusional disorders

113

452

2.55

18.72

1.2

1.3

57.48

60.73

mmol/l

0.37

362

Calcific aortic valvular stenosis

403

2424

1.63

18.67

1.3

60.41

62.15

mmol/l

0.41

323

1947

Calcific aortic valvular stenosis, operated

403

2424

1.63

18.67

1.3

60.41

62.15

mmol/l

0.41

323

1947

Abnormal involuntary movements

166

784

2.15

18.63

1.7

1.4

60.36

64.14

mmol/l

0.70

135

632

Disturbances of skin sensation

269

1500

1.81

18.48

1.5

1.4

61.10

63.69

mmol/l

0.46

213

1191

Lumbar disc prolapse

624

3247

1.48

18.46

1.4

62.33

62.69

mmol/l

0.08

486

2533

Drug-induced neutropenia

107

421

2.60

18.38

1.3

65.87

62.55

mmol/l

0.35

344

Allergic asthma (mode), excluding more controls

166

771

2.12

18.19

1.5

1.4

59.86

69.68

mmol/l

2.19

134

607

Fracture of forearm

608

3793

1.48

18.17

1.5

1.4

62.79

62.64

mmol/l

0.03

483

3006

Calcific aortic valvular stenosis, including rheumatic fever

401

2424

1.62

18.15

1.3

59.85

61.86

mmol/l

0.51

321

1947

Chronic ulcer of skin, not elsewhere classified

109

436

2.56

18.10

1.7

1.3

48.31

62.59

mmol/l

4.67

343

Gout

345

1819

1.69

18.06

1.4

1.3

54.70

61.85

mmol/l

3.31

268

1438

Calcific aortic valvular stenosis, diagnosis (helper)

399

2417

1.62

17.98

1.3

59.78

61.89

mmol/l

0.54

319

1940

Operations 2 for CAVS

399

2417

1.62

17.98

1.3

59.78

61.89

mmol/l

0.54

319

1940

Visual field defects

121

510

2.42

17.92

1.6

1.3

74.27

62.61

mmol/l

1.70

105

400

Other inflammatory liver diseases

357

2.72

17.88

1.7

1.4

58.21

63.32

mmol/l

0.66

288

Acute sinusitis

477

2876

1.54

17.68

1.5

1.4

65.44

64.01

mmol/l

0.29

388

2229

Viral pneumonia (known virus, not influenza)

129

4.03

17.52

3.0

1.4

68.81

63.17

mmol/l

0.38

109

Exposure to other specified factors

731

4760

1.42

17.51

1.5

1.4

60.29

64.77

mmol/l

2.13

562

3766

Sleep disorders

869

4562

1.38

17.44

1.5

1.4

61.62

63.67

mmol/l

0.73

681

3597

Cerebral aneurysm, nonruptured

118

498

2.42

17.43

1.4

71.56

61.91

mmol/l

1.32

401

Other viral diseases

269

1522

1.78

17.42

1.9

1.6

69.91

65.81

mmol/l

0.63

230

1207

Charcot foot

5.37

17.39

1.3

1.2

54.67

65.10

mmol/l

0.82

Fitting and adjustment of other devices

417

2389

1.59

17.37

1.4

1.3

61.29

63.00

mmol/l

0.39

326

1895

Other condition

165

799

2.09

17.36

1.6

1.4

65.08

64.29

mmol/l

0.08

128

638

Thrombocytopenia, unspecified

107

433

2.53

17.35

1.9

1.4

65.54

61.88

mmol/l

0.30

347

ILD, hospital admission 2, with pulmonary infections

119

505

2.40

17.32

1.4

1.3

65.87

61.58

mmol/l

0.55

107

405

Statin medication

639

2454

1.47

17.30

1.3

1.4

62.87

64.89

mmol/l

0.50

511

1875

Speech and linguistic disorders, excluding more controls

240

3.02

17.28

3.1

2.3

76.62

71.83

mmol/l

0.31

208

Scoliosis

103

410

2.55

17.21

1.4

1.5

64.61

63.61

mmol/l

0.08

334

Malignant neoplasm of bronchus and lung

231

1035

1.88

17.21

1.3

63.26

64.05

mmol/l

0.10

183

824

Hydronephrosis

137

620

2.24

17.16

1.5

1.4

58.64

68.56

mmol/l

1.85

109

506

Congenital malformations, deformations and chromosomal abnormalities

572

3588

1.48

17.12

1.4

66.19

64.75

mmol/l

0.29

448

2824

Elevated blood glucose level

116

490

2.41

17.11

1.4

59.41

64.63

mmol/l

0.61

400

Abnormal findings on examination of urine, without diagnosis

235

3.11

16.93

1.5

1.4

62.05

63.85

mmol/l

0.14

198

Diabetic retinopathy, excluding more controls

301

968

1.76

16.93

1.3

1.4

56.84

61.04

mmol/l

1.08

244

756

Anaemia in chronic diseases classified elsewhere

124

4.03

16.82

1.6

1.3

59.19

63.87

mmol/l

0.36

101

Monoamine oxidase A inhibitors

129

574

2.28

16.82

1.4

1.3

58.31

64.68

mmol/l

0.95

472

Gout, FINNGEN

345

2113

1.64

16.77

1.4

1.3

54.70

62.97

mmol/l

4.41

268

1692

Diseases of pulp and periapical tissues, including avohilmo

1096

4264

1.34

16.75

1.5

1.4

64.67

63.35

mmol/l

0.42

863

3407

Other diseases of oesophagus

125

551

2.31

16.70

1.7

1.3

53.92

61.96

mmol/l

1.49

442

Pacemaker

432

2689

1.55

16.48

1.3

60.16

62.20

mmol/l

0.51

344

2171

Cervical disc disorders

374

2353

1.60

16.43

1.5

1.3

64.66

62.69

mmol/l

0.39

303

1838

Cardiomyopathy, other and unspecified

397

2.54

16.35

1.5

1.4

61.07

64.61

mmol/l

0.33

323

Duodenal ulcer

139

646

2.18

16.33

1.6

1.3

59.69

62.45

mmol/l

0.30

514

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

122

539

2.31

16.30

1.5

1.3

56.84

63.06

mmol/l

1.20

432

Fracture of neck

346

2.66

16.26

1.8

1.3

59.29

63.28

mmol/l

0.46

279

Other diseases of lip and oral mucosa

424

2754

1.55

16.22

1.4

60.14

63.49

mmol/l

0.95

348

2173

Diabetic maculopathy, excluding more controls

130

591

2.23

16.13

1.3

54.27

64.57

mmol/l

2.67

106

473

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

281

2.85

16.02

1.2

1.3

55.69

63.17

mmol/l

1.17

224

Other abnormal uterine and vaginal bleeding

274

1134

1.75

15.86

1.4

1.3

68.63

59.86

mmol/l

2.39

210

859

Malignant neoplasm of oral cavity

173

3.40

15.72

1.5

1.4

62.00

61.43

mmol/l

0.03

139

Post-traumatic stress disorder

182

3.27

15.70

3.1

1.4

54.12

66.45

mmol/l

1.01

161

Unspecified urinary incontinence

127

580

2.23

15.66

1.3

61.36

61.60

mmol/l

0.02

465

Acute upper respiratory infections

1068

4999

1.32

15.61

1.5

1.4

63.01

63.22

mmol/l

0.05

872

3937

Other viral diseases

313

1894

1.65

15.59

1.8

1.6

68.42

65.97

mmol/l

0.37

267

1494

Malignant neoplasm of oral cavity, including Hilmo

236

3.00

15.56

1.5

1.3

66.90

60.13

mmol/l

0.47

186

Degeneration of macula and posterior pole

593

3293

1.44

15.44

1.4

1.3

61.89

62.20

mmol/l

0.07

486

2624

Pulmonary heart disease

360

2285

1.59

15.31

1.4

63.49

62.19

mmol/l

0.24

274

1837

Other disorders involving the immune mechanism, not elsewhere classified

137

3.69

15.31

2.3

1.6

60.98

61.25

mmol/l

0.01

118

Pulmonary embolism

360

2287

1.59

15.26

1.4

63.49

62.15

mmol/l

0.25

274

1837

Cardiomyopathy (excluding other)

145

704

2.09

15.23

1.6

1.3

57.40

66.11

mmol/l

1.89

115

561

Vitamin deficiency, wide

250

2.91

15.20

1.6

1.3

68.63

61.32

mmol/l

0.59

206

Vitamin deficiency

250

2.91

15.20

1.6

1.3

68.63

61.32

mmol/l

0.59

206

Unspecified jaundice

250

2.90

15.18

1.5

1.3

58.80

63.35

mmol/l

0.33

191

Other arthritis (FG)

321

1986

1.63

15.17

1.5

1.4

64.41

63.56

mmol/l

0.13

260

1556

Type 1 diabetes, strict definition

239

2.91

15.03

2.7

2.0

62.55

81.51

mmol/l

2.81

199

Allergic asthma (mode)

166

829

1.97

15.03

1.5

1.4

59.86

67.38

mmol/l

1.46

134

660

Symptoms and signs involving speech and voice

362

2316

1.58

14.89

1.5

1.4

65.53

62.95

mmol/l

0.52

295

1846

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

126

3.77

14.82

2.1

1.6

62.18

62.45

mmol/l

0.01

108

Eating disorders

349

2.54

14.79

2.2

1.5

60.00

66.94

mmol/l

0.58

300

Infection of intervertebral disc (pyogenic)

5.90

14.77

2.1

1.4

58.95

52.05

mmol/l

0.35

Malignant neoplasm of digestive organs

441

2312

1.52

14.76

1.4

1.3

58.37

63.82

mmol/l

1.91

314

1845

Amputation of ankle bones

113

3.96

14.75

1.3

52.03

61.16

mmol/l

0.73

Superficial injury of lower leg

258

1521

1.71

14.73

1.5

1.4

60.93

64.92

mmol/l

0.80

207

1209

Other disorders of ear

956

4732

1.33

14.69

1.4

64.60

62.72

mmol/l

0.67

778

3720

Fissure and fistula of anal and rectal regions

234

1344

1.76

14.66

1.4

1.3

58.80

65.47

mmol/l

1.63

163

1082

Disorders of psychological development

106

424

2.34

14.66

2.5

2.4

85.08

72.17

mmol/l

1.39

361

Other viral diseases, not elsewhere classified

185

987

1.89

14.66

2.1

1.6

70.02

65.23

mmol/l

0.63

159

788

Dementia, including avohilmo

589

2839

1.44

14.66

1.3

64.69

60.81

mmol/l

1.64

474

2276

Dependent personality disorder

4.50

14.65

2.0

1.3

51.77

61.85

mmol/l

1.03

Primary_lymphoid and hematopoietic malignant neoplasms

291

1775

1.66

14.64

1.4

60.10

63.07

mmol/l

0.62

247

1428

Benign neoplasm of other and ill-defined parts of digestive system

221

1252

1.79

14.61

1.4

58.71

62.11

mmol/l

0.70

175

1009

Pure hyperglyceridaemia

5.06

14.61

1.3

1.2

58.00

70.74

mmol/l

0.78

All influenza (not pneumonia)

143

701

2.06

14.61

1.7

1.3

64.36

66.26

mmol/l

0.20

112

569

Vascular diseases of the intestine

245

2.90

14.60

1.4

1.3

60.92

62.20

mmol/l

0.09

206

Molar incisor enamel hypoplasia

140

3.53

14.59

2.3

3.4

77.29

83.98

mmol/l

0.37

130

Disorders of skin appendages

430

2864

1.51

14.56

1.4

1.5

61.21

65.01

mmol/l

1.09

333

2270

Paraplegia, diplegia of upper limbs

105

4.06

14.56

1.6

1.2

57.89

64.62

mmol/l

0.50

Type 1 diabetes, strict definition, subgroup 1

222

2.96

14.54

2.8

2.0

61.96

81.23

mmol/l

2.74

187

Alzheimer’s disease (Atypical or mixed), excluding more controls

102

342

2.41

14.47

1.2

57.74

60.54

mmol/l

0.33

270

Parkinson's disease, strict definition, excluding more controls

126

561

2.16

14.46

1.3

72.82

60.29

mmol/l

3.03

458

Encephalitis

143

3.53

14.39

1.3

1.4

65.98

65.23

mmol/l

0.04

119

Arthropathies in other diseases classified elsewhere

178

3.23

14.35

1.4

1.3

58.00

63.52

mmol/l

0.44

143

Cardiomyopathies, Primary/intrinsic

136

660

2.09

14.33

1.6

1.3

56.56

65.56

mmol/l

1.96

109

529

Misadventures to patients during surgical and medical care

162

837

1.96

14.33

1.5

1.4

57.23

64.36

mmol/l

1.30

132

678

DVT of lower extremities and pulmonary embolism

491

3365

1.46

14.25

1.3

1.4

63.54

62.19

mmol/l

0.30

369

2689

Other diseases of spinal cord

144

3.51

14.24

1.7

1.5

57.78

63.47

mmol/l

0.42

121

Cerebral cysts

248

2.83

14.20

2.4

1.4

75.91

68.80

mmol/l

0.44

202

Asthma and allergy, excluding more controls

369

2.45

14.19

1.6

1.4

61.80

72.43

mmol/l

1.36

291

Adjustment and management of implanted device

223

1279

1.76

14.13

1.9

1.3

57.66

63.05

mmol/l

1.25

179

1013

Other infectious diseases

118

547

2.19

14.05

1.5

1.4

63.58

64.69

mmol/l

0.11

439

ILD, hospital admissions 3, with pneumonia sepsis

105

464

2.30

14.04

1.4

1.3

67.75

61.73

mmol/l

0.76

378

Endocarditis

160

3.33

14.04

1.7

1.3

51.71

68.83

mmol/l

2.51

132

Reimbursement for rheumatic diseases

589

4183

1.41

14.01

1.5

1.4

62.53

62.87

mmol/l

0.07

482

3298

Insomnia

820

4460

1.34

13.99

1.4

61.88

63.48

mmol/l

0.49

647

3505

Need for other prophylactic measures

331

2.56

13.98

1.6

1.5

64.69

62.29

mmol/l

0.19

270

Faecal incontinence

123

581

2.15

13.98

1.5

1.3

61.15

62.35

mmol/l

0.12

471

Small fibre neuropathy

161

3.34

13.97

1.4

1.2

50.44

64.25

mmol/l

1.96

137

Mental and behavioural disorders due to cannabinoids

5.09

13.87

1.3

1.4

62.60

71.23

mmol/l

0.26

5-aminosalicylic acid

191

1051

1.83

13.86

2.1

1.4

62.38

65.25

mmol/l

0.37

130

850

Stomatitis and related lesions

207

1169

1.79

13.82

1.4

65.27

64.18

mmol/l

0.15

169

942

Isolated proteinuria

133

3.57

13.72

1.4

1.3

60.95

62.79

mmol/l

0.11

116

Alcohol abuse counselling and surveillance

5.10

13.70

1.2

1.4

63.87

61.40

mmol/l

0.09

Amputation of toe

101

446

2.31

13.59

1.4

1.3

53.49

62.00

mmol/l

1.53

356

Other diseases of upper respiratory tract

1154

4689

1.29

13.59

1.5

1.4

63.23

63.20

mmol/l

0.01

928

3683

Other congenital malformations of the digestive system

225

2.89

13.59

4.9

1.9

70.43

72.31

mmol/l

0.11

191

Assault by bodily force

294

2.62

13.55

1.5

1.4

72.63

66.64

mmol/l

0.32

244

Meningitis

238

2.83

13.54

1.3

1.4

76.36

65.40

mmol/l

0.90

199

Personal history of risk-factors, not elsewhere classified

5.77

13.48

1.3

67.84

69.80

mmol/l

0.05

Dementia

544

2630

1.43

13.43

1.3

65.07

61.07

mmol/l

1.60

440

2116

Glaucoma

652

4088

1.38

13.42

1.4

1.3

60.08

62.22

mmol/l

0.77

530

3248

Inflammatory bowel disease

294

1840

1.61

13.32

1.9

1.4

64.63

64.28

mmol/l

0.04

197

1470

Rheumatism, unspecified

159

838

1.92

13.30

1.4

62.17

62.76

mmol/l

0.07

133

662

Other encephalitis

131

3.54

13.29

1.3

1.4

67.22

65.73

mmol/l

0.07

111

Acute alcohol intoxication ICD-9

146

3.37

13.22

1.7

1.3

51.03

66.92

mmol/l

2.02

127

Zoster [herpes zoster]

548

3841

1.41

13.20

1.4

60.34

62.49

mmol/l

0.71

443

3049

Use of biperiden

270

2.69

13.18

1.6

1.3

52.74

60.83

mmol/l

1.05

215

Asthma and allergy

382

2.37

13.18

1.6

1.4

61.80

71.64

mmol/l

1.21

301

Nephrotic syndrome

167

3.21

13.16

1.5

1.6

52.36

67.72

mmol/l

1.83

137

Obesity and other hyperalimentation

560

3857

1.40

13.09

1.3

1.4

63.42

64.05

mmol/l

0.12

404

3055

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

168

879

1.87

12.95

1.7

1.8

68.26

67.26

mmol/l

0.09

140

711

Superficial injury of abdomen, lower back and pelvis

156

825

1.91

12.90

1.7

1.4

60.51

64.56

mmol/l

0.49

122

663

Certain disorders involving the immune mechanism

207

1194

1.75

12.90

1.6

1.4

65.40

63.72

mmol/l

0.23

173

955

Other and unspecified hydrocephalus

115

3.73

12.88

1.8

1.5

91.92

63.96

mmol/l

2.54

Migraine without aura and triptan purchases

119

573

2.09

12.80

1.7

1.6

69.68

66.31

mmol/l

0.27

456

Complications of other internal prosthetic devices, implants and grafts

246

2.75

12.79

1.7

1.4

72.82

63.06

mmol/l

0.78

202

Other specified/unspecified arthritis

282

1767

1.61

12.76

1.5

1.4

65.17

63.98

mmol/l

0.18

230

1399

Morphin

4.11

12.75

1.2

1.3

58.77

57.89

mmol/l

0.05

IgA nephropathy (IgA glomerulonephritis)

3.94

12.73

2.1

1.2

55.28

59.21

mmol/l

0.25

Tubulo-interstitial nephritis, not specified as acute or chronic

383

2.36

12.71

1.4

1.3

58.12

66.32

mmol/l

1.25

310

Other and unspecified local infections of skin and subcutaneous tissue

114

543

2.13

12.70

2.4

1.4

59.90

63.73

mmol/l

0.38

440

Cholelithiasis, broad definition with cholecystitis

871

4473

1.32

12.68

1.5

1.3

62.03

62.80

mmol/l

0.21

682

3568

Other diseases of stomach and duodenum

353

2.42

12.66

1.7

1.3

59.51

60.82

mmol/l

0.11

281

395

2320

1.50

12.61

1.4

1.3

61.43

61.29

mmol/l

0.03

318

1868

Mental retardation, excluding more controls

146

3.26

12.54

4.2

2.5

74.93

67.73

mmol/l

0.42

132

Obesity

553

3839

1.40

12.48

1.3

1.4

63.19

64.03

mmol/l

0.16

403

3042

Fracture of foot, except ankle

227

1356

1.69

12.42

1.4

63.50

64.28

mmol/l

0.10

179

1087

Pneumonia due to Streptococcus pneumoniae

178

3.04

12.39

1.5

1.3

61.53

61.73

mmol/l

0.01

147

Ulcerative colitis

229

1374

1.68

12.33

1.8

1.4

61.59

64.39

mmol/l

0.34

145

1104

Polyarthrosis

256

1466

1.64

12.29

1.4

1.3

65.84

60.54

mmol/l

1.22

204

1135

Diabetic neuropathy

150

794

1.91

12.28

1.5

1.4

58.17

61.06

mmol/l

0.42

122

617

Lichen simplex chronicus and prurigo

340

2.43

12.26

1.3

63.23

62.74

mmol/l

0.04

271

Other local infections of skin and subcutaneous tissue

120

591

2.06

12.25

2.3

1.4

61.48

63.65

mmol/l

0.19

481

Extrapyramidal and movement disorders

425

2935

1.46

12.23

1.3

1.4

64.20

63.24

mmol/l

0.19

338

2331

Intentional self-harm by unspecified means

6.21

12.21

1.9

1.3

56.54

62.86

mmol/l

0.23

Non-small cell lung cancer, including Hilmo

176

925

1.81

12.21

1.3

59.66

64.18

mmol/l

0.77

138

734

Other abnormalities of plasma proteins

4.09

12.17

1.3

56.36

64.99

mmol/l

0.49

Non-small cell lung cancer

124

615

2.03

12.13

1.3

57.99

62.74

mmol/l

0.71

494

Special screening examination for other diseases and disorders

106

499

2.14

12.13

1.4

1.3

60.27

64.19

mmol/l

0.48

393

Injuries to the neck

207

1215

1.72

12.11

1.5

1.4

61.58

65.28

mmol/l

0.64

166

970

Other viral diseases, not elsewhere classified

227

1359

1.67

12.05

2.0

1.7

67.62

65.20

mmol/l

0.30

194

1079

Cardiac arrest

184

2.82

11.98

2.6

1.2

60.91

71.18

mmol/l

0.73

149

Other diseases of biliary tract

119

590

2.05

11.97

1.6

1.3

59.64

63.58

mmol/l

0.45

476

Intentional self-harm by sharp object

4.61

11.94

2.3

1.4

62.30

68.67

mmol/l

0.23

Vitamin B12 deficiency anaemia

136

707

1.95

11.93

1.8

1.3

60.29

62.06

mmol/l

0.22

115

569

Rheumatoid arthritis

346

2061

1.52

11.92

1.5

1.3

62.64

61.78

mmol/l

0.14

278

1604

Abnormal findings on diagnostic imaging of central nervous system

232

2.73

11.91

1.7

1.3

80.35

65.09

mmol/l

1.17

191

Benign neoplasm: Colon, unspecified

292

1878

1.57

11.90

1.4

1.3

62.08

62.44

mmol/l

0.05

234

1509

Amputation of foot

157

3.17

11.85

1.4

1.3

56.28

60.68

mmol/l

0.29

130

Erosion of teeth , including avohilmo

209

1239

1.70

11.79

1.7

1.4

62.62

64.77

mmol/l

0.25

162

978

Barrett oesophagus

245

2.67

11.78

1.4

1.3

59.16

59.33

mmol/l

0.01

199

Obesity due to excess calories

404

2782

1.46

11.77

1.3

1.4

63.27

64.84

mmol/l

0.28

289

2220

Cervicalgia

210

1248

1.70

11.77

1.5

1.3

62.23

62.56

mmol/l

0.04

179

988

Hypercalcemia

281

2.56

11.75

2.7

1.4

62.17

60.21

mmol/l

0.13

228

Other shoulder lesions

102

481

2.15

11.69

1.4

1.3

66.05

64.98

mmol/l

0.08

381

Chronic viral hepatitis

184

2.93

11.68

1.6

1.3

42.94

67.82

mmol/l

3.26

151

Other disorders of eye and adnexa

149

804

1.87

11.65

1.6

1.4

60.09

64.33

mmol/l

0.58

121

644

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

164

912

1.82

11.65

1.3

1.4

62.17

63.54

mmol/l

0.15

132

732

Any dementia

497

2454

1.42

11.62

1.3

63.51

61.42

mmol/l

0.59

406

1978

Soft tissue disorders related to use, overuse and pressure

283

1817

1.57

11.60

1.4

61.44

62.60

mmol/l

0.18

237

1420

Myocardial infarction, strict

507

2580

1.41

11.49

1.4

1.3

60.23

62.54

mmol/l

0.65

405

2027

Recurrent aphthous stomatitis , including avohilmo

156

859

1.84

11.45

1.4

65.12

64.52

mmol/l

0.07

128

703

Non-small cell lung cancer, adenocarcinoma

345

2.36

11.44

1.3

1.4

59.28

63.27

mmol/l

0.37

273

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

175

966

1.77

11.44

1.7

1.8

67.86

66.96

mmol/l

0.09

146

782

Sleep disorders, other/unspecified

114

3.49

11.43

1.7

1.4

57.47

67.80

mmol/l

0.88

100

Oesophageal obstruction

187

2.91

11.42

1.7

1.3

51.57

61.54

mmol/l

0.84

154

Injuries to the ankle and foot

603

3962

1.36

11.42

1.4

1.5

61.77

65.32

mmol/l

1.16

467

3117

Fall involving bed

233

2.70

11.37

1.9

1.4

65.15

65.77

mmol/l

0.04

190

Generalized epilepsy

171

2.98

11.35

1.5

1.7

69.26

71.33

mmol/l

0.09

146

Other sleep disorders

110

540

2.06

11.34

1.3

58.56

66.58

mmol/l

1.32

426

Disorders of ocular muscles, binocular movement, accommodation and refraction

411

2835

1.44

11.33

1.8

1.5

71.81

64.39

mmol/l

2.40

335

2235

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

359

2.32

11.32

1.4

53.89

63.87

mmol/l

1.19

280

Other postsurgical states

353

2.33

11.29

1.8

1.6

76.44

65.63

mmol/l

0.94

285

Other specific joint derangements/joint disorders

650

3127

1.35

11.22

1.5

1.4

64.21

63.80

mmol/l

0.08

506

2446

Blood alcohol or alcohol intoxication level

4.15

11.19

1.3

1.5

49.30

55.67

mmol/l

0.27

Acute gastritis

412

2.22

11.16

1.6

1.3

60.60

61.14

mmol/l

0.04

331

Emphysema

406

2.23

11.13

1.5

1.3

63.14

63.36

mmol/l

0.02

326

Diffuse brain injury

116

3.42

11.13

1.4

1.2

76.40

66.87

mmol/l

0.37

Actinic keratosis

472

3127

1.41

11.11

1.3

61.96

61.50

mmol/l

0.10

387

2512

Dermatitis due to substances taken internally

282

2.49

11.10

1.3

1.4

63.87

66.85

mmol/l

0.26

233

Hyperkinetic disorders, excluding more controls

191

2.77

11.02

1.8

2.3

70.20

80.19

mmol/l

0.74

163

Other congenital malformations of the digestive system

281

2.49

11.01

4.6

2.0

68.39

72.57

mmol/l

0.31

235

Chronic hepatitis, not elsewhere classified

169

2.97

11.01

1.2

1.3

54.74

60.84

mmol/l

0.61

148

Secondary uncertain malignant neoplasm

148

813

1.84

10.98

1.3

59.39

63.17

mmol/l

0.49

118

653

500

3321

1.39

10.92

1.3

62.30

61.74

mmol/l

0.13

409

2663

Abnormal results of function studies

468

2.12

10.92

1.5

1.4

54.84

64.82

mmol/l

1.37

378

Emotional disorders starting during childhood or adolecense, excluding more controls

4.05

10.90

2.3

3.4

61.80

80.63

mmol/l

1.23

Other endocrine disorders

266

2.49

10.88

4.2

2.4

72.36

72.22

mmol/l

0.01

229

Crohn disease

122

631

1.95

10.87

2.3

1.4

68.19

65.89

mmol/l

0.18

504

Gout, idiopatic and unspecified

275

1784

1.56

10.83

1.5

1.3

54.21

63.44

mmol/l

4.41

211

1427

Other infectious diseases

470

2.12

10.82

1.6

1.4

63.68

63.78

mmol/l

0.01

383

Crohn's disease NAS

292

2.43

10.77

2.3

1.4

70.16

65.73

mmol/l

0.27

238

Chronic rhinitis, nasopharyngitis and pharyngitis

292

1920

1.53

10.76

1.5

1.4

58.88

64.13

mmol/l

1.45

236

1514

Open wound of forearm

105

518

2.05

10.73

1.5

1.4

66.14

64.21

mmol/l

0.16

421

Skin changes due to chronic exposure to nonionizing radiation

479

3191

1.39

10.68

1.3

62.13

61.58

mmol/l

0.12

392

2565

Conductive and sensorineural hearing loss

835

4383

1.29

10.64

1.5

1.4

64.94

62.42

mmol/l

0.91

669

3458

Diseases of salivary glands

315

2112

1.50

10.60

1.3

1.4

64.95

63.15

mmol/l

0.32

257

1682

Malignant neoplasm of tongue, including Hilmo

136

3.18

10.55

1.5

1.4

62.12

62.79

mmol/l

0.03

108

Trochanteric bursitis

161

919

1.77

10.52

1.4

59.50

62.82

mmol/l

0.63

140

725

Tobacco use

236

2.59

10.48

1.5

1.3

48.34

65.77

mmol/l

2.16

197

Viral hepatitis

315

2.35

10.42

1.6

1.3

50.14

66.72

mmol/l

2.00

260

Sequelae of other external causes

297

2.40

10.41

1.9

1.3

64.16

63.08

mmol/l

0.06

236

Valvular operations

153

863

1.79

10.41

1.6

1.3

63.65

64.85

mmol/l

0.13

133

692

Viral encephalitis, not elsewhere classified/unspecified

102

3.55

10.40

1.4

82.57

61.77

mmol/l

1.57

Drug-induced cataract

122

3.30

10.38

2.1

1.2

59.00

64.26

mmol/l

0.31

108

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

122

566

1.93

10.37

1.9

2.3

66.88

75.40

mmol/l

1.03

481

Other disorders of kidney and ureter

153

865

1.79

10.36

1.6

1.3

57.99

63.99

mmol/l

1.32

134

701

Fibromyalgia

406

2.17

10.29

1.4

1.3

63.89

64.61

mmol/l

0.06

312

Malignant neoplasm of tongue

3.59

10.28

1.6

1.3

60.50

65.36

mmol/l

0.20

Event of undetermined intent

274

2.44

10.28

1.5

1.4

68.02

67.13

mmol/l

0.04

232

L01XE Protein kinase inhibitors

356

2.27

10.28

1.3

1.4

58.84

59.71

mmol/l

0.06

284

Other symptoms and signs involving general sensations and perceptions

233

2.59

10.26

1.3

1.4

49.02

61.12

mmol/l

1.89

186

Pemphigoid

171

2.90

10.24

1.4

1.3

56.20

62.35

mmol/l

0.49

138

Abscess of lung

4.02

10.24

2.0

1.3

51.26

64.58

mmol/l

1.08

Other disorders of eyelid

498

3475

1.37

10.19

1.3

1.4

61.29

62.40

mmol/l

0.26

409

2755

Late syphilis

3.89

10.16

1.3

64.84

61.71

mmol/l

0.17

Migraine with aura and triptan purchases

115

597

1.94

10.14

1.5

61.12

64.77

mmol/l

0.41

468

Amputation of thigh

189

2.77

10.09

1.5

1.3

59.22

61.51

mmol/l

0.14

154

Coxarthrosis [arthrosis of hip](FG)

575

3016

1.35

10.09

1.4

1.3

61.42

61.84

mmol/l

0.09

469

2352

Pneumonia derived septicemia

172

2.86

10.09

1.5

58.51

66.54

mmol/l

0.65

145

Urethral stricture

259

2.47

10.04

1.2

60.60

66.32

mmol/l

0.59

208

Hallux valgus (acquired)

362

1798

1.46

10.01

1.3

64.68

61.79

mmol/l

0.63

277

1401

Immunodeficiencies

254

2.49

9.99

1.6

1.5

68.53

64.97

mmol/l

0.28

211

Acute posthaemorrhagic anaemia

196

2.72

9.94

1.7

1.3

63.13

60.60

mmol/l

0.15

158

Abnormal findings on diagnostic imaging of other body structures

150

855

1.77

9.89

1.4

1.3

62.59

63.22

mmol/l

0.06

127

689

Hypoplasia of dental enamel , including avohilmo

137

3.04

9.82

2.1

3.1

79.34

84.18

mmol/l

0.23

126

Lesion of ulnar nerve

139

776

1.81

9.82

1.4

60.04

64.47

mmol/l

0.57

112

619

Trigeminal neuralgia

331

2.27

9.78

1.2

1.3

67.97

60.96

mmol/l

0.83

267

Sicca syndrome [Sjögren]

107

551

1.97

9.77

1.4

1.3

60.63

60.69

mmol/l

0.01

451

Salpingitis and oophoritis

174

1037

1.69

9.76

1.5

1.4

64.01

61.96

mmol/l

0.24

134

814

Retinal vascular occlusion

151

867

1.76

9.74

1.5

1.3

62.56

62.52

mmol/l

0.00

121

682

Malignant neoplasm of urinary organs

111

579

1.94

9.74

1.4

1.3

54.02

62.88

mmol/l

2.02

455

Sensorineural hearing loss

803

4272

1.28

9.73

1.5

1.4

64.72

62.22

mmol/l

0.88

649

3370

Other viral hepatitis

251

2.46

9.70

1.6

1.3

49.87

67.38

mmol/l

1.65

209

Other meningitis

4.04

9.67

1.3

68.59

58.90

mmol/l

0.41

Other specified/unspecified systemic involvement of connective tissue

314

2.30

9.64

1.4

1.3

58.62

61.63

mmol/l

0.26

260

Hepatocellular carcinoma, including Hilmo

155

2.91

9.57

1.3

57.62

63.70

mmol/l

0.37

122

Other and unspecified intracranial injuries

144

2.98

9.57

1.3

61.23

65.24

mmol/l

0.25

119

Retinal vascular disorders

152

879

1.75

9.57

1.5

1.3

62.60

62.34

mmol/l

0.03

122

694

285

1799

1.50

9.56

1.4

1.3

61.46

60.68

mmol/l

0.13

234

1442

Gout, unspecified

226

1446

1.58

9.54

1.5

1.3

53.45

62.97

mmol/l

3.90

173

1158

Cholelithiasis

813

4412

1.27

9.51

1.4

1.3

62.07

62.76

mmol/l

0.18

632

3522

Chronic sinusitis

388

2763

1.41

9.48

1.4

62.53

63.35

mmol/l

0.15

316

2148

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

472

3373

1.37

9.47

1.4

63.39

63.13

mmol/l

0.05

388

2617

Nummular dermatitis

454

2.06

9.47

1.4

1.3

57.54

63.02

mmol/l

0.69

371

Benign neoplasm: Stomach

123

671

1.86

9.44

1.4

1.3

57.53

61.71

mmol/l

0.72

106

538

Corns and callosities

395

2.14

9.42

1.4

60.25

63.09

mmol/l

0.25

310

Bronchiectasis

503

2.00

9.41

1.4

59.84

61.80

mmol/l

0.19

411

Thyrotoxicosis, other and/or unspecified

196

1216

1.62

9.41

1.4

64.25

62.57

mmol/l

0.22

157

968

Hernia of abdominal wall

448

3276

1.37

9.40

1.8

1.3

56.17

63.76

mmol/l

3.96

332

2598

Pericarditis

162

2.83

9.38

1.3

64.53

67.07

mmol/l

0.14

129

Asthma and opportunity respiratory infection

306

2.31

9.36

1.5

1.2

58.29

61.58

mmol/l

0.26

245

Contact with and exposure to communicable diseases

204

1272

1.60

9.36

1.6

1.7

67.57

67.85

mmol/l

0.03

156

1010

Excessive, frequent and irregular menstruation

345

1299

1.46

9.33

1.8

1.4

63.04

61.66

mmol/l

0.23

276

993

Other skin changes

197

1227

1.62

9.33

1.4

60.39

63.02

mmol/l

0.40

157

987

Speech and linguistic disorders

366

2.15

9.33

3.2

2.3

78.84

75.43

mmol/l

0.22

309

Other arthrosis

533

2754

1.35

9.32

1.4

1.3

63.08

61.55

mmol/l

0.33

422

2145

Ulcer of oesophagus

377

2.15

9.31

1.5

1.3

60.19

63.10

mmol/l

0.25

302

Crohn's disease of small intestine

306

2.28

9.29

2.3

1.4

70.10

65.19

mmol/l

0.27

253

Unspecified privation

118

638

1.87

9.29

1.6

1.4

62.09

62.07

mmol/l

0.00

518

Sequelae of injuries of neck and trunk

137

2.99

9.15

1.8

1.2

56.93

62.65

mmol/l

0.29

120

Other or ill-defined heart diseases

228

2.49

9.13

1.3

55.11

66.71

mmol/l

1.27

182

Hypogonadotropic hypogonadism

106

3.28

9.09

1.2

1.3

75.30

64.51

mmol/l

0.60

Ventral hernia

255

1694

1.52

9.08

1.7

1.3

56.96

63.49

mmol/l

1.85

184

1349

Mixed hyperlipidaemia

106

3.26

9.06

1.4

1.2

54.96

73.31

mmol/l

2.40

Irregular menses

349

1933

1.43

9.04

1.7

1.4

67.29

62.44

mmol/l

1.04

282

1527

Dissociative [conversion] disorders

122

3.08

9.00

1.2

63.45

68.07

mmol/l

0.22

105

Diplopia

141

813

1.75

8.98

1.5

1.3

70.29

63.05

mmol/l

1.06

120

652

Anorexia (incl.atypical)

200

2.58

8.97

2.2

1.4

59.56

65.63

mmol/l

0.28

174

Malignant neoplasm of kidney, except renal pelvis

101

526

1.95

8.95

1.4

53.60

62.37

mmol/l

1.88

417

Social phobias

230

2.45

8.94

1.9

1.6

56.79

68.15

mmol/l

1.04

197

Degenerative diseases of the nervous system

444

2388

1.38

8.93

1.4

1.3

61.10

61.26

mmol/l

0.03

357

1914

Right hemicolectomy

384

2.12

8.93

1.7

1.3

52.81

61.47

mmol/l

1.15

310

Fall on same level involving ice and snow

551

4190

1.32

8.92

1.4

62.24

63.16

mmol/l

0.19

434

3309

Other noninfective disorders of lymphatic vessels and lymph nodes

196

2.61

8.88

1.3

58.18

62.01

mmol/l

0.25

163

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

511

2590

1.34

8.86

1.3

60.40

63.46

mmol/l

0.96

411

2056

Hyperplasia of prostate

329

1290

1.46

8.77

1.4

1.3

63.12

63.84

mmol/l

0.11

268

1020

Primary biliary cholangitis (PBC)

109

3.21

8.73

1.3

1.4

58.52

56.57

mmol/l

0.09

Other epidermal thickening

246

2.40

8.72

1.8

1.4

61.30

67.11

mmol/l

0.51

202

Diseases of male genital organs

440

1610

1.38

8.70

1.5

63.15

66.88

mmol/l

0.90

355

1251

Extreme obesity with alveolar hypoventilation

228

2.46

8.70

1.4

1.3

66.47

60.03

mmol/l

0.32

189

Disorders of sclera, cornea, iris and ciliary body

505

3807

1.33

8.70

1.4

63.97

63.38

mmol/l

0.11

413

2989

Dissocial personality disorder

4.49

8.67

1.4

1.3

67.25

58.30

mmol/l

0.18

Malignant neoplasm of skin

515

2650

1.34

8.67

1.3

1.4

59.78

63.69

mmol/l

1.42

419

2102

Syphilis

120

3.08

8.65

1.2

1.3

62.14

62.85

mmol/l

0.04

102

Syphilis

120

3.08

8.65

1.2

1.3

62.14

62.85

mmol/l

0.04

102

Mental and behavioural disorders due to use of other stimulants, including caffeine

3.99

8.63

1.8

1.4

58.56

72.10

mmol/l

0.37

Other malignant neoplasms of skin (=non-melanoma skin cancer)

485

2481

1.35

8.54

1.3

59.59

63.40

mmol/l

1.36

398

1968

Benign neoplasm of meninges

128

730

1.78

8.53

1.2

1.3

73.63

61.46

mmol/l

2.21

106

590

Injury of other and unspecified intrathoracic organs

331

2.18

8.52

1.6

1.2

54.54

62.43

mmol/l

0.91

265

Inflammatory diseases of female pelvic organs

537

2993

1.32

8.52

1.5

1.4

63.29

62.03

mmol/l

0.27

422

2376

Nonalcoholic fatty liver disease

514

1.93

8.51

1.5

1.3

61.37

63.14

mmol/l

0.14

413

Viral infections of the central nervous system

364

2.12

8.51

1.3

72.58

62.05

mmol/l

1.24

293

Myeloproliferative diseases

102

543

1.91

8.50

1.2

1.3

57.00

61.32

mmol/l

0.63

433

Psoriasis

263

1784

1.48

8.48

1.5

1.4

62.26

63.71

mmol/l

0.20

195

1417

Other congenital malformations

411

2.04

8.47

2.3

2.0

84.54

67.25

mmol/l

1.79

355

Malignant cancer of tonsil and base of tongue, including Hilmo

122

3.03

8.43

1.8

1.3

56.37

65.07

mmol/l

0.47

Burns and corrosions

127

724

1.77

8.43

1.4

59.53

67.59

mmol/l

1.07

578

Chronic laryngitis and laryngotracheitis

144

851

1.71

8.42

1.3

56.49

63.50

mmol/l

1.40

113

679

Other aneurysm

307

2.22

8.42

1.4

1.3

66.15

63.58

mmol/l

0.16

255

Benign neoplasm: Cerebral meninges

118

660

1.81

8.41

1.2

1.3

72.01

61.10

mmol/l

1.79

534

Squamous cell neoplasms and carcinomas of the skin

105

566

1.88

8.40

1.3

60.20

62.20

mmol/l

0.22

440

Exclusion endpoint for clefts

3.38

8.39

4.1

3.1

83.13

75.07

mmol/l

0.28

Colonic or urogenital fistula

254

1715

1.49

8.39

1.4

59.88

64.15

mmol/l

0.90

176

1373

Superficial injury of thorax

148

882

1.69

8.38

1.5

1.3

58.27

63.07

mmol/l

0.77

113

709

Assault by unspecified means

4.05

8.38

1.5

1.4

49.81

66.02

mmol/l

0.72

Vasculitis limited to skin, not elsewhere classified

150

2.81

8.37

1.4

1.2

58.00

60.09

mmol/l

0.12

120

Agoraphobia

3.78

8.36

1.5

1.3

48.57

67.69

mmol/l

1.33

Abnormal blood-pressure reading, without diagnosis

214

2.47

8.34

1.8

1.4

64.62

63.92

mmol/l

0.04

175

Ulcerative colitis, NAS

129

741

1.76

8.34

1.8

1.4

65.08

65.63

mmol/l

0.03

592

Excessive earwax

558

4193

1.30

8.26

1.4

61.50

63.33

mmol/l

0.51

448

3334

Type1 diabetes, definitions combined, early onset

214

2.44

8.23

3.3

2.0

65.82

85.21

mmol/l

2.37

184

Acquired absence of limb

4.72

8.21

1.8

1.3

54.00

66.50

mmol/l

0.51

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

112

621

1.83

8.20

1.4

1.3

53.45

62.99

mmol/l

2.47

490

Other diseases of pericardium

222

2.43

8.20

1.4

70.87

63.94

mmol/l

0.65

175

Gout, strict definition

198

1276

1.57

8.19

1.4

1.3

52.78

63.38

mmol/l

4.12

153

1025

Personal history of other diseases and conditions

428

1.99

8.18

2.8

1.8

69.24

70.76

mmol/l

0.09

359

Dislocation of lens

3.49

8.17

1.2

1.3

64.00

62.36

mmol/l

0.08

Other salmonella infections

169

2.65

8.15

1.8

1.3

49.66

63.63

mmol/l

1.73

140

Other Crohn's disease

298

2.21

8.13

2.5

1.4

66.16

66.38

mmol/l

0.01

244

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

148

888

1.68

8.12

1.3

62.69

61.92

mmol/l

0.08

117

710

Other surgical follow-up care

130

2.90

8.10

2.6

1.4

60.45

64.03

mmol/l

0.20

102

Bullous disorders

372

2.08

8.09

1.3

64.35

60.61

mmol/l

0.34

304

Ovarian dysfunction

181

2.56

8.07

2.5

1.3

74.51

63.62

mmol/l

0.59

157

Diabetic retinopathy, strict definition

190

1071

1.58

8.06

1.4

54.82

60.70

mmol/l

1.68

160

831

Cardiodefibrillation

388

2843

1.37

8.04

1.3

61.92

62.61

mmol/l

0.12

315

2279

Vitamin D deficiency

3.61

8.03

1.3

1.4

68.16

59.83

mmol/l

0.27

Nonischemic cardiomyopathy

105

574

1.85

8.03

1.4

1.3

61.66

64.87

mmol/l

0.32

460

Viral pneumonia (unknown virus, not influenza)

346

2.11

8.02

2.1

1.3

65.68

66.23

mmol/l

0.03

279

Covid-19 suspected case

171

1069

1.61

8.01

1.6

1.4

64.75

65.44

mmol/l

0.07

134

855

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

115

3.04

8.01

1.4

1.3

61.42

62.65

mmol/l

0.04

Other disorders of white blood cells

307

2.19

8.01

1.5

1.4

64.16

62.85

mmol/l

0.10

246

Adverse effects, not elsewhere classified

174

1093

1.60

8.01

1.9

1.5

57.95

64.04

mmol/l

1.24

142

879

Bell's palsy

120

685

1.77

7.97

1.5

1.4

62.13

65.15

mmol/l

0.29

548

Papulosquamous disorders

371

2709

1.38

7.96

1.4

62.81

63.50

mmol/l

0.11

279

2153

Thyroiditis, ILD-related definition

113

634

1.80

7.95

1.4

61.92

64.89

mmol/l

0.34

511

Complications of genitourinary prosthetic devices, implants and grafts

110

3.07

7.95

1.3

57.52

65.44

mmol/l

0.61

Viral infections of the central nervous system

395

2.02

7.91

1.3

1.4

72.43

62.07

mmol/l

1.25

321

Pain in thoracic spine

135

798

1.70

7.90

1.7

1.3

60.83

63.89

mmol/l

0.36

115

615

Polyglandular dysfunction

13.59

7.87

1.2

81.31

62.55

mmol/l

0.46

Use of pramipexole

243

1650

1.48

7.87

1.4

60.17

63.12

mmol/l

0.67

196

1308

Discitis, unspecified

4.15

7.86

1.4

1.3

48.31

51.59

mmol/l

0.13

Pain and other conditions associated with female genital organs and menstrual cycle

140

766

1.69

7.85

1.5

1.4

64.29

64.98

mmol/l

0.06

112

576

Myeloproliferative diseases (CML excluded)

501

1.90

7.85

1.2

1.4

57.49

60.88

mmol/l

0.41

398

Schizotypal disorder

3.84

7.83

1.1

1.3

64.93

67.13

mmol/l

0.07

Neuralgia and neuritis, unspecified

233

2.35

7.83

1.3

63.17

61.11

mmol/l

0.11

183

Convalescence

240

2.32

7.77

1.7

1.4

58.90

62.10

mmol/l

0.24

185

Periapical abscess

392

2898

1.36

7.77

1.4

64.26

63.43

mmol/l

0.12

305

2286

Localized swelling, mass and lump of skin and subcutaneous tissue

299

2115

1.42

7.76

1.5

1.4

62.14

64.53

mmol/l

0.45

243

1685

Anterior Iridocyclitis

194

1261

1.55

7.73

1.3

1.4

62.22

62.77

mmol/l

0.06

161

1005

Iridocyclitis

218

1453

1.51

7.72

1.3

1.4

62.44

62.79

mmol/l

0.04

176

1157

Hyperparathyroidism

222

1469

1.51

7.72

1.4

1.3

55.22

59.72

mmol/l

1.31

181

1160

Other respiratory diseases principally affecting the interstitium

198

1294

1.54

7.72

1.5

1.3

65.22

62.63

mmol/l

0.39

179

1033

Other diseases of blood and blood-forming organs

406

2.00

7.71

1.3

56.06

62.50

mmol/l

0.87

323

Cramp and spasm

229

2.35

7.68

1.6

1.4

59.49

65.49

mmol/l

0.63

193

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

267

2.25

7.68

1.3

51.50

64.83

mmol/l

1.38

208

Speech therapy

274

1914

1.44

7.65

1.6

1.4

60.27

63.17

mmol/l

0.63

241

1521

Burns and corrosions of external body surface, specified by site

103

569

1.83

7.65

1.4

61.51

67.61

mmol/l

0.60

465

Cluster headache, wide

140

2.75

7.63

1.3

65.39

65.88

mmol/l

0.02

120

Abscess of anal and rectal regions

366

2.04

7.63

1.5

1.3

65.42

68.29

mmol/l

0.18

301

Problems related to social environment

146

2.73

7.62

1.3

53.07

65.74

mmol/l

1.13

123

Endocrine disorders, other/unspecified

3.24

7.61

1.4

1.3

62.10

63.37

mmol/l

0.05

Other and unspecified nerve root and plexus disorders, also in other diseases

179

1147

1.57

7.60

1.4

62.87

63.41

mmol/l

0.06

151

916

Non-Hodgkin lymphoma, all, including Hilmo

137

823

1.68

7.59

1.4

1.3

59.02

63.46

mmol/l

0.70

113

655

Basal cell carcinoma

462

2415

1.33

7.56

1.3

58.74

63.51

mmol/l

1.91

378

1923

Other extrapyramidal and movement disorders in other diseases

245

1680

1.47

7.56

1.3

1.4

64.47

63.29

mmol/l

0.17

198

1340

Malignant cancer of tonsil and base of tongue

3.15

7.51

1.8

1.3

54.21

66.82

mmol/l

0.65

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

107

602

1.80

7.51

2.1

1.4

58.61

63.99

mmol/l

0.69

486

Other disorders of the musculoskeletal system and connective tissue

158

987

1.62

7.51

1.4

1.3

60.75

62.77

mmol/l

0.28

130

790

Other and unspecified psoriasis

369

2.03

7.50

1.5

1.4

60.09

60.82

mmol/l

0.05

305

Arthropathies

799

3256

1.25

7.49

1.6

1.5

63.62

64.29

mmol/l

0.16

638

2552

Urticaria and erythema

310

2220

1.40

7.49

1.7

1.5

64.51

64.61

mmol/l

0.01

241

1770

Maltreatment syndromes

165

2.57

7.44

1.7

1.5

62.45

70.34

mmol/l

0.48

146

Diseases of the ear and mastoid process

1061

4415

1.21

7.43

1.4

64.77

63.21

mmol/l

0.52

838

3468

Malignant neoplasm of liver and intrahepatic bile ducts

154

2.66

7.43

1.3

56.64

64.36

mmol/l

0.39

121

Bacterial meningitis

154

2.65

7.41

1.4

77.20

62.89

mmol/l

1.08

136

Other and unspecified vasculitis limited to skin

132

2.80

7.36

1.4

1.2

57.97

61.02

mmol/l

0.17

105

Clear cell adenocarcinoma of kidney

240

2.29

7.36

1.5

1.3

52.12

61.75

mmol/l

1.24

196

Alcoholic gastritis

3.59

7.34

1.8

1.3

52.40

62.25

mmol/l

0.48

Disorders of speech understanding and production

229

2.31

7.34

3.9

1.9

78.79

71.25

mmol/l

0.48

193

Paracetamol or NSAID medication

147

441

1.69

7.34

1.9

1.7

66.84

69.77

mmol/l

0.31

129

347

Cholecystitis

152

946

1.62

7.34

1.8

1.3

58.75

63.85

mmol/l

0.91

122

753

Non-small cell lung cancer, adenocarcinoma, helper endpoint

414

1.96

7.33

1.3

1.4

59.28

60.92

mmol/l

0.13

334

Congenital malformations of the urinary system

312

2.11

7.31

1.6

1.5

59.55

68.81

mmol/l

1.06

257

L01XX Other antineoplastic agents

387

2.00

7.31

1.3

54.05

61.75

mmol/l

1.47

310

Haemorrhoids and perianal venous thrombosis

296

2112

1.41

7.24

1.4

1.3

59.89

65.17

mmol/l

1.64

234

1688

Disorders of tooth development and eruption

127

607

1.70

7.24

1.6

1.5

70.56

64.43

mmol/l

0.79

103

470

Psoriasis vulgaris

171

1098

1.57

7.23

1.6

1.4

61.01

63.86

mmol/l

0.40

125

878

Chronic nephritic syndrome

192

2.44

7.22

1.6

1.3

55.38

63.39

mmol/l

0.85

158

Thyrotoxicosis

247

1713

1.45

7.20

1.5

1.4

62.05

62.84

mmol/l

0.11

200

1363

Mental disorders, not otherwise specified

307

2.10

7.18

1.7

1.4

54.22

65.75

mmol/l

1.29

259

Spondylolisthesis/Spondylolysis

174

1124

1.56

7.17

1.3

60.26

63.20

mmol/l

0.48

136

892

Benign neoplasm: Adrenal gland

481

1.88

7.16

1.5

1.3

61.05

60.89

mmol/l

0.01

387

Other congenital malformations

109

625

1.76

7.15

2.1

1.8

73.93

67.04

mmol/l

0.64

514

Mucosal proctocolitis

105

596

1.78

7.14

1.9

1.4

62.12

65.57

mmol/l

0.27

480

Disorders of optic nerve and visual pathways

495

1.86

7.14

2.0

1.4

69.89

64.88

mmol/l

0.45

410

Other joint disorders

762

3239

1.24

7.10

1.5

65.39

64.02

mmol/l

0.36

593

2536

Toxic effects of substances chiefly nonmedicinal as to source

103

583

1.78

7.09

1.9

1.4

61.39

63.38

mmol/l

0.15

472

Obesity, other/unspecified

264

1858

1.43

7.08

1.3

1.4

64.85

63.83

mmol/l

0.13

202

1486

Pneumococcal septicemia

188

2.44

7.07

1.4

1.6

56.13

69.48

mmol/l

1.38

161

Obstructive hydrocephalus

3.31

7.05

2.0

1.7

99.08

68.53

mmol/l

1.81

Secondary right heart disease

271

2.18

7.03

1.5

1.4

65.19

62.50

mmol/l

0.17

221

Unstable angina pectoris

398

2354

1.34

7.03

1.4

1.3

60.27

62.17

mmol/l

0.50

320

1873

Pyogenic arthritis

378

1.98

7.03

1.4

59.48

66.43

mmol/l

0.63

302

Strabismus

232

1593

1.46

7.02

1.5

77.25

63.84

mmol/l

3.57

185

1291

Shoulder lesions

723

3525

1.25

7.02

1.4

64.38

62.48

mmol/l

0.54

597

2732

Non-Hodgkin lymphoma, all

239

2.26

7.00

1.6

1.3

64.50

62.63

mmol/l

0.12

192

Postprocedural musculoskeletal disorders, not elsewhere classified

478

1.87

6.98

1.5

1.4

61.59

60.85

mmol/l

0.07

386

Menorrhagia

314

1248

1.40

6.95

1.4

63.06

60.41

mmol/l

0.51

247

950

Methotrexate

137

843

1.64

6.94

1.7

1.4

62.82

63.09

mmol/l

0.03

120

682

Glaucoma suspect

390

2936

1.34

6.94

1.4

60.89

62.46

mmol/l

0.36

325

2332

Cervicobrachial syndrome

188

1244

1.52

6.93

1.5

1.4

65.08

63.01

mmol/l

0.29

166

976

Other neurotic disorders

266

2.18

6.92

1.8

1.2

61.40

60.12

mmol/l

0.08

208

Crohn's disease of large intestine

228

2.27

6.86

2.2

1.4

66.87

65.52

mmol/l

0.06

191

Other salmonella infections

191

2.39

6.82

1.8

1.3

49.08

65.08

mmol/l

2.16

153

Other pulmonary heart/vessel disease

308

2.08

6.81

1.5

1.4

64.00

63.19

mmol/l

0.05

253

Diabetic retinopathy

376

1743

1.35

6.81

1.3

1.4

56.90

59.88

mmol/l

0.82

303

1364

Bullous pemphigoid

138

2.69

6.80

1.4

1.3

56.72

59.91

mmol/l

0.17

114

Open wound of abdomen, lower back and pelvis

115

2.83

6.77

2.0

1.3

67.73

65.67

mmol/l

0.08

102

Visual impairment including blindness (binocular or monocular)

447

1.88

6.77

1.9

1.4

68.87

62.69

mmol/l

0.55

359

Atopic dermatitis, strict definition with reimbursement

201

1307

1.49

6.76

1.6

1.7

61.10

69.04

mmol/l

1.68

143

1042

Seropositive rheumatoid arthritis

254

1786

1.43

6.75

1.5

1.3

64.51

62.73

mmol/l

0.27

205

1392

Secondary parkinsonism+Parkinsonism in other disease

162

2.53

6.74

1.3

59.87

60.47

mmol/l

0.03

131

IBD patients in KELA-register

177

1164

1.53

6.73

1.8

1.4

65.47

64.93

mmol/l

0.05

113

936

Other disorders starting during childhood or adolecense, excluding more controls

115

2.77

6.73

3.3

76.85

77.14

mmol/l

0.01

108

Autoimmune polyglandular failure

17.24

6.71

1.3

82.60

67.29

mmol/l

—

Benign neoplasm of mouth and pharynx

114

676

1.70

6.70

1.5

1.3

57.06

62.90

mmol/l

0.82

545

Hepatomegaly and splenomegaly, not elsewhere classified

5.68

6.70

1.2

1.5

47.20

66.48

mmol/l

—

Other and unspecified visual disturbances

101

579

1.76

6.69

1.6

1.4

62.66

62.65

mmol/l

0.00

463

Varicose veins

622

3754

1.26

6.69

1.3

64.91

62.35

mmol/l

0.85

504

2979

Congenital malformations of the circulatory system

133

795

1.64

6.69

1.8

79.38

67.16

mmol/l

1.83

107

654

Basal cell carcinoma, including avohilmo

470

2497

1.30

6.68

1.3

59.43

63.14

mmol/l

1.31

390

1978

Brain meningioma

297

2.09

6.66

1.2

1.4

80.98

61.46

mmol/l

2.81

245

SLE (Finngen)

145

2.59

6.64

1.3

48.97

59.85

mmol/l

0.84

112

Myocarditis

116

2.78

6.64

1.2

71.46

77.63

mmol/l

0.36

Congenital malformations of the urinary system

331

2.02

6.63

1.6

1.5

59.05

68.47

mmol/l

1.11

272

Other and unspecified disorders of skin and subcutaneous tissue

373

1.96

6.61

1.4

59.33

62.67

mmol/l

0.27

295

Left bundle-branch block

408

1.91

6.60

1.3

58.27

63.02

mmol/l

0.52

325

Brain meningioma, including Hilmo

305

2.07

6.59

1.2

1.4

80.06

61.30

mmol/l

2.66

249

Excessive attrition of teeth

441

3401

1.30

6.58

1.5

1.4

60.99

64.91

mmol/l

1.15

358

2686

Dermatophytosis

132

817

1.63

6.58

1.3

62.73

63.36

mmol/l

0.06

102

659

Injury of eye and orbit

109

641

1.71

6.58

1.7

1.4

61.27

66.13

mmol/l

0.48

505

Vitreous haemorrhage

108

635

1.72

6.56

1.4

57.59

62.53

mmol/l

0.66

505

Coxarthrosis

509

2624

1.29

6.54

1.4

1.3

60.73

61.60

mmol/l

0.19

414

2065

Arthrosis

667

2939

1.25

6.54

1.3

61.95

62.05

mmol/l

0.02

540

2283

Acute and subacute iridocyclitis

180

1197

1.51

6.53

1.3

1.4

62.41

62.99

mmol/l

0.07

150

945

Hypermobility syndrome

170

2.44

6.53

2.2

1.5

70.03

70.39

mmol/l

0.02

150

Coxarthrosis, primary

635

4328

1.25

6.53

1.4

1.3

60.18

61.98

mmol/l

0.60

520

3432

Presence of other devices

250

1765

1.42

6.51

1.5

1.3

61.22

62.29

mmol/l

0.18

198

1421

Secondary parkinsonism

165

2.48

6.50

1.3

59.87

60.68

mmol/l

0.04

135

Multiple myeloma, including Hilmo

260

2.15

6.50

1.2

1.3

54.31

63.75

mmol/l

1.43

204

Mental retardation

213

2.28

6.49

4.2

2.6

74.93

72.38

mmol/l

0.12

190

Other and unspecified vascular occlusions

113

675

1.69

6.49

1.6

1.3

60.52

62.44

mmol/l

0.23

528

Radiculopathy

160

1039

1.55

6.49

1.3

62.69

62.26

mmol/l

0.04

130

814

Flat foot [pes planus] (acquired)

563

1.76

6.46

1.2

1.4

68.47

63.22

mmol/l

0.65

450

Other abnormal findings of blood chemistry

241

2.19

6.45

1.4

57.52

65.07

mmol/l

0.73

203

Injuries to unspecified part of trunk, limb or body region

105

616

1.72

6.43

1.5

1.4

56.52

63.71

mmol/l

1.04

500

148

2.56

6.43

1.4

1.3

62.17

61.62

mmol/l

0.02

125

Ulcerative enterocolitis

136

2.62

6.41

2.1

1.3

39.50

66.68

mmol/l

4.86

115

Malignant neoplasm, without specification of site, including Hilmo

275

2.10

6.37

1.2

1.3

54.10

62.60

mmol/l

0.86

211

Other bursopathies

129

801

1.62

6.35

1.4

1.3

63.99

63.44

mmol/l

0.04

104

626

Viral warts

493

1.80

6.32

1.4

1.5

63.93

65.97

mmol/l

0.16

403

Disorders of vestibular function (Vertigo)

481

3711

1.28

6.32

1.4

63.25

61.84

mmol/l

0.35

386

2943

Other specified and unspecified disorders of eye and adnexa

211

2.27

6.31

1.3

1.4

58.03

62.85

mmol/l

0.32

170

Disorders of conjunctiva

738

4859

1.22

6.30

1.4

60.33

64.38

mmol/l

1.85

590

3837

Cutaneous lupus erythematosus

126

2.68

6.28

1.4

1.2

52.89

60.22

mmol/l

0.62

104

Other (seronegative) rheumatoid arthritis, wide

199

1365

1.47

6.23

1.5

1.3

57.67

62.55

mmol/l

1.06

153

1094

D07AA Corticosteroids, weak (group I)

126

780

1.62

6.23

1.4

1.8

59.40

65.99

mmol/l

0.86

104

630

3.62

6.23

1.8

1.3

51.00

59.55

mmol/l

0.68

Portal vein thrombosis

3.04

6.19

1.5

1.3

54.00

66.73

mmol/l

1.07

Specific development disorders of speech and language

274

2.06

6.17

3.6

2.3

74.13

70.35

mmol/l

0.22

230

Pre-eclampsia or poor fetal growth

181

1215

1.49

6.16

1.5

1.4

63.41

64.83

mmol/l

0.18

147

937

Open wound of ankle and foot

564

1.74

6.15

1.5

1.4

55.81

66.68

mmol/l

1.31

454

Emotional disorders and disorders of social functioning with onset specific to childhood

136

2.55

6.15

2.5

3.9

64.07

82.31

mmol/l

1.43

123

Drug-induced hypoglycaemia without coma

3.10

6.14

2.0

1.2

49.35

64.14

mmol/l

1.86

Other embolism and thrombosis

132

833

1.60

6.11

1.4

1.3

58.58

63.72

mmol/l

0.78

674

Retinal detachments and breaks

358

2716

1.32

6.10

1.4

58.55

63.31

mmol/l

1.75

293

2136

Infections with a predominantly sexual mode of transmission

193

1318

1.47

6.10

1.4

60.01

65.06

mmol/l

0.92

157

1022

Malignant neoplasm of other and unspecified parts of tongue

3.25

6.09

1.6

1.4

67.39

66.61

mmol/l

0.02

Subjective visual disturbances

230

1628

1.42

6.07

1.5

1.4

62.04

63.23

mmol/l

0.16

190

1301

Blepharochalasis

313

2332

1.35

6.06

1.3

1.4

58.68

62.27

mmol/l

1.05

260

1844

Ulcerative ileocolitis

171

2.37

6.01

1.6

1.3

63.84

63.81

mmol/l

0.00

149

Vasomotor and allergic rhinitis

289

2089

1.36

5.98

1.5

1.6

67.61

65.83

mmol/l

0.26

222

1650

Sleep apnoea, including avohilmo

907

4708

1.20

5.97

1.4

64.37

62.53

mmol/l

0.64

721

3703

Other fall from one level to another

190

1304

1.46

5.92

1.5

68.75

66.06

mmol/l

0.31

146

1052

In situ neoplasms

384

2955

1.31

5.91

1.3

1.4

59.38

62.79

mmol/l

0.88

313

2354

Superficial injury of forearm

468

1.79

5.86

2.0

1.4

55.94

65.93

mmol/l

1.38

385

Hypertrophic cardiomyopathy

251

2.11

5.86

1.8

1.3

61.26

62.85

mmol/l

0.12

207

Other maltreatment syndromes

2.85

5.86

1.8

1.3

54.12

67.92

mmol/l

0.62

Open wound of shoulder and upper arm

3.06

5.84

1.9

1.3

58.89

65.01

mmol/l

0.33

Diseases of inner ear

542

4213

1.25

5.81

1.4

1.3

63.85

61.91

mmol/l

0.55

432

3356

Ovarian cyst

295

1249

1.37

5.76

1.5

1.3

61.88

60.75

mmol/l

0.17

249

950

Mixed connective tissue disease

363

1.90

5.76

1.4

1.3

60.21

61.88

mmol/l

0.13

295

Exposure to smoke, fire and flames

103

2.77

5.73

1.2

1.3

62.85

61.02

mmol/l

0.08

Atopic dermatitis

419

2673

1.29

5.73

1.6

1.5

59.10

66.95

mmol/l

3.30

316

2126

Rash and other nonspecific skin eruption

577

1.70

5.70

1.4

60.53

65.38

mmol/l

0.59

466

Inflammatory bowel disease, strict (require KELA)

177

1208

1.47

5.70

1.8

1.4

65.47

65.11

mmol/l

0.03

113

966

Dementia in other diseases classified elsewhere

302

1.99

5.68

1.5

1.3

63.93

61.08

mmol/l

0.19

241

Diseases of spleen

2.95

5.68

1.7

1.4

57.47

60.95

mmol/l

0.14

Simple and mucopurulent chronic bronchitis

234

2.12

5.67

1.6

1.5

60.14

62.71

mmol/l

0.14

189

Prurigo nodularis

127

2.57

5.67

1.3

61.31

61.56

mmol/l

0.01

110

Unspecified event, undetermined intent

2.80

5.66

1.2

1.4

58.61

67.49

mmol/l

0.45

Other necrotizing vasculopathies (FG)

387

1.86

5.65

1.6

1.3

53.95

61.69

mmol/l

1.36

302

Mental retardation, wide definition

233

2.12

5.65

4.1

2.5

74.70

70.97

mmol/l

0.20

207

Infections with a predominantly sexual mode of transmission

237

1588

1.39

5.65

1.4

61.67

67.12

mmol/l

1.14

191

1240

Cervicocranial syndrome

579

1.69

5.62

1.3

1.4

59.05

62.36

mmol/l

0.43

447

Cerebral palsy

3.35

5.62

8.3

2.9

87.15

69.39

mmol/l

0.56

Idiopathic pulmonary fibrosis

520

1.73

5.61

1.3

69.01

61.95

mmol/l

0.84

413

Redundant prepuce, phimosis and paraphimosis

151

991

1.52

5.61

1.8

1.4

63.26

67.59

mmol/l

0.63

119

764

Other ulcerative colitis

262

2.05

5.59

2.1

1.4

68.13

66.46

mmol/l

0.07

217

ILD, hospital admissions

158

1060

1.50

5.59

1.4

1.3

65.78

62.87

mmol/l

0.41

142

859

Familial hypercholesterolemia, with ischemic heart disease

105

643

1.65

5.55

1.3

64.93

63.35

mmol/l

0.16

513

Other and unspecified disorders of white blood cells

224

2.13

5.49

1.6

1.3

60.33

61.49

mmol/l

0.07

187

Atypical facial pain

271

2.02

5.49

1.3

58.75

60.02

mmol/l

0.10

222

Gingival hyperplasia

198

2.21

5.48

1.7

1.6

74.53

64.99

mmol/l

0.47

174

ILD, hospital admissions 1, main diag only

143

944

1.53

5.48

1.4

1.3

65.53

63.08

mmol/l

0.32

129

760

Primary ovarian failure

3.39

5.47

4.3

1.3

75.64

59.52

mmol/l

0.73

Sleep apnoea

857

4671

1.19

5.45

1.4

64.53

62.59

mmol/l

0.68

683

3679

Vascular dementia

118

720

1.60

5.44

1.3

57.93

59.02

mmol/l

0.12

572

Other strabismus

177

1216

1.46

5.43

1.5

1.6

77.13

64.58

mmol/l

2.45

142

971

Interstitial lung disease

160

1084

1.49

5.41

1.4

1.3

65.59

62.95

mmol/l

0.37

144

879

Interstitial lung disease endpoints

160

1084

1.49

5.41

1.4

1.3

65.59

62.95

mmol/l

0.37

144

879

Acute pharyngitis

102

618

1.65

5.40

2.6

1.5

73.61

67.71

mmol/l

0.63

496

Fibroblastic disorders

216

1548

1.40

5.37

1.4

1.3

60.34

63.44

mmol/l

0.60

177

1205

Progressive vascular leukoencephalopathy

295

1.97

5.36

1.3

55.13

59.20

mmol/l

0.42

236

Haemolytic anaemias

187

2.23

5.35

1.5

1.3

60.83

65.89

mmol/l

0.34

152

Postmenopausal bleeding

290

1146

1.36

5.34

1.4

1.3

61.29

59.60

mmol/l

0.28

221

868

Hepatocellular carcinoma

119

2.58

5.34

1.2

1.4

62.67

64.56

mmol/l

0.07

Conjunctivitis

647

4459

1.21

5.31

1.4

1.5

59.93

64.37

mmol/l

1.92

521

3535

Cholangitis (primary sclerosing, PSC)

388

1.83

5.30

1.9

1.4

55.26

64.52

mmol/l

1.07

307

Noninflammatory disorders of female genital tract

344

1310

1.32

5.30

1.8

1.4

62.21

61.61

mmol/l

0.09

280

1002

Nail disorders

439

1.77

5.29

1.4

60.09

64.58

mmol/l

0.45

359

Disease of hard tissues of teeth, NOS

516

2160

1.25

5.29

1.4

1.3

63.78

62.15

mmol/l

0.37

423

1704

Drug-induced osteoporosis

3.14

5.29

1.5

1.3

74.80

60.67

mmol/l

0.58

Other interstitial pulmonary diseases

160

1090

1.48

5.27

1.4

1.3

65.59

62.97

mmol/l

0.36

144

882

Certain conditions originating in the perinatal period

279

1.92

5.26

3.1

2.5

86.37

78.32

mmol/l

0.48

240

Other noninflammatory disorders of uterus, except cervix

231

1123

1.39

5.23

1.4

1.3

63.49

59.59

mmol/l

0.77

192

855

Diffuse large B-cell lymphoma, helper endpoint

270

1.99

5.20

1.7

1.4

62.33

63.68

mmol/l

0.08

216

Diffuse large B-cell lymphoma, including Hilmo

270

1.99

5.20

1.7

1.4

62.33

63.68

mmol/l

0.08

216

Diffuse large B-cell lymphoma

270

1.99

5.20

1.7

1.4

62.33

63.68

mmol/l

0.08

216

Herpesviral [herpes simplex] infections

104

646

1.62

5.20

1.4

68.38

64.72

mmol/l

0.46

520

Secondary and unspecified malignant neoplasm of lymph nodes

449

1.75

5.20

1.4

60.22

62.74

mmol/l

0.21

359

Complications of labour and delivery

310

2263

0.76

5.19

1.4

61.44

63.70

mmol/l

0.42

246

1789

Cholangitis (primary sclerosing, PSC), with reimbursement 202

2.85

5.19

1.5

48.63

71.55

mmol/l

1.55

Infective dermatitis

103

640

1.62

5.15

1.4

61.60

64.67

mmol/l

0.29

511

Dislocation, sprain and strain of joints and ligaments of thorax

158

2.31

5.15

1.4

1.3

62.37

64.53

mmol/l

0.08

137

Seronegative rheumatoid arthritis

117

750

1.57

5.14

1.4

1.3

57.45

62.63

mmol/l

0.81

591

!Aliquae complicationes praecoces traumatis

217

2.10

5.12

1.2

1.3

59.73

64.28

mmol/l

0.29

178

Early complications of trauma

217

2.10

5.12

1.2

1.3

59.73

64.28

mmol/l

0.29

178

Chronic tubulo-interstitial nephritis

204

2.14

5.10

1.4

1.3

51.35

60.36

mmol/l

0.95

163

Herpesviral [herpes simplex] infections

189

1337

1.42

5.08

1.4

68.33

64.22

mmol/l

0.67

158

1063

Palmar fascial fibromatosis [Dupuytren]

145

976

1.50

5.08

1.4

1.3

60.03

63.55

mmol/l

0.57

116

764

Other disorders of nervous system

379

1.81

5.07

1.4

62.31

60.70

mmol/l

0.12

304

Symptoms and signs involving emotional state

128

2.46

5.07

1.5

1.4

65.46

68.92

mmol/l

0.16

104

Hypersomnia

3.48

5.06

1.1

1.4

71.33

69.12

mmol/l

0.06

Unspecified misadventure during surgical and medical care

322

1.89

5.06

1.6

1.4

60.02

62.57

mmol/l

0.15

259

Assault by sharp object

3.46

5.05

1.2

1.3

68.64

65.61

mmol/l

0.05

Lesion of lateral popliteal nerve

252

2.01

5.05

1.6

1.3

51.93

60.33

mmol/l

1.00

202

Ill-defined and unknown causes of mortality

591

1.64

5.01

1.4

1.3

61.80

62.42

mmol/l

0.05

471

Pneumothorax

366

1.82

5.00

1.5

1.3

54.89

64.65

mmol/l

1.22

299

Contact with heat and hot substances

246

2.01

5.00

1.4

1.5

62.42

69.53

mmol/l

0.43

205

Infection due to other mycobacteria

2.80

5.00

1.5

1.3

65.67

60.85

mmol/l

0.20

Other demyelinating diseases of the central nervous system

129

2.43

4.98

1.3

1.5

49.17

71.26

mmol/l

2.90

113

Benign neoplasm: Rectum, anus and anal canal

202

1453

1.40

4.97

1.4

1.3

57.87

62.91

mmol/l

1.17

157

1171

Rheumatoid arthritis, including avohilmo

370

2907

1.28

4.94

1.5

1.3

62.23

62.68

mmol/l

0.07

297

2306

Thyrotoxicosis with diffuse goitre

118

767

1.55

4.88

1.3

68.28

61.62

mmol/l

0.85

608

Benign neoplasm: Sigmoid colon

190

1358

1.41

4.86

1.5

1.3

62.34

62.76

mmol/l

0.05

145

1105

Single delivery by forceps and vacuum extractor

337

0.39

4.84

1.3

1.5

71.71

66.19

mmol/l

0.17

259

Benign neoplasm: Pancreas

163

2.26

4.83

1.3

54.48

62.46

mmol/l

0.70

136

Other and unspecified abdominal hernia

243

2.01

4.82

3.3

1.3

57.17

63.66

mmol/l

0.57

203

Carcinoma in situ of skin of other and unspecified parts of face

106

676

1.59

4.82

1.2

1.3

56.82

61.82

mmol/l

0.72

542

Temporomandibular joint disorders, including avohilmo

306

2320

1.30

4.80

1.4

1.5

64.73

64.35

mmol/l

0.05

263

1816

Hemiplegia

278

1.93

4.79

1.7

1.3

68.74

63.51

mmol/l

0.33

222

Acute bronchiolitis

230

1.97

4.78

3.3

2.8

69.39

78.25

mmol/l

0.72

205

Crohn disease (strict definition, require KELA)

264

1.95

4.78

2.3

1.5

69.78

66.18

mmol/l

0.17

222

Other hearing loss

299

2246

1.31

4.78

1.5

1.3

61.25

61.99

mmol/l

0.12

242

1796

Olecranon bursitis

314

1.87

4.77

1.4

1.3

62.96

62.55

mmol/l

0.02

247

Coronary artery bypass grafting

265

1483

1.34

4.77

1.4

1.3

63.10

62.77

mmol/l

0.05

218

1178

Malignant neoplasm of small intestine

120

2.47

4.76

1.8

1.4

62.43

63.62

mmol/l

0.05

Left ventricular outflow tract obstruction (LVOTO), broad definition

537

1.65

4.76

1.5

64.17

65.87

mmol/l

0.12

433

Complications of cardiac and vascular prosthetic devices, implants and grafts

114

2.51

4.76

2.0

1.3

62.09

61.73

mmol/l

0.01

Generalized skin eruption due to drugs and medicaments

217

2.06

4.75

1.3

1.5

70.21

65.99

mmol/l

0.27

179

Disorders of synovium and tendon

450

3176

1.24

4.75

1.4

62.68

62.86

mmol/l

0.03

352

2465

Unspecific neurodegenerative disorder

481

2662

1.24

4.72

1.3

64.64

61.15

mmol/l

1.23

389

2143

Lesion of radial nerve

204

2.09

4.72

1.3

45.70

62.13

mmol/l

2.72

165

Childhood asthma (age<16), excluding more controls

211

1.95

4.72

1.7

1.6

77.08

78.35

mmol/l

0.06

166

Other congenital malformations of circulatory system

127

2.41

4.69

1.8

1.3

89.76

60.23

mmol/l

1.84

109

Chondrocostal junction syndrome [Tietze]

198

2.10

4.68

1.4

1.3

74.12

58.63

mmol/l

1.05

161

Diseases of external ear

303

2338

1.30

4.68

1.4

64.62

63.79

mmol/l

0.12

227

1874

Other disorders of optic [2nd] nerve and visual pathways

360

1.80

4.67

2.0

1.5

72.87

66.37

mmol/l

0.48

294

Urticaria

230

1707

1.35

4.66

1.4

1.5

66.14

64.93

mmol/l

0.16

184

1368

Ocular pain

434

1.72

4.66

1.7

1.4

59.83

65.24

mmol/l

0.62

351

Aortic valve malfunction, age under 60 years

487

1.68

4.65

1.6

1.3

61.71

66.26

mmol/l

0.39

391

Malignant neoplasm of colon

149

1028

1.46

4.65

1.4

1.3

51.29

62.31

mmol/l

3.49

101

820

Pituitary-dependent Cushing's disease

8.75

4.65

1.9

1.1

61.78

61.27

mmol/l

—

Other specified/unspecified dorsopathies

159

2.23

4.65

1.3

60.41

56.97

mmol/l

0.15

127

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

480

1.68

4.64

1.6

1.4

54.60

62.41

mmol/l

1.10

386

Benign neoplasm: Transverse colon

112

730

1.55

4.63

1.4

1.3

57.47

62.96

mmol/l

0.86

593

Other peripheral vascular diseases

450

1.70

4.63

1.4

61.75

63.28

mmol/l

0.11

373

Rare circulating lymphoid malignancy, including Hilmo

153

2.26

4.63

1.5

2.0

74.39

66.49

mmol/l

0.29

127

Disorders of refraction and accommodation

201

1459

1.38

4.58

2.2

1.6

68.23

64.09

mmol/l

0.66

166

1164

Colorectal cancer

226

1641

1.35

4.58

1.4

1.3

57.06

63.87

mmol/l

1.64

154

1318

Dilated cardiomyopathy

113

740

1.54

4.57

1.6

1.3

58.83

63.07

mmol/l

0.56

589

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

421

1.72

4.56

1.3

71.39

61.40

mmol/l

0.97

335

Other necrotizing vasculopathies

483

1.68

4.55

1.6

1.3

51.64

60.58

mmol/l

1.99

391

Lymphoid leukaemia

356

1.79

4.54

1.3

1.6

68.20

63.61

mmol/l

0.29

287

Malignant neoplasm of ovary, including Hilmo

408

1.74

4.54

1.2

1.3

59.77

60.83

mmol/l

0.08

328

Malignant neoplasm of colon, including Hilmo

184

1324

1.40

4.53

1.5

1.3

54.50

63.38

mmol/l

2.45

129

1064

Burn and corrosion of shoulder and upper limb, except wrist and hand

2.63

4.50

1.4

1.5

72.44

63.58

mmol/l

0.29

Autoimmune hyperthyroidism

277

1.89

4.50

1.3

72.10

61.16

mmol/l

0.85

217

Disorders of muscles

546

1.62

4.48

1.3

57.74

65.62

mmol/l

0.89

426

Dystonia

314

1.84

4.47

1.3

1.4

55.37

61.30

mmol/l

0.48

254

Other ill-defined and unspecified causes of mortality

524

1.64

4.46

1.4

1.3

62.08

62.57

mmol/l

0.04

419

Polymyalgia rheumatica

151

1055

1.44

4.45

1.4

1.3

61.57

60.70

mmol/l

0.10

126

841

Cerebral atherosclerosis

2.75

4.45

1.3

63.38

60.30

mmol/l

0.10

Anankastic personality disorder

130

2.33

4.44

1.4

66.67

70.27

mmol/l

0.15

113

Childhood asthma (age<16)

216

1.90

4.44

1.7

1.6

77.08

78.35

mmol/l

0.06

170

Generalized epilepsy, mode (most common among epilepsy diagnosis)

124

2.37

4.43

1.7

1.6

61.91

70.78

mmol/l

0.42

107

Coeliac disease

100

642

1.57

4.42

1.5

1.4

66.08

65.56

mmol/l

0.04

525

Rotator cuff syndrome

561

3336

1.21

4.41

1.3

1.4

64.92

62.24

mmol/l

0.74

462

2588

Status post-ami

262

1517

1.32

4.41

1.4

1.3

60.67

62.40

mmol/l

0.30

202

1212

Unspecified dementia

134

822

1.48

4.40

1.3

65.75

59.89

mmol/l

0.95

106

642

Inguinal hernia

521

2864

1.22

4.40

1.4

65.15

63.45

mmol/l

0.38

416

2248

Xerosis cutis

2.72

4.37

1.9

1.2

50.29

64.43

mmol/l

1.01

Other disorders of veins

366

2901

1.26

4.37

1.4

63.13

62.53

mmol/l

0.10

297

2310

Degenerative macular diseases

133

911

1.47

4.36

1.4

1.3

59.81

61.87

mmol/l

0.26

113

717

Crohn disease (strict definition, require KELA, min 2 HDR)

259

1.91

4.35

2.3

1.5

69.71

66.41

mmol/l

0.15

219

Ulcerative proctitis

252

1.92

4.35

1.8

1.4

65.87

68.04

mmol/l

0.11

213

Personal history of certain other diseases

3.25

4.35

1.2

1.3

37.63

83.29

mmol/l

—

Essential (haemorrhagic) thrombocythaemia

211

2.02

4.34

1.1

1.4

54.09

62.40

mmol/l

0.79

165

Follicular cysts of skin and subcutaneous tissue

156

1101

1.42

4.33

1.4

58.39

64.44

mmol/l

1.18

119

877

Injury of unspecified body region

459

1.67

4.33

1.5

52.76

64.31

mmol/l

2.53

369

Acne vulgaris

204

2.02

4.31

1.5

1.9

75.34

76.54

mmol/l

0.04

180

Other hammer toe(s) (acquired)

191

1287

1.38

4.30

1.2

1.3

63.25

59.95

mmol/l

0.57

153

1008

Respiratory conditions due to other external agents

120

2.38

4.29

1.5

1.3

54.23

64.68

mmol/l

0.77

101

Single spontaneous delivery

262

1811

0.76

4.28

1.3

1.4

64.06

60.54

mmol/l

0.69

213

1443

Multiple myeloma

152

2.21

4.28

1.2

1.4

55.46

63.06

mmol/l

0.67

122

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

152

2.21

4.28

1.2

1.4

55.46

63.06

mmol/l

0.67

122

Other and unspecified mononeuropathies of upper limb

139

2.26

4.27

1.9

1.3

80.15

64.01

mmol/l

0.78

117

Overexertion and strenuous or repetitive movements

522

1.62

4.27

1.8

1.4

61.47

63.51

mmol/l

0.17

425

Seborrhoeic dermatitis

530

1.62

4.27

1.3

1.5

61.19

64.30

mmol/l

0.32

435

Hypothermia

102

2.50

4.26

1.5

1.3

77.18

62.40

mmol/l

0.52

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

290

1.84

4.25

2.2

1.5

68.03

67.59

mmol/l

0.02

243

Other diseases of peritoneum

255

1.91

4.23

1.3

61.78

61.33

mmol/l

0.03

203

Other and unspecified diseases of blood and blood-forming organs

127

2.32

4.23

1.3

50.46

62.78

mmol/l

0.84

111

Polycythaemia vera

200

2.03

4.21

1.3

60.25

62.20

mmol/l

0.12

157

Erythema intertrigo

134

2.28

4.19

1.5

1.3

56.16

64.22

mmol/l

0.47

111

Oligomenorrhoea

121

2.34

4.19

1.6

1.4

62.43

63.31

mmol/l

0.04

Diabetic maculopathy

129

833

1.47

4.19

1.3

54.27

61.05

mmol/l

1.48

106

641

Acute generalized exanthematous pustulosis

249

1.91

4.18

1.3

1.5

67.44

66.57

mmol/l

0.05

207

Other/unspecified rheumatoid arthritis

129

886

1.47

4.18

1.5

1.3

59.65

61.12

mmol/l

0.16

100

711

Pedestrian injured in transport accident

382

1.72

4.11

1.4

1.3

61.06

61.94

mmol/l

0.05

306

Thoracic aortic aneurysm

125

856

1.47

4.11

1.4

1.3

65.46

64.16

mmol/l

0.13

101

699

Moderate visual impairment, binocular

202

2.01

4.11

1.5

74.36

60.59

mmol/l

1.01

164

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

3.27

4.09

1.5

1.4

61.50

66.02

mmol/l

—

Other noninflammatory disorders of vagina

413

1.68

4.08

1.5

1.4

62.40

61.35

mmol/l

0.07

315

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

246

1874

1.31

4.08

1.4

1.5

64.88

66.61

mmol/l

0.23

184

1493

Acetic acid derivatives and related substances

270

1072

1.31

4.08

1.3

1.4

63.68

61.06

mmol/l

0.46

215

842

Gonarthrosis [arthrosis of knee](FG)

680

3352

1.18

4.06

1.3

62.59

62.04

mmol/l

0.13

549

2597

Carpal tunnel syndrome

541

3984

1.20

4.06

1.4

1.3

62.58

62.21

mmol/l

0.07

425

3136

Dermatophytosis

508

4223

1.20

4.04

1.4

61.17

63.99

mmol/l

0.83

410

3315

Multiple myeloma and malignant plasma cell neoplasms

325

1.78

4.04

1.3

1.4

53.23

63.26

mmol/l

1.67

265

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

433

3447

1.22

4.04

1.4

57.81

64.44

mmol/l

2.87

350

2727

Emotional disorders starting during childhood or adolescence

141

2.20

4.03

2.3

2.6

65.19

83.60

mmol/l

1.28

126

Coxarthrosis, primary, with hip surgery

491

3813

1.21

4.02

1.4

1.3

60.59

62.18

mmol/l

0.44

410

3032

Hypotension due to drugs

2.60

4.01

1.7

1.3

49.94

60.84

mmol/l

1.14

Secondary malignant neoplasm of other and unspecified sites

2.48

4.01

1.3

60.63

64.07

mmol/l

0.12

Allergic conjunctivitis

453

3634

1.22

4.01

1.5

1.4

58.12

64.42

mmol/l

2.67

366

2882

Congenital malformations of cardiac septa

343

1.74

4.01

2.0

2.1

76.69

69.60

mmol/l

0.49

294

Delivery

267

1817

0.77

4.01

1.3

1.4

64.28

60.49

mmol/l

0.78

219

1447

Atypical mycobacterium lung infection

2.89

4.00

1.6

1.3

57.62

59.13

mmol/l

0.05

Aortic aneurysm

205

1505

1.34

4.00

1.4

1.3

62.37

64.10

mmol/l

0.26

164

1217

Atopic dermatitis, strict definition

185

1337

1.36

3.95

1.6

1.8

61.27

68.54

mmol/l

1.33

135

1068

Lichen simplex chronicus

164

2.10

3.94

1.4

1.3

56.44

65.30

mmol/l

0.80

138

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

2.96

3.94

1.9

1.4

43.18

66.98

mmol/l

2.25

Vascular dementia (subcortical)

248

1.89

3.93

1.2

1.3

65.38

59.28

mmol/l

0.60

194

Gestational diabetes (for exclusion)

838

0.63

3.91

1.3

1.5

61.77

69.31

mmol/l

0.68

661

Inflammatory diseases of prostate (prostatitis)

101

670

1.52

3.90

1.4

1.3

65.67

65.87

mmol/l

0.01

534

Arterial embolism and thrombosis

358

1.72

3.90

1.5

1.3

55.33

63.02

mmol/l

0.72

295

Benign neoplasm: Vagina

2.84

3.90

1.2

1.4

69.54

64.00

mmol/l

0.23

Additional codes for the location of defect, injury or illness

321

1.76

3.89

1.3

1.4

69.17

62.98

mmol/l

0.43

258

Non-follicular lymphoma

639

1.53

3.89

1.5

1.4

57.13

63.15

mmol/l

0.89

514

Schizoid personality disorder

2.82

3.88

1.8

1.3

36.80

57.95

mmol/l

—

Malignant neoplasm of oesophagus, including Hilmo

186

2.02

3.85

1.2

1.3

56.55

62.27

mmol/l

0.43

150

Malignant neoplasm of small intestine, including Hilmo

159

2.11

3.85

1.8

1.4

61.12

62.70

mmol/l

0.08

125

Cardiac murmurs and other cardiac sounds

430

1.64

3.85

1.7

63.00

66.18

mmol/l

0.23

352

Pre-eclampsia or eclampsia

140

992

1.42

3.84

1.3

1.4

62.85

63.70

mmol/l

0.09

110

773

Other and unspecified coagulation defects

228

1.91

3.84

1.6

1.4

75.45

65.98

mmol/l

0.53

191

Systemic lupus erythematosus

187

2.01

3.80

1.3

1.4

48.97

62.95

mmol/l

1.25

154

Disturbance of activity and attention

324

1.73

3.77

1.7

2.6

73.19

78.49

mmol/l

0.35

277

Other coagulation defects

392

1.67

3.77

1.5

1.4

65.17

64.91

mmol/l

0.01

316

HSIL lesion of the cervix uteri, vagina or vulva

107

724

1.48

3.75

1.6

1.4

54.79

66.24

mmol/l

2.12

570

Labour and delivery complicated by fetal stress [distress]

459

0.53

3.75

1.2

1.5

58.38

69.30

mmol/l

0.71

359

Respiratory tuberculosis, confirmed

2.49

3.75

1.4

1.3

52.94

60.39

mmol/l

0.41

Arterial embolism and thrombosis of lower extremity artery

209

1.94

3.74

1.6

1.3

54.27

61.62

mmol/l

0.60

178

Malignant neoplasm of endocrine gland

386

1.67

3.72

1.4

64.37

64.19

mmol/l

0.01

313

Embolic stroke

289

1.78

3.70

1.4

1.3

61.49

62.09

mmol/l

0.03

230

Ingrowing nail

253

1.84

3.68

1.4

64.66

64.99

mmol/l

0.02

207

Cholecystectomy

652

4818

1.17

3.68

1.6

1.3

62.24

62.31

mmol/l

0.01

523

3827

Parkinson's disease, including avohilmo

160

1171

1.38

3.67

1.3

71.32

62.05

mmol/l

2.12

124

944

Need for immunization against other single viral diseases

2.46

3.67

1.6

1.4

59.31

64.27

mmol/l

0.18

Special screening examination for infectious and parasitic diseases

116

585

1.46

3.66

1.4

1.3

66.00

65.68

mmol/l

0.02

447

Striking against or struck by other objects

243

1887

1.29

3.65

1.6

1.5

61.26

66.33

mmol/l

0.93

193

1500

Special screening examination for neoplasms

261

1.82

3.64

1.5

1.3

59.81

63.45

mmol/l

0.24

198

Superficial injuries involving multiple body regions

117

2.25

3.60

1.5

1.3

45.89

63.75

mmol/l

1.88

105

Thiazolidinediones

111

765

1.46

3.60

1.4

58.77

62.68

mmol/l

0.46

628

Other disorders of bone

144

1039

1.39

3.59

1.3

1.4

63.81

63.48

mmol/l

0.03

111

831

Pedestrian injured in collision with pedal cycle

150

2.09

3.59

1.5

1.3

53.44

61.77

mmol/l

0.46

121

Seropositive rheumatoid arthritis, strict definition

137

982

1.40

3.57

1.4

69.03

62.17

mmol/l

1.12

109

791

Malignant neoplasm of breast, HER2-negative, including Hilmo

377

1992

1.23

3.53

1.4

60.82

62.31

mmol/l

0.27

284

1583

Malignant neoplasm of breast, including Hilmo

377

1992

1.23

3.52

1.4

60.82

62.31

mmol/l

0.27

284

1583

Keratitis

295

2360

1.25

3.52

1.5

1.4

64.34

63.61

mmol/l

0.11

244

1865

Other female pelvic inflammatory diseases

135

968

1.40

3.51

1.5

1.4

65.49

62.12

mmol/l

0.43

105

777

Acute suppurative otitis media

149

1011

1.38

3.51

2.1

1.8

73.80

68.90

mmol/l

0.49

114

812

Seropositive rheumatoid arthritis, wide

254

1999

1.28

3.49

1.5

1.4

64.51

62.55

mmol/l

0.31

205

1596

Outcome of delivery

350

0.49

3.49

1.2

1.4

68.52

63.94

mmol/l

0.16

265

Delayed milestone in childhood

118

2.18

3.48

5.0

4.0

91.83

83.08

mmol/l

0.35

109

ILD-related respiratory insufficiency

208

1.90

3.47

1.2

1.3

71.50

63.64

mmol/l

0.54

171

Diseases of tongue

363

1.67

3.47

1.4

1.3

53.57

59.22

mmol/l

0.74

277

Benign neoplasm: Rectum

171

1277

1.35

3.47

1.4

1.3

56.45

63.31

mmol/l

1.68

132

1030

Malignant neoplasm of breast, HER2-negative

369

1970

1.23

3.47

1.3

1.4

61.20

62.18

mmol/l

0.16

279

1564

Malignant neoplasm of hypopharynx, including Hilmo

3.65

3.46

1.8

1.5

43.46

71.88

mmol/l

1.66

Malignant neoplasm, without specification of site

187

1.95

3.46

1.3

52.85

62.92

mmol/l

0.72

146

Injury of nerves and spinal cord at neck level

100

2.34

3.45

1.6

1.3

57.25

60.59

mmol/l

0.14

Use of other anti-dementia drugs

310

2067

1.25

3.45

1.3

62.42

60.64

mmol/l

0.37

248

1664

Use of memantine

310

2067

1.25

3.45

1.3

62.42

60.64

mmol/l

0.37

248

1664

Other maternal disorders predominantly related to pregnancy

259

2055

0.79

3.45

1.4

64.62

63.39

mmol/l

0.16

206

1613

Prolonged pregnancy

381

0.43

3.43

1.3

1.6

68.93

67.07

mmol/l

0.05

299

Acquired haemolytic anaemia

133

2.14

3.42

1.6

1.3

57.68

64.61

mmol/l

0.48

114

Necrosis of pulp, including avohilmo

426

3540

1.20

3.42

1.6

1.4

64.99

64.43

mmol/l

0.09

324

2771

Orchitis and epididymitis

474

1.57

3.40

1.4

1.3

56.81

68.15

mmol/l

1.65

385

Other/unspecified synovitis and tenosynovitis

635

1.49

3.38

1.4

1.3

64.70

65.02

mmol/l

0.02

497

Chronic mastoiditis

154

2.05

3.38

1.4

1.3

72.29

64.37

mmol/l

0.47

130

Other deformities of toe(s)

203

1.90

3.37

1.3

73.29

60.83

mmol/l

1.00

163

Respiratory tuberculosis, bacteriologically and histologically confirmed

2.35

3.36

1.4

1.3

52.94

60.45

mmol/l

0.42

Other specified disorders of muscle

134

2.12

3.35

1.3

51.50

60.39

mmol/l

0.51

106

Autonomic disorders

108

2.26

3.34

1.2

1.3

82.53

65.15

mmol/l

0.80

Other inflammation of eyelid

117

827

1.42

3.33

1.3

1.4

66.96

63.30

mmol/l

0.37

655

Spasmodic torticollis

148

2.05

3.33

1.4

1.3

56.92

61.40

mmol/l

0.19

128

Psoriasis (vulgaris), strict definition

148

2.05

3.32

1.5

1.3

57.63

63.31

mmol/l

0.34

128

Other diseases of arteries and capillaries

525

1.53

3.32

1.4

1.3

63.25

61.78

mmol/l

0.10

428

Congenital malformations of heart and great arteries

105

705

1.45

3.31

1.8

1.9

74.51

68.01

mmol/l

0.65

579

Myelodysplastic syndrome, including Hilmo

169

1.98

3.31

1.3

1.4

52.88

61.98

mmol/l

0.58

134

Persons encountering health services in circumstances related to reproduction

297

2477

0.81

3.30

1.5

1.6

70.29

63.70

mmol/l

1.48

235

1907

Benign neoplasm: Rectosigmoid junction

263

1.77

3.30

1.6

1.3

55.88

59.24

mmol/l

0.27

214

Burns and corrosions of multiple and unspecified body regions

2.32

3.28

2.0

1.3

56.13

62.16

mmol/l

0.19

Allergic contact dermatitis

680

1.46

3.28

1.5

1.4

63.19

64.87

mmol/l

0.13

541

Optic neuritis

156

2.01

3.25

2.2

1.3

62.85

64.63

mmol/l

0.08

134

Malignant neoplasm of breast

369

1979

1.22

3.25

1.3

1.4

61.02

62.17

mmol/l

0.19

278

1572

Other follicular disorders

301

1.71

3.25

1.5

1.4

65.74

66.70

mmol/l

0.05

251

Fistulae involving female genital tract

2.48

3.24

1.7

1.3

62.30

57.71

mmol/l

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

229

981

1.29

3.24

1.4

1.3

61.38

60.66

mmol/l

0.10

184

776

Septal defects

332

1.66

3.24

2.0

2.2

72.90

72.23

mmol/l

0.04

286

Superficial injury of shoulder and upper arm

625

1.48

3.24

1.5

1.4

65.57

63.58

mmol/l

0.18

509

Female genital prolapse

266

1190

1.27

3.24

1.4

1.3

64.95

60.29

mmol/l

1.02

217

903

Cluster headache, strict, including avohilmo

213

1.85

3.23

1.3

66.71

66.83

mmol/l

0.01

185

6-mercaptopurine

103

2.25

3.23

1.2

2.0

84.94

67.14

mmol/l

0.90

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

561

1.51

3.22

1.4

1.3

60.59

61.97

mmol/l

0.11

451

Other/unspecified enthesopathies of lower limb, excluding foot

317

1.68

3.22

1.4

61.91

64.40

mmol/l

0.17

257

Benign neoplasm of other and unspecified female genital organs

265

1.76

3.22

1.3

1.4

68.03

60.89

mmol/l

0.51

208

Colon adenocarcinoma

113

800

1.42

3.21

1.3

50.92

61.78

mmol/l

2.52

637

Car occupant injured in other and unspecified transport accidents

134

976

1.38

3.21

1.5

1.4

59.45

64.68

mmol/l

0.67

105

770

Injuries involving multiple body regions

178

1.93

3.20

1.4

1.3

46.42

63.99

mmol/l

1.95

149

Tuberculosis, IBD comorbidity

458

1.56

3.20

1.5

1.3

53.78

61.55

mmol/l

1.02

365

Other/unspecified seropositive rheumatoid arthritis

249

1980

1.26

3.18

1.5

1.4

64.86

62.58

mmol/l

0.37

200

1579

Systemic atrophies primarily affecting the central nervous system

251

1.77

3.18

1.6

1.4

59.70

63.01

mmol/l

0.21

206

Myopia

538

1.51

3.18

2.6

1.4

67.81

63.63

mmol/l

0.31

426

Benign neoplasm of middle ear and respiratory system

451

1.56

3.17

1.5

1.4

54.20

61.25

mmol/l

0.86

361

Anuria and oliguria

3.55

3.15

1.3

1.4

62.43

55.97

mmol/l

—

Spondyloarthritis

139

1022

1.37

3.14

1.6

1.3

59.82

63.80

mmol/l

0.57

111

822

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

215

1.82

3.13

1.7

1.5

72.55

67.11

mmol/l

0.25

179

Wet age-related macular degeneration

200

1505

1.30

3.13

1.3

60.71

60.41

mmol/l

0.04

150

1209

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

106

745

1.43

3.13

1.5

1.4

60.65

62.92

mmol/l

0.23

589

Undefined dementia

135

911

1.37

3.12

1.3

65.81

59.74

mmol/l

1.02

107

716

Vertigo of central origin

2.37

3.11

1.5

1.3

55.71

59.21

mmol/l

0.23

Right bundle-branch block

173

1.93

3.11

1.4

1.3

52.37

64.56

mmol/l

1.39

138

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

244

1942

1.26

3.11

1.5

1.4

65.77

62.41

mmol/l

0.60

195

1553

Metatarsalgia

501

1.53

3.10

1.4

1.3

64.91

63.98

mmol/l

0.07

392

Benign paroxysmal vertigo

281

2273

1.24

3.10

1.4

61.32

62.46

mmol/l

0.20

231

1810

Maternal care related to the fetus and amniotic cavity and possible delivery problems

161

1252

0.75

3.10

1.4

1.5

67.13

65.56

mmol/l

0.16

134

967

Restless leg syndrome

116

831

1.40

3.09

1.2

1.4

67.10

62.70

mmol/l

0.50

672

7.81

3.09

1.2

1.0

98.00

70.13

mmol/l

—

Malignant neoplasm of ovary

299

1.69

3.07

1.2

1.3

58.37

60.08

mmol/l

0.11

246

Drug-induced myopathy

6.17

3.07

1.3

1.6

44.57

51.75

mmol/l

—

malignant neoplasm of female genital organs

160

1201

1.33

3.06

1.3

1.4

58.04

61.51

mmol/l

0.57

124

972

Gonarthrosis

580

2838

1.17

3.06

1.3

62.91

61.65

mmol/l

0.31

466

2213

SLE, ICD10

174

1.92

3.06

1.3

1.4

50.31

64.97

mmol/l

1.17

143

SLE, strict definition

174

1.92

3.06

1.3

1.4

50.31

64.97

mmol/l

1.17

143

Other specified/unspecified soft tissue disorders

284

1.71

3.06

1.6

1.2

55.02

62.56

mmol/l

0.74

216

Inguinal hernia, bilateral

592

1.48

3.06

1.4

1.3

69.37

65.56

mmol/l

0.35

474

Conjunctivitis (acute, non atopic)

213

1664

1.28

3.06

1.4

1.5

62.59

65.54

mmol/l

0.46

169

1320

Central retinal artery occlusion

126

2.10

3.05

1.7

1.3

75.19

61.29

mmol/l

0.76

101

Other specified and unspecified retinal disorders

203

1.85

3.05

1.4

1.3

55.19

62.23

mmol/l

0.49

164

Secondary polycythaemia

106

2.20

3.05

1.5

1.3

70.12

61.80

mmol/l

0.43

Cluster headache, wide,, including avohilmo

232

1.78

3.05

1.3

65.60

66.19

mmol/l

0.03

198

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

206

1.82

3.04

3.1

2.9

73.06

81.43

mmol/l

0.52

191

329

1.65

3.04

1.7

1.3

57.71

59.27

mmol/l

0.12

257

Acne

291

1.69

3.04

1.6

1.8

76.20

72.42

mmol/l

0.18

249

Otitis externa

176

1348

1.31

3.04

1.4

66.93

64.95

mmol/l

0.23

137

1092

Other intracranial haemorrhages

189

1.88

3.03

1.5

1.3

66.00

64.29

mmol/l

0.08

154

All dysplastic lesions of the cervix uteri, vagina or vulva

157

1165

1.33

3.03

1.5

1.4

55.26

66.36

mmol/l

3.15

136

909

Memory loss

660

1.45

3.02

1.3

58.82

60.24

mmol/l

0.13

524

Demyelinating diseases of the central nervous system

346

1.63

3.02

1.5

1.4

57.64

65.92

mmol/l

0.96

286

Dronedarone medication

161

1.95

3.02

1.5

1.3

67.79

63.92

mmol/l

0.21

129

Psoriatic and enteropathic arthropathies

643

1.45

3.02

1.3

68.49

65.18

mmol/l

0.26

503

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

2.81

3.02

1.1

1.4

63.50

65.60

mmol/l

0.07

Pleural plaque

586

1.48

3.02

1.4

1.3

59.64

64.13

mmol/l

0.49

473

Malignant neoplasm of accessory sinuses

10.52

3.01

1.0

2.4

52.60

72.00

mmol/l

—

Postprocedural disorders of nervous system

240

1.76

3.01

1.2

1.5

85.49

66.72

mmol/l

1.41

204

Entropion and trichiasis of eyelid

579

1.48

2.99

1.5

1.3

63.30

60.28

mmol/l

0.27

469

Primary coxarthrosis, bilateral

295

2410

1.23

2.99

1.4

1.3

62.92

62.73

mmol/l

0.03

247

1917

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

162

1.94

2.97

1.4

55.24

63.02

mmol/l

0.55

130

Coxibs

258

1082

1.26

2.97

1.3

1.4

64.82

61.50

mmol/l

0.60

213

851

Scabies

604

1.46

2.96

1.5

1.6

69.38

66.64

mmol/l

0.22

488

Enthesopathies of lower limb, excluding foot

160

1214

1.32

2.96

1.3

1.4

62.95

63.33

mmol/l

0.04

132

948

HSIL lesion of the cervix uteri

604

1.46

2.96

1.7

1.4

55.76

67.10

mmol/l

1.72

473

Fracture at wrist and hand level

259

2083

1.24

2.96

1.6

1.4

62.59

64.97

mmol/l

0.46

206

1642

Use of antiglaucoma preparations and miotics

614

1.46

2.95

1.3

60.12

61.29

mmol/l

0.11

483

Mesothelioma

2.90

2.95

1.6

1.3

92.88

62.62

mmol/l

—

Alzheimer disease, including avohilmo

406

2401

1.19

2.95

1.3

63.99

60.89

mmol/l

0.94

331

1934

Parkinson's disease

147

1104

1.34

2.94

1.3

71.59

62.02

mmol/l

2.17

114

893

Idiopathic gout

606

1.46

2.94

1.4

1.3

53.20

63.18

mmol/l

1.82

486

Benign neoplasm: Tongue

163

1.93

2.92

1.6

1.3

54.21

61.78

mmol/l

0.42

138

Malignant neoplasm of pancreas, including Hilmo

525

1.50

2.92

1.3

66.87

62.22

mmol/l

0.41

416

Postpartum haemorrhage

781

0.64

2.92

1.2

1.4

69.96

68.40

mmol/l

0.09

606

Otitis media, unspecified

482

1.50

2.91

2.0

2.1

75.85

71.81

mmol/l

0.30

404

Acanthosis nigricans

6.93

2.90

1.2

1.6

51.83

61.78

mmol/l

—

Unspecified/other endometriosis

296

1.66

2.89

1.3

1.4

62.57

64.07

mmol/l

0.09

223

Myositis

129

2.04

2.88

1.1

1.3

60.65

58.74

mmol/l

0.11

101

Other and unspecified glaucoma

519

1.50

2.88

1.3

58.92

62.61

mmol/l

0.42

410

Other specified/unspecified inflammatory spondylopathies

157

1.92

2.85

1.7

1.4

66.56

64.42

mmol/l

0.08

132

Colorectal adenocarcinoma

177

1367

1.30

2.85

1.4

1.3

57.82

63.93

mmol/l

1.08

120

1099

Inguinal or femoral hernia, bilateral

610

1.45

2.84

1.4

1.3

69.51

65.60

mmol/l

0.37

489

Use of donepezil

144

1815

0.76

2.84

1.2

1.3

65.43

60.22

mmol/l

0.85

109

1455

Rosacea

635

1.44

2.84

1.3

1.4

61.27

63.70

mmol/l

0.22

514

Intussusception

103

2.17

2.82

1.5

54.12

60.60

mmol/l

0.35

Other and unspecified urticaria

150

1137

1.32

2.82

1.5

1.4

65.75

65.30

mmol/l

0.04

127

916

Hyperkinetic disorders

368

1.57

2.81

1.7

2.5

71.43

78.19

mmol/l

0.49

311

Other enthesopathy of foot (+metatarsalgia)

538

1.48

2.80

1.4

1.3

65.27

64.03

mmol/l

0.09

421

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

229

1835

1.25

2.79

1.4

1.3

65.98

64.12

mmol/l

0.25

183

1446

Congenital malformations of eye, ear, face and neck

292

1.65

2.78

1.8

1.7

68.05

70.83

mmol/l

0.18

249

Malignant neoplasm of pancreas

402

1.55

2.78

1.2

1.3

66.57

62.17

mmol/l

0.31

319

Premature rupture of membranes

526

0.61

2.77

1.2

1.5

79.42

67.37

mmol/l

0.92

411

Delivery, wide proxy

237

1566

0.80

2.77

1.3

1.4

65.18

60.46

mmol/l

0.92

188

1256

Other noninflammatory disorders of vulva and perineum

458

1.51

2.77

1.9

1.4

51.28

62.30

mmol/l

1.84

352

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

113

823

1.38

2.76

1.8

1.4

63.90

65.56

mmol/l

0.14

651

Other disorders starting during childhood or adolescence

193

1.81

2.76

3.3

3.1

76.29

79.57

mmol/l

0.16

176

Amiodarone users

673

1.42

2.75

1.5

1.3

68.97

63.06

mmol/l

0.80

544

Enteropathic arthropathies

2.22

2.75

1.3

1.4

65.18

62.71

mmol/l

0.07

Viral warts

152

1160

1.31

2.73

1.5

65.94

66.07

mmol/l

0.01

127

930

Congenital malformations of aortic and mitral valves

211

1.77

2.72

1.2

1.5

80.20

69.33

mmol/l

0.56

178

Tuberculosis, wide

485

1.50

2.71

1.5

1.3

53.62

61.48

mmol/l

1.06

386

Retinal detachment with retinal break

116

853

1.37

2.69

1.3

51.24

63.65

mmol/l

4.54

676

Deviated nasal septum

252

2048

1.23

2.68

1.3

66.05

62.68

mmol/l

0.62

210

1577

Other orthopaedic follow-up care

257

1.69

2.68

1.3

62.76

61.75

mmol/l

0.07

200

Left hemicolectomy

140

1.96

2.68

1.4

1.3

60.68

62.09

mmol/l

0.08

117

Otalgia

446

1.51

2.67

1.4

1.5

61.37

67.01

mmol/l

0.55

361

Burn and corrosion of hip and lower limb, except ankle and foot

2.15

2.66

1.5

1.3

83.81

65.29

mmol/l

0.69

Benign neoplasm: Small intestine

258

1.69

2.66

1.6

1.3

66.41

60.45

mmol/l

0.37

209

Contraceptive management

173

1552

0.78

2.66

1.3

1.4

65.72

63.47

mmol/l

0.25

133

1176

Mesothelioma, including Hilmo

2.44

2.66

1.6

1.5

87.44

61.64

mmol/l

—

Biological medication for rheuma

113

829

1.37

2.66

1.9

1.4

68.58

65.73

mmol/l

0.24

660

Synovial cyst of popliteal space [Baker]

439

1.51

2.65

1.4

1.3

59.80

61.21

mmol/l

0.09

345

Raynaud syndrome

447

1.51

2.65

1.3

1.4

66.80

63.07

mmol/l

0.24

363

Chronic conjunctivitis

162

1.87

2.64

1.3

1.4

56.73

68.20

mmol/l

0.88

132

Bulimia nervosa (incl. atypical)

2.40

2.63

2.1

1.8

65.40

81.52

mmol/l

—

Supervision of normal pregnancy

458

0.63

2.63

1.3

1.4

73.42

65.36

mmol/l

0.47

347

Foreign body in alimentary tract

305

1.62

2.62

1.4

56.76

65.11

mmol/l

0.67

247

Burn and corrosion of trunk

148

1.91

2.62

1.3

1.4

60.14

66.95

mmol/l

0.35

126

Malignant neoplasm of oesophagus

134

1.97

2.62

1.2

1.4

64.63

62.87

mmol/l

0.08

107

Polyarthritis, unspecified

199

1.78

2.61

1.4

54.19

59.99

mmol/l

0.44

162

Dementia in Alzheimer disease

191

1274

1.27

2.61

1.3

62.76

60.11

mmol/l

0.44

149

1018

Alzheimer’s disease (undefined)

0.00

2.61

0.0

1.2

—

56.06

—

therapeutic use

192

1.79

2.60

1.5

1.3

65.17

62.97

mmol/l

0.13

155

Any prescribed medicine buy

6.94

2.60

1.3

3.6

81.50

91.80

mmol/l

—

Allergic rhinitis

196

1539

1.26

2.59

1.6

67.41

67.18

mmol/l

0.02

147

1226

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

125

936

1.34

2.59

1.7

1.4

65.13

64.70

mmol/l

0.03

742

Sequelae of injuries of lower limb

482

1.48

2.58

1.3

55.34

63.33

mmol/l

1.15

388

Presbycusis

152

1160

1.30

2.58

1.4

1.3

59.85

60.82

mmol/l

0.13

124

913

Osteosarcoma

7.50

2.58

3.2

2.1

75.80

74.14

mmol/l

—

Otitis externa, unspecified

581

1.44

2.58

1.5

73.38

65.22

mmol/l

0.69

475

Disorders of aromatic amino-acid metabolism

7.39

2.57

15.0

2.3

94.40

61.86

mmol/l

—

Post-traumatic wound infection, not elsewhere classified

128

1.98

2.57

1.0

1.2

59.61

60.20

mmol/l

0.02

109

Long labour

789

0.67

2.55

1.4

61.16

68.35

mmol/l

0.62

611

Other peripheral vertigo

625

1.42

2.54

1.5

1.3

72.76

62.54

mmol/l

1.35

504

Etanercept

292

1.62

2.54

1.7

1.5

68.92

65.69

mmol/l

0.20

244

Other crystal arthropathies

122

2.00

2.53

1.3

1.4

51.27

59.51

mmol/l

0.61

Oxicams

224

1021

1.25

2.52

1.2

1.4

60.72

61.03

mmol/l

0.04

176

804

Dislocation, sprain and strain of joint and ligaments of hip

224

1.72

2.52

1.6

1.3

62.38

61.68

mmol/l

0.03

188

Malignant neoplasm of bladder, including Hilmo

705

1.39

2.52

1.3

54.30

64.49

mmol/l

2.23

562

Sulfasalazine

208

1671

1.25

2.51

1.4

1.3

63.87

64.22

mmol/l

0.04

175

1325

Fenamates

142

733

1.32

2.51

1.4

1.3

63.00

61.55

mmol/l

0.14

117

578

Other benign neoplasms of skin

335

2823

1.19

2.51

1.3

1.4

61.12

62.87

mmol/l

0.38

267

2238

Acute nephritic syndrome

2.13

2.50

1.5

1.3

52.33

59.95

mmol/l

0.46

Subacute thyroiditis

180

1.80

2.48

1.2

1.4

58.78

59.42

mmol/l

0.03

144

Non-small cell lung cancer, squamous

225

1.70

2.47

1.2

1.3

56.48

62.67

mmol/l

0.55

174

Other enthesopathies

226

1838

1.23

2.45

1.3

1.4

63.91

63.23

mmol/l

0.08

184

1437

Alzheimer disease

349

2158

1.19

2.45

1.3

61.98

61.06

mmol/l

0.18

281

1732

Other specified/unspecified bacterial intestinal infections

407

1.51

2.44

2.7

1.4

54.10

63.05

mmol/l

1.05

331

Astigmatism

327

1.57

2.42

1.6

1.8

67.33

67.52

mmol/l

0.01

270

Viral haemorrhagic fevers, not elsewhere classified/unspecified

132

1007

1.32

2.42

1.3

1.5

55.52

65.69

mmol/l

2.48

107

820

Traumatic secondary and recurrent haemorrhage

6.72

2.42

1.8

64.20

43.50

mmol/l

—

Open wound of wrist and hand

315

2588

1.19

2.42

1.5

1.4

64.85

64.87

mmol/l

0.00

246

2009

Pediculosis, acariasis and other infestations

265

1.63

2.41

1.7

1.3

68.61

65.26

mmol/l

0.18

218

Pre-eclampsia

120

904

1.33

2.41

1.3

1.4

62.46

63.70

mmol/l

0.14

703

Conduct disorder

2.37

2.39

1.3

2.8

37.50

75.36

mmol/l

—

Asthma mixed form (mode), excluding more controls

182

1.77

2.39

1.3

66.60

67.73

mmol/l

0.06

150

Viral infections of central nervous system, not elsewhere classified/unspecified

2.45

2.38

1.1

1.3

69.36

60.15

mmol/l

0.30

Adalimumab

401

1.50

2.38

2.2

1.4

63.22

66.83

mmol/l

0.20

327

Impetigo

190

1.75

2.38

2.2

1.6

57.96

73.30

mmol/l

1.08

160

Exposure to other and unspecified inanimate mechanical forces

369

1.53

2.38

1.8

1.3

72.00

64.88

mmol/l

0.30

302

Ulcerative colitis (strict definition, require KELA)

115

863

1.34

2.38

1.7

1.4

63.90

64.75

mmol/l

0.07

686

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

190

1522

1.25

2.38

1.3

1.4

62.00

64.57

mmol/l

0.38

151

1207

Residual foreign body in soft tissue

205

1.72

2.38

1.8

1.4

65.04

67.56

mmol/l

0.12

161

Medical abortion

530

2507

1.15

2.37

1.3

1.4

62.03

61.38

mmol/l

0.12

416

1990

Left ventricular outflow tract obstruction, narrow definition

260

1.63

2.33

1.3

1.8

76.52

70.84

mmol/l

0.26

220

Paralytic strabismus

436

1.48

2.33

1.3

75.11

62.24

mmol/l

1.23

347

Dermatographic urticaria

307

1.57

2.33

1.2

1.4

61.11

63.45

mmol/l

0.16

257

Voice disturbances

217

1769

1.23

2.33

1.4

64.62

63.70

mmol/l

0.12

180

1417

Unspecified chronic bronchitis

184

1.75

2.32

1.2

63.28

58.89

mmol/l

0.26

149

Other disorders of the genitourinary system

125

954

1.32

2.32

1.5

1.3

62.00

60.93

mmol/l

0.12

111

768

Osteonecrosis due to drugs

2.16

2.31

1.3

60.00

61.29

mmol/l

0.05

Other and unspecified types of non-Hodgkin lymphoma, hilmo

261

1.63

2.31

1.5

1.3

57.94

60.37

mmol/l

0.17

212

Other specified/unspecified hearing loss

528

1.43

2.30

2.2

1.4

62.65

61.16

mmol/l

0.10

412

Oral lichen planus

148

1.85

2.30

1.3

1.4

62.85

57.93

mmol/l

0.22

126

Ptosis of eyelid

103

766

1.35

2.29

1.3

1.4

63.77

60.76

mmol/l

0.35

618

Other misadventures during surgical and medical care

134

1.89

2.28

1.8

1.3

70.65

64.01

mmol/l

0.23

114

Superficial injury of ankle and foot

537

1.42

2.28

1.8

1.6

59.00

68.13

mmol/l

1.32

438

Benign neoplasm: Other and unspecified parts of mouth

193

1.73

2.28

1.4

1.3

60.86

61.12

mmol/l

0.01

158

Poor fetal growth

293

1.57

2.27

1.8

1.6

66.41

66.91

mmol/l

0.03

239

Superficial injury of wrist and hand

137

1063

1.29

2.25

1.4

1.5

67.69

65.71

mmol/l

0.20

110

842

Graves disease, strict definition

514

1.43

2.24

1.3

1.4

72.09

63.70

mmol/l

0.71

412

Parapsoriasis

2.12

2.24

1.4

60.33

62.39

mmol/l

0.07

Malignant neoplasm of heart, mediastinum and pleura

2.37

2.24

1.6

1.5

86.78

64.12

mmol/l

—

Spirochaetal infections, other/unspecified

164

2053

0.80

2.23

1.3

1.4

61.88

64.24

mmol/l

0.33

126

1649

Impacted cerumen

693

1.36

2.22

1.5

66.76

65.19

mmol/l

0.12

562

Benign neoplasm: Duodenum

150

1.82

2.22

1.6

1.3

69.35

63.21

mmol/l

0.27

129

Disorders of parathyroid gland, other and/or unspecified

2.58

2.22

1.2

1.3

49.00

63.12

mmol/l

0.85

Sulfonylureas

350

2380

1.17

2.22

1.4

1.3

56.54

62.18

mmol/l

2.15

274

1922

Benign neoplasm: Caecum

102

762

1.35

2.21

1.3

55.94

62.57

mmol/l

1.38

619

Benign neoplasm: Hypopharynx

3.45

2.21

1.5

1.3

56.50

60.83

mmol/l

—

Nonsuppurative otitis media

139

935

1.29

2.21

2.0

1.7

69.99

68.72

mmol/l

0.11

107

762

Toxic effect of ethanol

150

1.81

2.20

3.9

1.3

60.64

70.15

mmol/l

0.34

124

Thyroiditis

376

1.50

2.20

1.2

1.4

62.62

61.99

mmol/l

0.04

309

malignant neoplasm of male genital organs

214

1061

1.23

2.20

1.3

61.69

65.87

mmol/l

0.82

175

836

Crystal arthropathies, rheuma endpoint

129

1.89

2.19

1.3

51.27

59.14

mmol/l

0.58

Crohn disease (strict definition, all UC cases excluded)

218

1.66

2.19

1.7

1.4

71.25

67.21

mmol/l

0.20

185

Hydrocele

643

1.37

2.19

1.3

1.4

61.29

67.47

mmol/l

0.72

515

Glaucoma secondary to other eye disorders

242

1.63

2.17

1.2

1.3

57.52

62.75

mmol/l

0.36

195

Artrosis, including avohilmo

721

3532

1.12

2.16

1.3

1.4

63.39

62.53

mmol/l

0.20

574

2741

Benign neoplasm: Descending colon

452

1.45

2.16

1.4

1.3

71.02

61.06

mmol/l

1.13

362

Anorexia

2.33

2.16

1.6

1.4

89.89

64.55

mmol/l

—

Ganglion

146

1149

1.27

2.16

1.4

65.81

63.53

mmol/l

0.25

120

891

Contact with other hot fluids

144

1.82

2.15

1.3

1.5

54.79

68.67

mmol/l

0.79

122

Follow-up examination after treatment for malignant neoplasms

603

1.38

2.15

1.3

52.90

61.58

mmol/l

1.41

469

Endometriosis

255

1241

1.21

2.15

1.3

61.81

60.73

mmol/l

0.16

211

944

Tumor necrosis factor alpha inhibitors

731

1.35

2.14

2.0

1.4

68.91

64.45

mmol/l

0.38

583

Other and unspecified injuries of lower leg

346

1.51

2.14

1.6

1.5

63.76

66.36

mmol/l

0.22

288

Other obstructive and reflux uropathy

189

1.70

2.14

1.5

1.3

57.42

71.25

mmol/l

0.98

156

Sequelae of injuries of upper limb

528

1.41

2.13

1.4

1.3

63.53

63.49

mmol/l

0.00

422

Lyme disease

164

2040

0.80

2.13

1.3

1.4

61.88

64.20

mmol/l

0.33

126

1639

Calculus of kidney and ureter

165

2051

0.80

2.13

1.4

68.73

64.21

mmol/l

0.60

126

1639

Retinal haemorrhage

160

1.77

2.11

1.3

83.62

61.26

mmol/l

0.99

130

Arthropod-borne viral fevers and viral haemorrhagic fevers

144

1135

1.27

2.11

1.3

1.5

56.34

65.32

mmol/l

2.15

118

922

Other spirochaetal diseases

166

2058

0.80

2.10

1.4

61.59

64.24

mmol/l

0.39

128

1651

Viral infections of central nervous system, not elsewhere classified/unspecified

2.60

2.09

1.1

1.3

69.45

61.44

mmol/l

0.21

Other spirochaetal diseases

168

2079

0.81

2.09

1.4

61.45

64.32

mmol/l

0.44

129

1667

Panniculitis affecting regions of neck and back

153

1.78

2.08

1.4

1.3

69.38

59.13

mmol/l

0.41

121

Behavioural disorders

2.28

2.08

1.3

2.9

39.44

80.10

mmol/l

—

Endometriosis of rectovaginal septum and vagina

431

1.45

2.07

1.4

55.89

62.07

mmol/l

0.73

334

Pregnancy hypertension

243

1816

1.20

2.07

1.3

1.4

67.25

63.75

mmol/l

0.58

192

1423

Sarcoidosis

109

832

1.32

2.06

1.3

65.54

62.48

mmol/l

0.32

670

Intermittent heterotropia

261

1.58

2.05

1.7

1.9

72.88

69.64

mmol/l

0.18

226

Macular pucker

143

1133

1.27

2.04

1.4

1.3

59.67

63.12

mmol/l

0.47

120

906

Other congenital malformations of skin

200

1.66

2.03

1.4

1.5

97.91

66.50

mmol/l

1.82

171

Secondary malignant neoplasm of respiratory and digestive organs

1.99

2.02

1.4

58.00

61.29

mmol/l

0.11

Spinal instabilities

111

1.91

2.01

1.5

1.3

76.19

57.15

mmol/l

0.97

Malignant neoplasm of stomach, including Hilmo

335

1.50

2.01

1.4

1.3

52.61

63.07

mmol/l

1.71

260

Spontaneous rupture of synovium and tendon

484

1.41

2.01

1.4

1.3

54.36

62.12

mmol/l

0.80

382

Other abnormal products of conception

728

0.74

2.00

1.3

1.5

70.77

66.57

mmol/l

0.35

559

Other disorders of cornea

603

1.37

2.00

1.4

1.3

60.59

62.25

mmol/l

0.15

488

Seborrhoeic keratosis

205

1693

1.22

2.00

1.4

1.3

60.96

63.35

mmol/l

0.38

174

1349

Malignant neoplasm of stomach

280

1.55

1.98

1.3

53.23

63.35

mmol/l

1.39

212

Gonococcal infection

141

1.79

1.97

1.7

1.4

52.00

61.05

mmol/l

0.54

119

Malignant neoplasm of cervix uteri, including Hilmo

112

1.89

1.97

2.2

1.3

60.50

63.69

mmol/l

0.12

Maternal care for known or suspected abnormality of pelvic organs

643

0.72

1.96

1.3

1.5

63.17

67.39

mmol/l

0.31

501

Heterophoria

395

1.45

1.95

1.8

1.6

81.69

64.07

mmol/l

1.75

319

Malignant neoplasm of prostate

209

1030

1.22

1.95

1.3

1.4

61.70

66.03

mmol/l

0.84

172

814

Pleural plaque with presence of asbestos

437

1.43

1.95

1.4

1.3

60.62

65.83

mmol/l

0.47

358

Atrial septal defect

209

1.63

1.94

1.3

2.3

78.62

72.46

mmol/l

0.24

183

Neovascular glaucoma

250

1.57

1.93

1.2

1.3

57.52

62.15

mmol/l

0.31

204

Umbilical hernia

199

1645

1.21

1.93

1.4

1.3

56.94

63.96

mmol/l

1.69

150

1300

Vulvovaginal ulceration/inflammation in other diseases

219

1.61

1.91

2.2

1.4

60.60

64.69

mmol/l

0.25

181

Benign neoplasm of brain and other parts of central nervous system

381

1.45

1.90

1.7

1.5

73.87

62.46

mmol/l

0.93

306

L04AC Interleukin inhibitors

251

1.56

1.90

2.2

1.5

68.22

64.63

mmol/l

0.13

220

Gonarthrosis, primary, with knee surgery

562

3999

1.12

1.89

1.3

63.72

61.37

mmol/l

0.75

464

3163

Other specified/unspecified disorders of bone/cartilage

121

1.84

1.89

1.3

50.00

61.80

mmol/l

1.11

102

Malignant neoplasm of breast, HER-negative

184

1485

1.22

1.89

1.3

1.4

67.14

62.10

mmol/l

0.72

141

1188

Disorders of puberty, all

2.33

1.88

6.9

2.2

101.00

77.47

mmol/l

0.98

Injuries to the wrist and hand

836

5278

1.10

1.88

1.4

63.91

63.86

mmol/l

0.01

668

4170

Systemic lupus erythematosus, unspecified

151

1.74

1.88

1.3

1.4

49.90

63.34

mmol/l

0.91

129

Other and unspecified injuries of shoulder and upper arm

151

1.74

1.88

1.8

1.3

78.48

66.40

mmol/l

0.35

130

Impingement syndrome of shoulder

185

1524

1.22

1.87

1.4

64.49

63.15

mmol/l

0.15

154

1189

Malignant neoplasm of bladder

374

1.45

1.86

1.4

54.68

61.97

mmol/l

0.74

295

1.95

1.86

1.3

1.4

97.50

63.52

mmol/l

1.01

Obstructed labour due to maternal pelvic abnormality

860

0.72

1.85

1.4

58.47

63.29

mmol/l

0.51

663

Adult respiratory distress syndrome

2.24

1.85

2.3

1.4

78.77

59.20

mmol/l

0.54

Congenital malformations and deformations of the musculoskeletal system

422

1.42

1.85

2.7

2.0

74.72

71.99

mmol/l

0.15

360

Idiopathic thrombocytopenic purpura

160

1.70

1.83

1.5

1.4

74.22

63.28

mmol/l

0.34

129

Amblyopia ex anopsia

222

1.59

1.82

1.3

1.6

57.04

72.74

mmol/l

1.28

187

Dislocation, sprain and strain of joints and ligaments at neck level

656

1.33

1.82

1.5

1.4

62.62

65.19

mmol/l

0.22

524

Alzheimer’s disease (Early onset)

327

0.55

1.82

1.3

80.92

60.67

mmol/l

0.96

258

Other secondary coxarthrosis

191

1.64

1.82

1.8

1.3

70.50

61.68

mmol/l

0.61

156

Diabetes mellitus in pregnancy

663

0.74

1.82

1.4

1.5

68.27

69.02

mmol/l

0.04

519

Malignant neoplasm of prostate, including Hilmo

214

1059

1.20

1.81

1.3

60.68

65.81

mmol/l

1.11

175

835

Giant cell arteritis

295

1.51

1.81

1.5

1.3

56.11

61.03

mmol/l

0.53

240

Other disorders of penis

503

1.38

1.80

1.5

63.39

68.30

mmol/l

0.40

407

Single delivery by caesarean section

421

0.69

1.80

1.2

1.5

67.17

65.48

mmol/l

0.09

318

DVT of lower extremities

162

1323

1.23

1.80

1.4

1.3

65.56

63.19

mmol/l

0.28

117

1051

Melanocytic naevi, other sites/unspecified

411

1.42

1.79

1.4

56.31

64.00

mmol/l

0.98

340

Gonococcal infection

146

1.73

1.78

1.7

1.4

52.00

62.25

mmol/l

0.63

122

Tongue abnormality

412

1.42

1.78

1.3

57.31

59.00

mmol/l

0.14

333

Other localized connective tissue disorders

102

1.89

1.77

1.3

77.64

64.81

mmol/l

0.35

Disorder of external ear, unspecified

177

1.65

1.77

1.2

1.3

55.23

62.28

mmol/l

0.51

148

Bruxism

2.11

1.77

1.6

1.4

68.93

73.80

mmol/l

0.11

UC patients in KELA-register (code 208), prior to 1994

240

1.55

1.77

2.2

1.3

62.63

61.83

mmol/l

0.04

197

Malignant neoplasm of breast, ER-negative, including Hilmo

200

1591

1.20

1.76

1.4

66.23

61.71

mmol/l

0.67

154

1267

Carbimazole or st.post thyroidectomy, condition for graves disease

157

1281

1.23

1.76

1.3

1.4

67.50

63.45

mmol/l

0.52

119

1024

Stenosis and insufficiency of lacrimal passages

626

1.33

1.76

1.4

56.59

61.03

mmol/l

0.49

499

Vascular dementia (undefined)

286

1.50

1.75

1.4

1.3

48.31

59.58

mmol/l

1.60

224

Family history of malignant neoplasm

489

1.38

1.74

1.3

1.4

70.16

64.30

mmol/l

0.39

384

Pediculosis, acariasis and other infestations

102

792

1.29

1.74

1.5

71.72

65.37

mmol/l

0.73

635

Acute lymphadenitis

265

1.52

1.74

2.5

1.5

62.91

68.27

mmol/l

0.32

215

Malignant neoplasm of thyroid gland, including Hilmo

397

1.42

1.73

1.2

1.3

63.07

63.80

mmol/l

0.04

324

Primary open-angle glaucoma

326

2744

1.15

1.73

1.3

60.75

61.49

mmol/l

0.13

260

2187

Other and unspecified rosacea

482

1.38

1.72

1.4

60.25

62.60

mmol/l

0.18

389

Temporal arteritis

258

1.53

1.72

1.6

1.3

59.50

60.54

mmol/l

0.08

210

Lateral epicondylitis

654

1.32

1.72

1.3

61.01

62.61

mmol/l

0.12

511

Dacryoadenitis

0.00

1.72

0.0

1.3

—

63.58

—

Benign lipomatous neoplasm of other sites/unspecified

594

1.34

1.72

1.4

1.3

57.15

60.97

mmol/l

0.47

475

Unspecified abortion

202

1.59

1.71

1.4

64.93

66.74

mmol/l

0.08

155

Foreign body in ear

1.93

1.71

1.6

1.4

88.36

72.77

mmol/l

0.53

Benign neoplasm: Ascending colon

123

982

1.26

1.70

1.3

65.29

61.89

mmol/l

0.45

103

796

ILD medications: pirfenidone

2.22

1.69

1.4

1.3

70.25

58.96

mmol/l

0.46

Male infertility

156

1.68

1.69

1.2

1.3

83.15

67.22

mmol/l

0.70

119

Malignant neoplasm of mesothelium and soft tissue

219

1.57

1.68

1.3

1.4

74.04

61.14

mmol/l

0.78

170

Psoriatic arthropathies

544

1.35

1.68

1.3

69.08

65.57

mmol/l

0.25

427

Atrophic disorders of skin

117

930

1.26

1.68

1.5

1.3

67.58

62.85

mmol/l

0.66

738

Bicuspidal aortic valve syndrome

180

1.62

1.67

1.2

1.5

70.71

65.69

mmol/l

0.22

151

All dysplastic lesions of the cervix uteri

117

922

1.26

1.67

1.6

1.4

57.18

66.87

mmol/l

1.87

719

Other and unspecified tonsillitis

176

1227

1.21

1.65

2.2

1.5

65.19

66.97

mmol/l

0.19

140

941

Benign neoplasm of major salivary glands

616

1.32

1.64

1.3

55.60

62.57

mmol/l

1.01

493

Other arterial embolism and thrombosis

150

1.68

1.64

1.3

1.2

58.95

62.67

mmol/l

0.13

129

Vasomotor rhinitis (mode)

419

1.39

1.63

1.4

1.3

65.17

61.88

mmol/l

0.27

339

Other deformity of hallux (acquired)

2.43

1.63

1.0

1.3

65.80

54.00

mmol/l

—

Malignant neoplasm of thyroid gland

352

1.43

1.63

1.2

1.4

64.68

64.70

mmol/l

0.00

286

Follow-up care involving plastic surgery

166

1.64

1.62

1.3

64.44

64.21

mmol/l

0.01

130

Other disorders of conjunctiva

119

953

1.25

1.62

1.3

67.85

64.20

mmol/l

0.43

760

Use of levodopa decarboxylase inhibitor

125

1007

1.25

1.61

1.2

1.3

73.23

62.42

mmol/l

2.20

816

Pollen allergy

756

1.28

1.61

1.8

1.9

64.43

70.13

mmol/l

0.50

622

Urolithiasis

189

2244

0.84

1.61

1.4

68.01

64.26

mmol/l

0.53

141

1799

Abnormal serum enzyme levels

235

1958

1.17

1.61

1.4

60.82

64.66

mmol/l

0.81

194

1560

Perineal laceration during delivery

408

0.65

1.61

1.3

1.6

78.36

68.27

mmol/l

0.41

317

Other congenital malformations of skin

395

1.40

1.60

1.5

72.68

66.08

mmol/l

0.35

325

Enteropathogenic Escherichia coli infection

3.10

1.60

2.5

1.3

72.67

67.85

mmol/l

—

Third [oculomotor] nerve palsy

106

1.82

1.60

1.3

89.54

66.31

mmol/l

0.98

Primary gonarthrosis, bilateral

489

3759

1.12

1.60

1.4

1.3

63.22

61.47

mmol/l

0.47

398

2967

Other predominantly sexually transmitted diseases, not elsewhere classified

776

1.28

1.60

1.4

60.75

66.39

mmol/l

0.56

605

Bacterial, viral and other infectious agents

438

1.38

1.59

1.4

58.75

66.82

mmol/l

0.79

354

Meniscus derangement

466

2808

1.12

1.57

1.4

1.3

65.66

61.80

mmol/l

1.22

368

2183

Congenital malformations of genital organs

369

1.41

1.57

2.2

1.8

76.20

70.54

mmol/l

0.28

315

Effects of foreign body entering through natural orifice

170

1418

1.20

1.56

1.4

61.85

65.64

mmol/l

0.52

134

1130

Suppurative and unspecified otitis media

210

1579

1.18

1.56

1.6

70.72

67.37

mmol/l

0.41

156

1269

Carcinoma in situ of skin of upper limb, including shoulder

184

1.60

1.56

1.3

1.4

55.38

60.11

mmol/l

0.19

148

Glaucoma, exfoliation

111

887

1.26

1.55

1.3

58.82

60.13

mmol/l

0.15

699

Other retinal artery occlusion

130

1.71

1.54

1.6

1.4

53.53

64.66

mmol/l

0.75

104

Other benign neoplasm of uterus: Other parts/unspecified

374

1.40

1.54

1.3

65.48

58.70

mmol/l

0.57

300

Burn and corrosion of wrist and hand

161

1.63

1.53

1.7

1.4

63.00

67.99

mmol/l

0.20

138

Other predominantly sexually transmitted diseases, not elsewhere classified

658

1.29

1.53

1.4

61.60

64.59

mmol/l

0.23

524

Giant cell arteritis with polymyalgia rheumatica

266

1.48

1.52

1.6

1.3

59.50

60.80

mmol/l

0.10

216

Gonarthrosis,primary

826

4687

1.09

1.52

1.3

1.4

64.14

61.32

mmol/l

1.16

668

3694

Inflammatory disease of uterus

615

1.30

1.52

1.3

1.4

58.51

63.61

mmol/l

0.45

489

Other disorders of pigmentation

266

1.48

1.52

1.5

1.4

58.06

62.05

mmol/l

0.26

217

Supervision of high-risk pregnancy

453

0.73

1.50

1.5

1.4

72.13

64.37

mmol/l

0.51

339

Tinnitus

184

1553

1.19

1.50

1.3

1.4

62.40

63.88

mmol/l

0.18

152

1233

Meralgia paraesthetica

162

1.62

1.50

1.1

1.3

81.90

61.99

mmol/l

1.09

137

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

162

1.62

1.50

1.5

53.76

65.68

mmol/l

0.46

138

Tonsillectomy and adenotomy

247

1989

0.86

1.50

1.5

1.7

67.22

67.49

mmol/l

0.03

202

1554

Valgus deformity, not elsewhere classified

2.48

1.49

6.9

1.2

72.78

60.90

mmol/l

—

Congenital malformations and deformations of the musculoskeletal system

536

1.32

1.48

2.5

1.9

73.05

69.72

mmol/l

0.21

448

Carcinoma in situ of skin of trunk

219

1.52

1.47

1.2

1.4

58.08

62.11

mmol/l

0.30

180

Benign neoplasm: Parotid gland

488

1.34

1.47

1.3

55.76

61.75

mmol/l

0.63

393

Alzheimer’s disease (Late onset)

244

1774

1.16

1.47

1.3

62.55

60.71

mmol/l

0.33

195

1417

Maternal care for other known or suspected fetal problems

452

0.73

1.46

1.7

1.6

70.53

69.25

mmol/l

0.06

349

Other and unspecified follicular disorders

171

1.59

1.46

1.4

1.3

63.29

68.64

mmol/l

0.24

145

Obstructed labour due to malposition and malpresentation of fetus

726

0.74

1.46

1.4

61.89

68.82

mmol/l

0.50

566

Infective bursitis

140

1.66

1.45

1.4

1.3

67.89

63.52

mmol/l

0.17

110

Abrasion of teeth

248

2153

1.15

1.43

1.4

57.23

63.52

mmol/l

1.59

199

1713

Hypermetropia

395

1.37

1.43

2.2

1.8

68.66

65.15

mmol/l

0.25

325

Benign neoplasm: Skin of other and unspecified parts of face

711

1.27

1.41

1.3

59.44

62.57

mmol/l

0.38

569

Malignant neoplasm of eye and adnexa

2.29

1.41

1.4

69.67

67.40

mmol/l

—

Parkinson's disease, strict definition

126

1034

1.22

1.41

1.3

72.82

62.20

mmol/l

2.45

842

Polyp of the female genital tract

245

1216

1.16

1.41

1.3

62.92

60.41

mmol/l

0.37

191

925

Benign neoplasm: Anus and anal canal

173

1.57

1.41

1.4

1.3

55.65

63.65

mmol/l

0.62

149

Asthma mixed form (mode)

213

1.51

1.40

1.3

66.60

67.36

mmol/l

0.04

175

Other bursal cyst

1.91

1.40

1.6

1.3

95.29

61.68

mmol/l

1.01

Other benign neoplasms of uterus

441

1.35

1.40

1.3

63.47

58.57

mmol/l

0.43

353

Diseases of middle ear and mastoid

388

2837

1.12

1.39

1.5

67.97

65.22

mmol/l

0.52

293

2255

Universal erythroderma, KELA reimbursement

1.96

1.39

1.6

1.3

67.29

63.43

mmol/l

—

Divergent concomitant strabismus

381

1.37

1.38

1.3

1.4

63.53

63.11

mmol/l

0.02

313

Bronchitis, not specified as acute or chronic

467

1.33

1.38

1.5

1.3

60.31

63.83

mmol/l

0.32

374

Benign neoplasm: salivary glands, exclude unknown (D119)

546

1.31

1.38

1.3

1.4

54.24

62.25

mmol/l

1.07

441

Erectile dysfunction

459

1.34

1.38

1.5

1.4

65.47

67.25

mmol/l

0.13

374

Varicella [chickenpox]

198

1.52

1.38

1.4

78.55

73.93

mmol/l

0.21

167

Donors of organs and tissues

2.21

1.37

1.3

1.2

66.56

77.66

mmol/l

—

Phlebitis and thrombophlebitis (not including DVT)

176

1495

1.18

1.36

1.4

63.41

63.64

mmol/l

0.02

143

1189

Multiple delivery

419

0.67

1.35

1.5

68.41

61.54

mmol/l

0.41

314

Glucosamine medication

484

3503

1.10

1.35

1.3

63.62

61.06

mmol/l

0.78

382

2786

Disorders of puberty

2.16

1.34

8.4

1.8

98.67

77.22

mmol/l

—

Examination and encounter for administrative purposes

216

1.49

1.33

1.4

1.3

69.00

63.12

mmol/l

0.25

170

Alzheimer’s disease (Atypical or mixed)

110

890

1.23

1.33

1.3

57.36

60.52

mmol/l

0.45

693

Alzheimer’s disease (undefined), excluding more controls

0.00

1.33

0.0

1.2

—

57.75

—

Antenatal screening

471

0.76

1.33

1.4

69.59

65.24

mmol/l

0.29

358

Pedal cyclist injured in transport accident

155

1306

1.19

1.33

1.4

67.68

64.89

mmol/l

0.30

129

1038

Sequelae of other and unspecified infectious and parasitic diseases

241

1.46

1.32

1.3

1.4

66.00

65.14

mmol/l

0.04

197

Trigger finger

100

807

1.24

1.32

1.3

59.04

65.16

mmol/l

0.85

627

Postmenopausal atrophic vaginitis

233

1113

1.16

1.32

1.3

63.86

60.22

mmol/l

0.69

185

845

Melanocytic naevi

205

1769

1.16

1.31

1.3

1.4

62.75

64.06

mmol/l

0.20

156

1409

Complications associated with artificial fertilization

0.00

1.31

0.0

1.7

—

76.42

—

Bacterial, viral and other infectious agents

411

1.34

1.31

1.4

58.91

66.79

mmol/l

0.69

332

Postpartum hemorraghe, all women as controls

773

0.76

1.30

1.2

1.5

69.96

68.29

mmol/l

0.10

602

Abdominal aortic aneurysm (AAA)

581

1.28

1.30

1.4

1.3

57.31

65.27

mmol/l

1.19

474

Normal-pressure hydrocephalus

369

1.36

1.30

1.6

1.3

70.73

59.93

mmol/l

1.22

298

Brachial plexus disorders

369

1.36

1.29

1.5

1.4

54.30

65.56

mmol/l

1.32

290

Embedded and impacted teeth

786

0.79

1.28

1.7

1.6

68.65

70.66

mmol/l

0.13

638

Other secondary gonarthrosis

319

1.39

1.27

1.4

1.3

58.11

60.39

mmol/l

0.22

253

Sudden idiopathic hearing loss

633

1.27

1.2

1.4

65.21

63.94

mmol/l

0.10

511

Carcinoma in situ of cervix uteri

319

1.38

1.27

1.3

1.5

62.23

64.65

mmol/l

0.13

264

Carcinoma in situ of skin

652

1.26

1.2

1.3

63.72

61.03

mmol/l

0.22

524

Pyoderma

1.76

1.26

5.6

1.3

67.00

63.72

mmol/l

0.06

Dislocation, sprain and strain of joints and ligaments of knee

322

3319

0.89

1.25

1.5

1.4

61.20

65.33

mmol/l

1.07

251

2595

Dysplasia of cervi uteri

138

836

1.20

1.24

1.5

1.4

53.92

62.89

mmol/l

2.20

120

625

Hallux rigidus

117

969

1.21

1.23

1.3

67.32

63.42

mmol/l

0.48

764

Other otitis externa (chronic)

364

1.35

1.23

1.2

1.4

62.83

63.50

mmol/l

0.04

299

Serous carcinoma of ovary, including Hilmo

204

1.48

1.23

1.3

1.4

63.04

61.05

mmol/l

0.10

165

Impacted teeth

541

0.74

1.23

1.8

1.6

72.84

72.54

mmol/l

0.01

443

Melanocytic naevi of trunk

636

1.26

1.23

1.2

1.4

73.87

63.22

mmol/l

1.52

513

Spontaneous abortion

229

1764

0.87

1.22

1.4

68.57

63.28

mmol/l

1.05

185

1387

Bursitis of shoulder

116

1.65

1.22

1.3

80.79

56.96

mmol/l

0.78

Tuberculosis

408

1.33

1.22

1.5

1.3

54.44

61.49

mmol/l

0.90

325

Crowding of teeth, including avohilmo

272

1.37

1.21

3.4

2.5

83.56

79.72

mmol/l

0.17

239

Benign neoplasm: Other and unspecified parts of small intestine

101

1.70

1.21

1.5

1.3

61.30

61.09

mmol/l

—

Malignant neoplasm of rectum, including Hilmo

772

1.23

1.21

1.4

1.3

61.55

62.97

mmol/l

0.12

612

Varicella [chickenpox]

246

1.43

1.21

1.5

1.8

78.93

75.08

mmol/l

0.20

213

Congenital iodine-deficiency syndrome/hypothyroidism

189

1.49

1.19

1.5

1.4

60.45

61.62

mmol/l

0.05

149

Suggestive for eosinophilic asthma

524

1.28

1.18

1.3

71.24

63.79

mmol/l

0.70

422

Undescended testicle

1.90

1.18

5.3

3.1

86.58

84.22

mmol/l

0.05

Other acquired deformities of musculoskeletal system and connective tissue

256

1.41

1.18

1.2

1.3

55.79

62.13

mmol/l

0.46

205

Crushed, pushed or stepped on by crowd or human stampede

290

1.38

1.17

2.1

1.4

63.85

72.41

mmol/l

0.63

234

Hypertrophic disorders of skin

248

1.42

1.17

1.3

1.4

52.46

66.27

mmol/l

1.42

202

Vertical strabismus

182

1.49

1.16

1.5

1.4

97.24

62.99

mmol/l

2.09

150

Pedal cyclist injured in other and unspecified transport accidents

606

1.26

1.15

1.3

1.4

63.14

64.68

mmol/l

0.12

485

Rare circulating lymphoid malignancy

2.38

1.13

1.4

1.3

48.00

69.92

mmol/l

—

Fourth [trochlear] nerve palsy

127

1.59

1.12

1.3

79.86

62.13

mmol/l

0.77

109

Ulcerative rectosigmoiditis

379

1.32

1.12

1.5

1.4

57.73

65.32

mmol/l

0.66

311

Atopic conjunctivitis

209

1.44

1.10

1.6

1.5

68.91

72.35

mmol/l

0.13

172

Puerperal sepsis

708

0.77

1.10

1.5

1.4

64.91

65.28

mmol/l

0.02

552

Pedal cyclist injured in noncollision transport accidents

610

1.25

1.10

1.4

68.51

65.91

mmol/l

0.16

493

Ankylosing spondylitis

389

1.32

1.10

1.5

1.3

61.36

64.64

mmol/l

0.26

308

Convergent concomitant strabismus

243

1.40

1.09

1.2

1.5

73.63

67.74

mmol/l

0.21

202

Corneal scars and opacities

152

1.52

1.09

1.1

1.3

62.50

60.15

mmol/l

0.11

130

Cholesteatoma of middle ear

328

0.67

1.09

1.2

1.4

66.06

61.72

mmol/l

0.18

264

Corneal ulcer

128

1084

1.18

1.09

1.6

1.4

66.24

64.27

mmol/l

0.19

105

864

Acute nasopharyngitis (common cold)

563

1.26

1.08

1.4

59.09

64.96

mmol/l

0.62

439

FESS (DNB20)

666

1.23

1.08

1.2

1.4

68.70

64.24

mmol/l

0.45

535

Postpartum hemorraghe, parous women as controls

649

0.79

1.07

1.2

1.4

69.96

68.52

mmol/l

0.08

508

Carcinoma in situ of other and unspecified digestive organs

211

1.43

1.07

1.6

1.3

53.25

61.15

mmol/l

0.74

177

Contusion of other and unspecified parts of foot

194

1.45

1.07

1.9

1.5

55.80

72.21

mmol/l

1.55

168

Disorders of optic nerve, not elsewhere classified

121

1.58

1.06

1.2

1.3

48.07

61.44

mmol/l

0.57

105

Arthropathic psoriasis

641

1.24

1.05

1.3

1.4

65.85

64.32

mmol/l

0.10

515

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

1.68

1.04

1.7

1.4

81.10

63.58

mmol/l

—

Complications predominantly related to the puerperium

1143

0.83

1.04

1.4

63.05

64.39

mmol/l

0.10

884

Toxic effect of alcohol

1.68

1.04

5.8

1.3

65.67

65.19

mmol/l

—

Carcinoma in situ of skin, other sites/unspecified

1.65

1.04

1.2

1.3

51.70

62.37

mmol/l

—

Papillary adenocarcinoma of thyroid gland

263

1.38

1.04

1.3

1.4

67.33

62.73

mmol/l

0.21

215

Gluteal tendinitis

171

1.47

1.02

1.3

65.45

59.20

mmol/l

0.30

137

Other and unspecified injuries of ankle and foot

171

1.47

1.02

1.5

1.3

56.27

70.10

mmol/l

0.90

147

Chronic iridocyclitis

281

1.36

1.02

1.2

1.5

60.19

62.91

mmol/l

0.22

229

Dental pulpitis, including avohilmo

647

3910

1.07

1.01

1.5

1.4

65.28

63.78

mmol/l

0.35

503

3063

Malignant melanoma, including Hilmo

130

1111

1.17

1.01

1.2

1.3

62.72

64.90

mmol/l

0.23

107

888

Primary hyperparathyroidism

799

1.21

1.01

1.3

54.75

61.41

mmol/l

1.24

644

Viral haemorrhagic fevers, not elsewhere classified/unspecified

421

1.29

1.01

1.4

1.3

47.61

62.51

mmol/l

3.11

342

Benign neoplasm: Skin of ear and external auricular canal

222

1.40

1.01

1.2

1.3

55.00

61.13

mmol/l

0.39

184

Dentofacial anomalies [including malocclusion]

480

3554

1.09

1.00

1.6

1.5

65.32

64.33

mmol/l

0.19

402

2782

Non-small cell lung cancer, squamous, helper endpoint

282

1.35

1.00

1.2

1.3

56.48

64.56

mmol/l

0.81

228

Burns and corrosions confined to eye and internal organs

1.63

1.00

1.1

1.3

55.64

65.15

mmol/l

0.40

Patent foramen ovale

107

1.60

1.00

3.5

1.9

78.12

69.87

mmol/l

0.36

L02BX Other hormone antagonists and related agents

317

1.33

1.00

1.2

1.3

61.06

66.37

mmol/l

0.41

265

Other and unspecified injuries of wrist and hand

189

1.44

0.99

1.5

1.6

58.55

63.55

mmol/l

0.29

155

Tarsal tunnel syndrome

1.86

0.99

1.3

57.00

64.37

mmol/l

—

False labour

629

0.82

0.98

1.2

1.5

74.34

68.93

mmol/l

0.45

489

Open wound of hip and thigh

140

1.51

0.97

1.3

1.4

55.45

66.04

mmol/l

0.28

121

Other bursitis of hip

116

1.56

0.97

1.3

54.58

57.75

mmol/l

0.12

Ectopic pregnancy

821

1.20

0.97

1.3

1.4

68.13

63.38

mmol/l

0.45

639

Biomechanical lesions, not elsewhere classified

284

1.34

0.97

1.2

1.3

64.85

61.63

mmol/l

0.16

233

Pustulosis palmaris et plantaris

224

1.39

0.96

1.3

1.4

65.95

59.94

mmol/l

0.22

188

Chondropathies

100

840

1.19

0.96

1.3

1.4

69.49

63.41

mmol/l

0.63

676

Spirochaetal infections, other/unspecified

541

1.24

0.96

1.3

1.4

58.78

61.90

mmol/l

0.24

437

Radial styloid tenosynovitis [de Quervain]

233

1.38

0.95

1.3

64.35

64.55

mmol/l

0.01

179

Combinations of oral blood glucose lowering drugs

222

1981

1.12

0.95

1.3

60.40

63.54

mmol/l

0.61

171

1597

Birth asphyxia

1.92

0.95

2.3

2.7

69.86

92.17

mmol/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

533

1.24

0.94

1.3

1.4

51.35

62.32

mmol/l

1.84

426

Glaucoma-related operations

444

1.27

0.94

1.3

52.91

60.15

mmol/l

0.76

355

Lesion of plantar nerve

373

1.29

0.94

1.3

62.55

60.00

mmol/l

0.17

302

Injury of muscle and tendon at wrist and hand level

760

1.20

0.94

1.3

64.43

63.52

mmol/l

0.07

598

Melanocytic naevi of upper limb, including shoulder

101

1.59

0.94

1.6

1.3

66.00

67.33

mmol/l

—

Other psoriatic arthropathies

561

1.23

0.93

1.3

69.68

63.72

mmol/l

0.47

447

Disorders in reading

1.74

0.92

2.0

3.2

84.00

83.38

mmol/l

—

Ethmoidectomy

698

1.21

0.92

1.2

1.4

69.60

63.90

mmol/l

0.63

564

Non-allergic asthma

543

0.77

0.92

1.6

1.4

61.97

66.07

mmol/l

0.22

437

Alzheimer’s disease, strict definition

252

1869

1.11

0.91

1.3

63.33

60.78

mmol/l

0.51

203

1493

Crossbite

298

1.31

0.90

5.0

2.5

70.11

74.67

mmol/l

0.26

263

Foreign body or object entering through skin

288

1.32

0.89

1.5

1.4

75.20

66.34

mmol/l

0.27

240

Primary angle-closure glaucoma

306

1.31

0.89

1.2

1.3

60.72

59.78

mmol/l

0.06

245

Iridocyclitis in diseases classified elsewhere

1.59

0.88

1.5

1.4

76.10

61.56

mmol/l

—

Reactive arthropathies, FINNGEN

351

1.29

0.87

1.5

1.4

55.03

65.46

mmol/l

1.32

278

Malignant melanoma

106

906

1.17

0.86

1.3

62.51

63.52

mmol/l

0.08

718

Malignant neoplasm of other and unspecified parts of biliary tract

1.68

0.85

1.2

1.5

55.29

63.75

mmol/l

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

595

1.21

0.85

1.5

1.4

71.00

62.66

mmol/l

0.70

479

Typhoid and paratyphoid fevers

1.96

0.85

1.0

1.3

95.50

54.31

mmol/l

—

Respiratory tuberculosis, confirmed and not-confirmed

335

1.29

0.85

1.6

1.3

53.60

61.51

mmol/l

0.86

265

Respiratory tuberculosis

335

1.29

0.85

1.6

1.3

53.60

61.51

mmol/l

0.86

265

Hypertrophic scar

230

1.35

0.85

1.4

53.64

66.91

mmol/l

1.26

186

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

1.79

0.84

1.1

1.2

82.63

60.53

mmol/l

—

Ménière disease

651

1.20

0.84

1.2

1.3

65.03

61.30

mmol/l

0.36

527

Pustular psoriasis

248

1.34

0.84

1.3

67.78

60.71

mmol/l

0.29

201

Benign neoplasm of breast

808

1.18

0.83

1.3

1.4

55.68

60.72

mmol/l

0.77

640

1.76

0.83

1.3

1.2

58.00

61.44

mmol/l

—

Struck by thrown, projected or falling objec

231

1.35

0.83

1.7

1.5

83.61

67.37

mmol/l

0.86

195

Procreative management

206

1540

1.12

0.82

1.9

1.6

70.86

65.27

mmol/l

0.88

169

1191

Other disorders of patella

101

864

1.17

0.82

1.4

66.21

64.93

mmol/l

0.10

677

Prolapse and hernia of ovary and fallopian tube

316

1.29

0.82

1.1

1.3

59.06

57.17

mmol/l

0.13

242

Disorders of vitreous body and globe

441

3939

1.08

0.81

1.3

61.90

62.07

mmol/l

0.03

352

3135

Disorders of vitreous body

428

3841

1.08

0.81

1.3

1.4

61.86

62.05

mmol/l

0.03

344

3057

Fall on and from ladder

427

1.25

0.81

1.2

1.4

66.78

65.20

mmol/l

0.09

347

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

268

2122

1.10

0.80

1.4

67.06

63.41

mmol/l

0.68

212

1664

Propionic acid derivatives

253

1151

1.11

0.80

1.3

1.6

66.82

63.64

mmol/l

0.50

206

915

Eustachian salpingitis and obstruction

294

1.30

0.79

1.1

1.5

63.17

68.51

mmol/l

0.20

244

Paranoid personality disorder

1.68

0.79

1.1

1.3

68.80

63.03

mmol/l

—

Nasal polyp

133

1167

1.14

0.78

1.3

68.34

63.30

mmol/l

0.68

105

918

Primary open-angle glaucoma, strict

250

2271

1.10

0.78

1.4

1.3

61.41

61.42

mmol/l

0.00

200

1812

Perforation of tympanic membrane

593

1.20

0.77

1.5

1.4

62.94

63.77

mmol/l

0.06

482

Appendectomy

459

4097

1.07

0.77

1.5

1.4

64.28

64.03

mmol/l

0.04

365

3198

Malignant neoplasm of corpus uteri, including Hilmo

732

1.18

0.77

1.3

57.57

61.37

mmol/l

0.42

589

Malignant neoplasm of rectum

576

1.20

0.76

1.5

1.4

65.78

62.20

mmol/l

0.26

462

Recurrent dislocation of patella

132

1.44

0.76

1.2

1.5

57.86

71.84

mmol/l

0.82

115

Other juvenile arthritis

149

1.41

0.75

1.6

1.9

59.20

74.63

mmol/l

0.77

127

Vascular syndromes of brain in cerebrovascular disorders

306

1.28

0.75

1.4

1.3

66.67

60.34

mmol/l

0.41

251

Ulcerative colitis (strict definition, all Crohn cases excluded)

724

1.18

0.75

1.5

1.4

66.19

66.06

mmol/l

0.01

572

Psoriatic arthropathies, ICD10

577

1.20

0.75

1.3

69.68

63.75

mmol/l

0.47

461

Other and unspecified mononeuropathies of lower limb

158

1.40

0.75

1.7

1.3

41.59

59.05

mmol/l

2.44

129

Contact with machinery

603

0.81

0.74

1.2

1.3

73.15

64.47

mmol/l

0.65

494

Artificial joint operation, meniscal resection

809

4989

1.05

0.74

1.4

63.52

61.74

mmol/l

0.62

650

3911

Myocardial infarction, unclassifiable

204

1645

1.11

0.74

1.5

1.3

62.98

61.51

mmol/l

0.19

163

1315

Sequelae of infectious and parasitic diseases

414

1.24

0.74

1.4

64.24

63.02

mmol/l

0.07

332

Other other unspecified disorders of the circulatory system

210

1.34

0.74

1.2

1.5

65.73

62.48

mmol/l

0.12

174

Haemorrhage in early pregnancy

117

1299

0.88

0.73

1.3

1.4

70.73

63.44

mmol/l

0.94

1009

Benign neoplasm: Rectum/anal canal icd-9

1.69

0.73

1.1

1.3

75.50

62.38

mmol/l

—

Foreign body in respiratory tract

281

1.29

0.72

1.2

1.5

61.54

64.89

mmol/l

0.14

226

Acute laryngitis and tracheitis

462

1.22

0.72

2.8

1.7

69.27

69.20

mmol/l

0.00

372

Adenocarcinoma and ductal carcinoma of pancreas

185

1.36

0.72

1.2

1.4

63.15

63.57

mmol/l

0.01

149

Other infective otitis externa

317

1.27

0.72

1.6

1.4

62.26

63.44

mmol/l

0.06

262

Other nonscarring hair loss

1.76

0.71

1.1

1.4

44.14

70.68

mmol/l

—

Deep bite

492

1.20

0.71

3.0

2.0

66.71

72.60

mmol/l

0.41

418

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

467

0.79

0.71

1.5

1.4

70.03

63.50

mmol/l

0.39

367

Malignant neoplasm of corpus uteri

646

1.18

0.71

1.3

57.45

61.65

mmol/l

0.49

519

Allergic urticaria

435

1.22

0.70

1.5

1.4

72.65

65.05

mmol/l

0.58

356

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

388

0.77

0.70

1.1

1.4

65.21

60.81

mmol/l

0.21

313

Peritonsillar abscess

115

1009

1.14

0.70

2.2

1.4

61.69

64.38

mmol/l

0.25

788

Deep endometriosis

546

1.19

0.69

1.4

55.04

62.87

mmol/l

1.08

442

Anogenital herpesviral [herpes simplex] infection

364

1.24

0.69

1.4

62.15

65.17

mmol/l

0.20

310

Other/unspecified disorders of vestibular function

266

1.28

0.68

1.4

1.3

63.15

60.64

mmol/l

0.14

211

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

383

1.23

0.68

1.3

1.4

56.09

59.57

mmol/l

0.25

309

Other puerperal infections

192

0.68

1.4

69.00

70.16

mmol/l

—

164

Ectropion of eyelid

276

1.27

0.67

1.1

1.3

56.82

61.73

mmol/l

0.37

222

Disorders of orbit

233

1.29

0.64

1.2

1.3

64.36

60.20

mmol/l

0.24

186

Other contact dermatitis

395

1.22

0.64

1.4

61.92

64.57

mmol/l

0.15

318

Episcleritis

251

1.28

0.64

1.2

1.3

61.58

62.32

mmol/l

0.03

215

Premenstrual syndrome

1.73

0.64

2.2

1.8

65.60

72.61

mmol/l

—

conjunctival haemorrhage

507

1.19

0.62

1.4

1.3

69.68

64.21

mmol/l

0.44

402

Caries of enamel

659

4524

1.05

0.61

1.6

1.5

66.14

63.82

mmol/l

0.62

545

3537

Vestibular neuronitis

563

1.18

0.61

1.4

1.3

63.81

61.42

mmol/l

0.18

453

Triptan medication for migraine, single purchase ok

473

3390

0.94

0.60

1.5

69.27

63.76

mmol/l

1.69

379

2648

Migraine, single triptan purchase ok & required. ICD-code if available is included

473

3390

0.94

0.60

1.5

69.27

63.76

mmol/l

1.69

379

2648

Nontoxic multinodular goitre

165

1499

1.10

0.59

1.3

60.02

61.07

mmol/l

0.14

128

1190

Unspecified lump in breast

117

1043

1.12

0.59

1.3

1.4

54.70

62.87

mmol/l

1.73

829

Hordeolum and other deep inflammation of eyelid

290

1.24

0.59

1.7

1.4

58.44

64.35

mmol/l

0.30

232

Thyrotoxicosis with toxic multinodular goitre

418

1.20

0.59

1.5

1.3

56.71

60.13

mmol/l

0.24

339

Other benign neoplasms of connective and other soft tissue

566

1.17

0.58

1.3

1.4

65.53

63.78

mmol/l

0.12

454

Pregnancy, childbirth and the puerperium

251

1417

0.92

0.58

1.3

1.4

63.00

59.72

mmol/l

0.62

196

1138

Foreign body entering into or through eye or natural orifice

437

1.19

0.58

1.3

1.4

59.95

66.28

mmol/l

0.47

353

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

282

1.24

0.58

1.2

1.4

74.96

65.83

mmol/l

0.43

229

Calcaneal spur

1.49

0.57

1.0

1.2

71.50

64.77

mmol/l

—

Sixth [abducent] nerve palsy

211

1.29

0.57

1.4

1.3

66.38

61.41

mmol/l

0.20

174

L02BG Aromatase inhibitors

231

2492

0.92

0.57

1.3

1.4

57.44

61.62

mmol/l

1.02

178

1972

Injury of muscle and tendon at lower leg level

820

1.14

0.57

1.8

1.4

57.28

64.53

mmol/l

1.14

653

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

115

1.40

0.57

1.2

1.4

52.89

62.38

mmol/l

—

Reactive arthropathies

475

1.18

0.56

1.5

1.4

55.27

66.48

mmol/l

1.71

369

Orthopaedic devices associated with adverse incidents

124

1.38

0.56

1.1

1.3

76.90

61.46

mmol/l

—

109

Lichen sclerosus et atrophicus

690

1.15

0.56

1.6

1.3

71.89

62.08

mmol/l

1.34

554

Acute appendicitis, no complications

358

3352

1.06

0.55

1.5

1.4

62.32

63.97

mmol/l

0.31

276

2605

Bullous keratopathy

1.51

0.55

1.4

1.3

60.89

62.94

mmol/l

—

Benign neoplasm: Skin of eyelid, including canthus

122

1098

1.11

0.54

1.4

1.3

63.56

62.55

mmol/l

0.10

884

Cyst of kidney

459

1.18

0.54

1.8

1.3

57.65

60.64

mmol/l

0.26

359

Other specified disorders of external ear

205

0.73

0.54

1.7

1.3

56.63

64.50

mmol/l

—

175

Medicines for HER+ breast cancer

277

2807

0.93

0.53

1.4

57.40

61.32

mmol/l

1.02

215

2230

Pleural plaque without asbestos

250

1.25

0.52

1.5

1.3

55.20

61.60

mmol/l

0.41

203

Foreign body on external eye

748

0.87

0.52

1.4

61.83

64.71

mmol/l

0.21

598

Inflammatory disease of cervix uteri

416

1.18

0.51

1.3

62.94

61.79

mmol/l

0.06

330

Female infertility

152

841

1.10

0.51

1.5

1.3

68.03

63.36

mmol/l

0.67

134

630

Use of galantamine

660

1.14

0.50

1.4

1.3

65.15

60.80

mmol/l

0.51

519

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

284

1.22

0.49

2.1

2.3

65.20

76.59

mmol/l

0.87

248

Adenocarcinoma and papilloma adenocarcinoma of rectum

576

1.15

0.49

1.5

1.4

69.87

62.22

mmol/l

0.60

462

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

1.41

0.48

1.1

1.4

52.75

61.12

mmol/l

—

Mixed conductive and sensorineural hearing loss

813

1.12

0.48

1.4

60.33

62.10

mmol/l

0.18

655

Other acute skin changes due to ultraviolet radiation

190

1.27

0.48

1.6

1.3

57.42

64.47

mmol/l

0.35

151

Childhood allergy (age < 16)

337

1.17

0.47

1.9

3.1

76.29

82.58

mmol/l

0.35

287

Spondylopathies (FG)

691

1.13

0.47

1.6

1.3

61.27

65.59

mmol/l

0.41

540

Malignant neoplasm of breast, ER-positive, including Hilmo

257

1857

1.07

0.46

1.4

56.07

62.02

mmol/l

1.79

200

1476

Other menopausal disorders

168

1026

0.92

0.46

1.6

1.3

55.76

61.21

mmol/l

1.12

135

772

Chronic diseases of tonsils and adenoids

522

3449

0.96

0.46

1.4

1.5

63.56

64.45

mmol/l

0.17

417

2701

Benign neoplasm: Skin, unspecified

228

1.23

0.45

1.5

1.4

60.90

61.94

mmol/l

0.04

186

Anti-inflammatory and antirheumatic products, non-steroids

245

1152

1.07

0.45

1.3

1.6

66.16

63.63

mmol/l

0.38

200

916

Lichen ruber planus, wide definition including periferal and oral lichen planus

167

1547

1.08

0.44

1.4

59.51

62.68

mmol/l

0.51

130

1241

Adenocarcinoma and papillary adenocarcinoma of stomach

148

1.29

0.43

1.4

58.07

63.06

mmol/l

0.25

116

Congenital malformations of ovaries, fallopian tubes and broad ligaments

193

1.25

0.43

1.2

1.4

74.32

68.15

mmol/l

0.21

165

Juvenile arthritis (FINNGEN)

175

1.26

0.43

1.5

1.8

59.20

71.38

mmol/l

0.57

144

Endometriosis ASRM stages 3,4

149

1375

1.08

0.43

1.4

60.54

62.62

mmol/l

0.26

124

1092

Mouth breathing

275

2591

1.06

0.43

1.6

1.5

66.12

64.62

mmol/l

0.23

226

2044

Injury of muscle and tendon at hip and thigh level

522

0.86

0.43

1.4

1.3

63.74

63.63

mmol/l

0.01

421

Lichen planus, including avohilmo

143

1318

1.09

0.43

1.4

1.3

61.46

63.20

mmol/l

0.21

113

1045

Blepharospasm

1.41

0.42

1.0

1.4

51.25

61.75

mmol/l

—

Caught, crushed, jammed or pinched in or between objects

221

1.22

0.42

1.3

1.5

51.24

68.59

mmol/l

1.43

184

Contact with nonpowered hand tool

194

1.24

0.42

1.5

1.3

68.32

65.29

mmol/l

0.11

162

Carcinoma in situ of rectum

1.39

0.41

1.8

1.3

48.75

60.43

mmol/l

—

Esophageal diverticulum (pouch)

0.00

0.41

0.0

1.5

—

51.20

—

Use of pergolide

0.00

0.41

0.0

1.0

—

57.07

—

Acne varioliformis

0.00

0.41

0.0

1.3

—

64.13

—

Triptan medication for migraine, min. 3 purchases

315

2278

1.06

0.41

1.4

70.77

63.48

mmol/l

1.81

253

1787

LSIL lesion of the vagina

1.36

0.41

1.3

1.4

44.75

65.02

mmol/l

—

Explosion of other materials

0.00

0.41

0.0

1.4

—

65.24

—

Congenital malformations of uterus and cervix

1.31

0.39

1.1

1.5

98.50

74.00

mmol/l

—

Other and unspecified disorders of vitreous body

314

3254

0.95

0.39

1.3

1.4

62.89

62.48

mmol/l

0.07

249

2586

Malignant neoplasm of breast, HER-positive

251

1848

1.06

0.38

1.4

56.32

62.07

mmol/l

1.65

195

1468

Cyst of Bartholin Gland

160

1.25

0.38

1.7

1.3

59.73

64.74

mmol/l

0.28

133

Benign neoplasm of thyroid gland

192

0.78

0.38

1.2

1.3

85.88

59.90

mmol/l

—

158

Other/unspecified reactive arthropathies

345

1.16

0.37

1.5

1.4

56.45

65.38

mmol/l

0.94

284

Gestational [pregnancy-induced] hypertension

112

1027

1.09

0.37

1.3

1.4

71.51

64.80

mmol/l

0.77

799

Dermatitis due to ingested food

154

1.25

0.37

5.6

3.6

79.33

82.92

mmol/l

0.10

138

Malignant melanoma of skin, including Hilmo

100

915

1.09

0.37

1.3

62.44

63.69

mmol/l

0.11

732

Retained placenta and membranes, without haemorrhage

619

1.12

0.37

1.3

1.4

60.14

65.62

mmol/l

0.56

482

Other degenerative diseases of the basal ganglia

108

1.30

0.35

1.2

1.3

71.33

61.27

mmol/l

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

502

1.10

0.35

1.6

1.5

71.83

68.83

mmol/l

0.22

389

Pilonidal cyst

319

1.16

0.35

1.5

1.4

63.96

69.84

mmol/l

0.29

250

Benign neoplasm: Skin of lower limb, including hip

153

1.25

0.35

1.5

1.3

57.83

62.09

mmol/l

0.15

129

Testicular hypofunction

126

1.27

0.35

1.4

1.3

75.18

64.22

mmol/l

0.35

103

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

827

0.91

0.35

1.1

1.3

57.33

62.38

mmol/l

0.57

659

Benign neoplasm of other and unspecified sites

199

1.21

0.35

1.2

1.3

63.63

63.91

mmol/l

0.01

164

Anogenital herpesviral [herpes simplex] infection

199

1.21

0.35

1.4

51.53

69.33

mmol/l

1.93

168

Malignant melanoma of skin

670

1.11

0.35

1.3

61.48

63.14

mmol/l

0.12

540

Embedded teeth, including avohilmo

301

1.16

0.35

1.3

1.5

68.17

69.30

mmol/l

0.05

252

Other obstructed labour

341

0.85

0.34

1.7

1.4

49.00

68.19

mmol/l

1.93

270

L02BA Anti-estrogens

105

1138

0.92

0.34

1.4

54.67

62.02

mmol/l

1.18

906

Abnormal spermatozoa

728

1.10

0.34

1.6

1.3

65.28

65.38

mmol/l

0.01

591

Plantar fascial fibromatosis

509

1.12

0.34

1.5

1.3

66.04

63.61

mmol/l

0.17

398

Other sexually transmitted chlamydial diseases

232

0.82

0.33

1.2

1.6

82.00

71.37

mmol/l

0.26

189

Exposure to other specified electric current

0.70

0.33

1.0

1.3

94.00

68.70

mmol/l

—

Other/unspecified enthesopathies, not elsewhere classified

492

1.12

0.32

1.4

1.3

63.43

63.08

mmol/l

0.02

382

Endometriosis of pelvic peritoneum

678

1.10

0.32

1.3

1.4

68.57

63.23

mmol/l

0.45

497

Impotence

285

1.16

0.32

1.2

1.3

60.64

66.70

mmol/l

0.41

233

LSIL lesion of the vulva

137

1.24

0.32

1.3

49.00

65.13

mmol/l

1.47

110

Nontoxic single thyroid nodule

436

1.13

0.32

1.1

1.3

65.81

62.01

mmol/l

0.26

351

Use of selegiline

294

0.85

0.31

1.3

70.41

60.71

mmol/l

0.46

237

Nontoxic goitre/thyroid nodule

247

2355

1.05

0.31

1.3

1.4

61.92

62.13

mmol/l

0.03

194

1881

Endometriosis of ovary

100

903

1.08

0.31

1.3

63.28

62.14

mmol/l

0.10

679

Other obstetric conditions, not elsewhere classified

521

1.09

0.30

1.6

1.5

70.88

68.23

mmol/l

0.19

405

Female infertility, cervical, vaginal, other or unspecified origin

135

822

1.07

0.29

1.4

1.3

66.11

63.37

mmol/l

0.32

117

617

Maternal care for known or suspected disproportion

112

1.25

0.28

1.2

1.6

53.43

68.31

mmol/l

—

Scleritis and episcleritis

308

1.14

0.28

1.2

1.3

61.72

61.51

mmol/l

0.01

255

Other keratitis

594

1.10

0.27

1.4

58.27

62.78

mmol/l

0.35

476

Artificial joint re-operation

518

1.10

0.27

1.4

58.69

61.06

mmol/l

0.18

416

Benign neoplasm: Parathyroid gland

1.24

0.27

1.5

1.3

80.13

63.65

mmol/l

—

Other and unspecified iridocyclitis

243

1.15

0.27

1.3

1.4

55.91

62.22

mmol/l

0.58

196

Biological medicines for asthma

1.21

0.26

1.8

1.5

50.38

67.61

mmol/l

—

Contact with other sharp object(s)

262

1.15

0.26

1.5

1.4

64.48

70.26

mmol/l

0.28

215

Benign neoplasm: Skin of lip

1.20

0.26

1.3

67.25

64.07

mmol/l

—

Granuloma annulare

0.69

0.26

1.6

1.2

52.20

65.38

mmol/l

—

Adhesive capsulitis of shoulder

111

1041

1.07

0.26

1.4

62.51

63.56

mmol/l

0.12

817

Torsion of ovary, ovarian pedicle and fallopian tube

1.25

0.25

1.4

1.5

52.00

62.54

mmol/l

—

Other disorders of breast

752

1.08

0.25

1.5

1.4

63.76

63.86

mmol/l

0.01

599

Normotensive glaucoma

646

1.09

0.25

1.4

1.3

60.81

62.03

mmol/l

0.10

519

Erythema nodosum

151

1.20

0.25

1.4

46.92

62.82

mmol/l

1.51

126

Suppurative otitis media, unspecified

114

1.23

0.25

1.3

1.4

68.89

68.59

mmol/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

311

1.13

0.25

1.2

1.4

74.96

66.19

mmol/l

0.41

256

Transient global amnesia

683

0.92

0.24

1.3

68.41

59.97

mmol/l

0.65

546

Uterine polyps

552

1.09

0.23

1.2

1.4

68.39

61.75

mmol/l

0.48

410

Tibial collateral bursitis [Pellegrini-Stieda]

1.32

0.23

1.0

1.2

47.80

51.21

mmol/l

—

Acute appendicitis, with complications

114

1207

0.94

0.23

1.4

73.78

63.31

mmol/l

1.56

958

Excessive vomiting in pregnancy

294

1.12

0.23

1.3

1.5

56.36

63.45

mmol/l

0.69

238

Medical treatment for female infertility

559

1.09

0.23

1.4

1.5

83.80

68.30

mmol/l

1.18

438

Tooth eruption problems

483

1.09

0.22

2.1

70.36

74.20

mmol/l

0.23

402

Disorders of breast

355

3125

1.03

0.22

1.4

57.66

62.23

mmol/l

1.45

281

2473

Benign neoplasm: Penis

0.00

0.21

0.0

1.6

—

62.30

—

Sunburn

0.00

0.21

0.0

1.5

—

71.10

—

Upper arm

0.00

0.21

0.0

1.4

—

61.64

—

Multiple congenital exostoses

0.00

0.21

0.0

1.4

—

70.20

—

Airway disease due to specific organic dust

0.00

0.21

0.0

1.4

—

67.30

—

Inhalation of gastric contents

0.00

0.21

0.0

1.5

—

66.82

—

Benign neoplasm: Ciliary body

0.00

0.21

0.0

1.5

—

64.40

—

Benign neoplasm: Extrahepatic bile ducts

0.00

0.21

0.0

1.5

—

59.82

—

Maxillary hypoplasia

0.00

0.21

0.0

1.9

—

79.80

—

Congenital heart conduction disorder

0.00

0.21

0.0

2.3

—

82.92

—

Craniosynostosis EXCLUDE syndromes

0.00

0.21

0.0

1.6

—

77.29

—

Benign neoplasm: Urinary organ, other/unspecified

0.00

0.21

0.0

1.2

—

50.67

—

Pseudopolyposis of colon

0.00

0.21

0.0

1.6

—

51.33

—

Syndactyly

0.00

0.21

0.0

1.5

—

61.08

—

Benign neoplasm: Liver

1.23

0.21

1.7

1.4

44.86

69.49

mmol/l

—

Other benign neoplasm of uterus: Corpus uteri

1.17

0.21

1.0

1.3

54.80

62.53

mmol/l

—

Inflammatory myopathy

0.00

0.21

0.0

1.5

—

62.38

—

Relapsing polychondritis

0.00

0.20

0.0

1.4

—

50.64

—

Congenital malformations of ear causing impairment of hearing

0.00

0.20

0.0

2.4

—

57.21

—

Lichen planus

858

1.06

0.20

1.3

64.97

62.24

mmol/l

0.25

690

Benign neoplasm of eye and adnexa

654

1.07

0.20

1.3

61.80

62.45

mmol/l

0.05

527

Use of glatiramer acetate

1.23

0.20

1.0

1.4

53.33

67.98

mmol/l

—

Rheumatic fever incl heart disease

174

1.15

0.19

1.3

56.64

61.86

mmol/l

0.21

139

Malignant neoplasm of other connective and soft tissue, including Hilmo

231

1.13

0.19

1.2

1.4

66.32

62.62

mmol/l

0.17

181

Preterm labour and delivery

125

1310

0.95

0.19

1.5

1.4

64.42

63.78

mmol/l

0.06

105

1013

Use of anticholinesterases

318

2578

0.97

0.18

1.3

66.69

60.53

mmol/l

2.14

252

2081

N06DA Anticholinesterases

318

2578

0.97

0.18

1.3

66.69

60.53

mmol/l

2.14

252

2081

Ankylosing spondylitis, ICD10

444

1.08

0.18

1.5

1.4

61.44

64.93

mmol/l

0.27

364

Testicular dysfunction

147

1.16

0.18

1.4

1.2

77.00

64.35

mmol/l

0.46

118

Lumbosacral root disorders, not elsewhere classified

1.15

0.17

1.1

1.2

66.14

60.93

mmol/l

—

Benign neoplasm: Appendix

1.11

0.17

1.6

1.3

43.43

62.83

mmol/l

—

Pterygium

173

0.87

0.16

1.3

54.20

64.05

mmol/l

—

146

Nonspecific lymphadenitis

282

1.10

0.16

1.4

1.3

56.12

64.41

mmol/l

0.52

235

Otosclerosis

495

0.93

0.16

1.6

1.3

75.22

61.13

mmol/l

0.94

397

Hypertrophy of breast in women and men

108

1032

1.05

0.16

1.5

1.4

58.70

64.57

mmol/l

0.94

817

Other lesions of median nerve

177

1.13

0.16

1.4

1.3

56.21

58.66

mmol/l

0.12

140

Internal derangement of knee

250

2418

1.03

0.16

1.4

58.49

62.85

mmol/l

0.95

202

1890

Follicular lymphoma, hilmo

273

1.10

0.16

1.4

1.3

67.20

60.20

mmol/l

0.38

216

Calcific tendinitis of shoulder

284

1.09

0.15

1.3

60.21

64.02

mmol/l

0.15

224

Benign mammary dysplasia

111

1066

1.04

0.14

1.4

59.80

62.12

mmol/l

0.24

841

Anomalies of dental arch relationship, including avohilmo

102

881

1.04

0.14

2.2

1.7

66.65

69.27

mmol/l

0.20

709

Carcinoma in situ of skin of scalp and neck

160

1.13

0.14

1.2

1.3

56.94

61.50

mmol/l

0.23

130

Infections of genitourinary tract in pregnancy

439

0.93

0.13

1.5

1.4

60.07

63.47

mmol/l

0.18

346

Congenital deformities of feet

0.83

0.13

1.3

1.5

52.38

76.87

mmol/l

—

Myocardial infarction, with ST-elevation

123

1275

0.96

0.13

1.3

65.19

62.27

mmol/l

0.43

1017

Acute appendicitis

472

4335

1.02

0.13

1.5

1.4

65.16

63.91

mmol/l

0.25

367

3381

Infectious mononucleosis

242

0.91

0.13

1.3

1.5

105.81

72.56

mmol/l

1.60

203

Abnormal findings in secretions and smears from cervix uteri vagina vulva

263

2033

0.98

0.13

1.5

1.4

59.29

64.40

mmol/l

1.18

221

1586

L02BB Anti-androgens

551

1.05

0.12

1.2

1.3

53.75

65.67

mmol/l

2.51

442

Early lumbar disc prolapse, operated

317

1.07

0.12

1.6

1.4

68.78

68.80

mmol/l

0.00

244

Other and/or unspecified nontoxic goitre

532

1.05

0.11

1.4

1.3

62.49

60.82

mmol/l

0.11

425

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

368

2864

1.02

0.11

1.5

1.4

60.68

64.27

mmol/l

0.93

308

2255

Dissection of aorta

183

1.09

0.10

1.1

1.2

81.07

64.43

mmol/l

0.86

152

Other congenital malformations of male genital organs

1.14

0.10

4.8

4.1

60.00

93.49

mmol/l

—

Muscular dystrophy

1.14

0.10

1.4

1.5

90.00

74.00

mmol/l

—

Habitual aborter

1.04

0.09

1.0

1.6

141.60

74.79

mmol/l

—

Pathological resorption of teeth

155

0.90

0.09

1.6

1.3

38.44

63.23

mmol/l

—

128

Benign neoplasm of bone and articular cartilage

419

1.05

0.09

1.4

58.37

65.34

mmol/l

0.50

338

Other congenital malformations of male genital organs

1.09

0.09

4.7

3.8

78.50

88.73

mmol/l

—

Haemangioma, any site

502

0.96

0.08

1.5

58.77

63.84

mmol/l

0.34

407

Melanoma in situ

292

1.06

0.08

1.1

1.3

65.04

61.24

mmol/l

0.13

236

LSIL lesion of the cervix uteri

390

1.05

0.08

1.7

1.4

59.39

66.55

mmol/l

0.64

316

Calculus of lower urinary tract

312

1.06

0.08

1.6

1.3

59.74

64.85

mmol/l

0.33

252

Lesion of sciatic nerve

297

0.94

0.08

1.2

1.3

61.14

60.08

mmol/l

0.05

239

Personal history of malignant neoplasm

358

0.95

0.08

1.6

1.4

62.93

62.04

mmol/l

0.05

292

Achilles tendinitis

549

1.04

0.08

1.2

1.3

59.21

61.14

mmol/l

0.18

428

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

225

1.07

0.07

1.3

62.00

60.46

mmol/l

0.07

182

Benign neoplasm: Connective and other soft tissue of head, face and neck

0.85

0.07

1.3

75.14

71.76

mmol/l

—

Benign neoplasm of ovary

125

1277

0.98

0.07

1.5

1.4

57.49

62.00

mmol/l

0.81

108

1012

LSIL lesion of the cervix uteri, vagina or vulva

580

1.03

0.07

1.6

1.4

55.76

65.49

mmol/l

1.44

452

Melanocytic naevi of other and unspecified parts of face

314

1.05

0.07

1.6

1.3

62.12

64.77

mmol/l

0.14

256

Hypertrophy of breast

872

0.97

0.06

1.4

59.69

64.64

mmol/l

0.59

684

Benign leiomyoma with endometriosis

115

1174

0.98

0.06

1.3

1.4

58.66

61.63

mmol/l

0.43

932

MS-disease / Multiple Sclerosis

276

1.05

0.06

1.3

1.4

60.67

66.14

mmol/l

0.32

232

Labour and delivery complicated by umbilical cord complications

172

0.93

0.06

1.3

1.5

56.91

68.11

mmol/l

0.30

138

Dislocation, sprain and strain of joints and ligaments of elbow

306

1.05

0.05

2.1

1.5

60.73

66.74

mmol/l

0.34

258

Cysts of oral region, not elsewhere classified

314

0.95

0.05

1.5

1.4

62.13

64.35

mmol/l

0.10

257

Benign lipomatous neoplasm

202

2047

0.99

0.05

1.3

1.4

60.91

63.10

mmol/l

0.35

167

1624

Conductive hearing loss, unspecified

465

0.97

0.05

2.8

1.4

78.09

64.10

mmol/l

0.99

366

Chalazion

606

0.97

0.05

1.5

1.4

58.00

65.35

mmol/l

0.67

483

Retinal breaks without detachment

105

1032

1.02

0.04

1.3

55.62

63.64

mmol/l

1.85

816

Pregnancy with abortive outcome

491

2544

1.01

0.04

1.3

1.4

62.05

61.32

mmol/l

0.14

400

2017

Oral lichen planus, including avohilmo , including avohilmo

397

1.03

0.04

1.5

1.4

59.71

60.49

mmol/l

0.04

322

Diseases of appendix

515

4613

1.01

0.04

1.5

1.4

65.16

63.53

mmol/l

0.37

404

3608

Maternal care for other conditions predominantly related to pregnancy

661

0.98

0.04

1.3

1.5

68.81

68.52

mmol/l

0.01

505

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

170

1684

1.01

0.03

1.3

1.4

59.17

63.91

mmol/l

0.94

138

1346

Glucagon-like peptide-1 (GLP-1) analogues

170

1684

1.01

0.03

1.3

1.4

59.17

63.91

mmol/l

0.94

138

1346

Adenomyosis (Endometriosis of uterus)

847

1.02

0.03

1.2

1.4

63.03

60.47

mmol/l

0.25

639

Presbyopia

320

0.97

0.03

1.6

1.3

59.35

62.30

mmol/l

0.16

262

Bitten or struck by other mammals

511

0.98

0.03

1.3

1.4

54.21

64.30

mmol/l

0.66

417

Recurrent dislocation and subluxation of joint

281

1.03

0.02

1.8

1.3

70.57

67.43

mmol/l

0.10

221

Spermatocele

401

1.02

0.02

1.4

1.3

75.39

66.04

mmol/l

0.57

328

Leiomyoma of uterus

483

2746

1.00

0.02

1.4

60.63

61.19

mmol/l

0.11

385

2170

Other blood glucose lowering drugs, excl. Insulins

120

1190

1.01

0.01

1.4

1.3

65.70

61.50

mmol/l

0.53

959

Appendicitis, broad definition

507

4571

1.00

0.01

1.5

1.4

65.00

63.56

mmol/l

0.31

399

3571

Laparoscopic right hemicolectomy

412

1.02

0.01

1.2

1.3

58.12

59.05

mmol/l

0.08

333

Benign neoplasm: Choroid

393

1.02

0.01

1.3

59.33

61.14

mmol/l

0.13

315

Chronic suppurative otitis media, including avohilmo

467

0.98

0.01

1.5

62.11

65.27

mmol/l

0.19

376

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

497

0.99

0.01

1.3

67.33

62.33

mmol/l

0.39

398

Benign neoplasm: Liver/bile ducts

114

1.05

0.00

1.8

1.4

44.86

66.58

mmol/l

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

256

0.98

0.00

1.6

1.3

48.06

67.10

mmol/l

1.46

203

Endometriosis ASRM stages 1,2

814

1.00

0.00

1.3

1.4

69.00

62.83

mmol/l

0.57

643

Chronic suppurative otitis media

401

1.00

0.00

1.4

62.68

65.11

mmol/l

0.12

325

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

347

1.01

0.00

1.6

1.4

69.67

65.49

mmol/l

0.16

275

Carcinoma in situ of breast, intraductal

575

0.99

0.00

1.1

1.3

62.49

60.46

mmol/l

0.13

452

Tooth agenesis EXCLUDE clefts and syndromes

126

1.03

0.00

2.2

2.5

70.31

78.95

mmol/l

0.21

113

Alzheimer’s disease (Early onset), excluding more controls

172

0.99

0.00

1.3

80.92

62.65

mmol/l

0.82

135

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

244

0.98

0.00

1.3

68.41

60.85

mmol/l

0.42

202

Early lumbar disc prolapse operation

356

1.01

0.00

1.6

1.4

70.93

66.68

mmol/l

0.25

285

Other superficial mycoses

456

1.01

0.00

1.7

1.3

62.97

65.67

mmol/l

0.16

373

Use of rivastigmine

134

1338

1.00

0.00

1.3

66.74

59.81

mmol/l

1.25

110

1058

Other osteochondropathies

338

1.01

0.00

1.2

1.4

66.45

67.25

mmol/l

0.04

282

Other congenital malformations of face and neck

111

0.99

0.00

1.3

70.83

67.41

mmol/l

—

Exposure to other and unspecified animate mechanical forces

119

1.01

0.00

2.1

1.6

58.17

72.34

mmol/l

0.93

102

Use of ropinirole

239

1.00

0.00

1.6

1.3

79.21

62.07

mmol/l

1.10

195

Mandibular retrognathia

262

0.99

0.00

1.8

2.2

66.10

71.14

mmol/l

0.24

228

Bicipital tendinitis

237

1.01

0.00

1.8

1.3

85.84

63.37

mmol/l

1.22

184

Haemangioma and lymphangioma, any site

535

0.99

0.00

1.5

1.4

62.13

63.99

mmol/l

0.10

431

Use of levodopa decarbox-comt-inhibitor

205

1.02

0.00

1.1

1.3

75.13

62.47

mmol/l

0.76

168

Noninfective disorders of pinna

0.00

0.0

1.8

—

66.00

—

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

0.00

0.0

1.6

—

68.44

—

Kaschin-Beck disease

0.00

0.0

1.1

—

48.25

—

Other injuries involving multiple body regions, not elsewhere classified

0.00

0.0

1.8

—

59.50

—

Other histiocytosis syndromes

0.00

0.0

1.0

—

93.29

—

Progressive osseous muscle inflammation

0.00

0.0

1.7

—

34.33

—

Gastric ulcer - Acute with haemorrhage, drug-induced

0.00

0.0

1.1

—

61.38

—

Retained (old) intraocular foreign body

0.00

0.0

1.7

—

67.50

—

Calculus of urinary tract in diseases classified elsewhere

0.00

0.0

1.8

—

61.20

—

Accident to watercraft causing other injury

0.00

0.0

1.8

—

41.40

—

Other disorders of bone development and growth

0.00

0.0

1.4

—

65.20

—

Nanophthalmos, microphthalmos and macrophthalmos

0.00

0.0

2.2

—

67.60

—

Defect, injury or illness of skull

0.00

0.0

1.6

—

72.29

—

Congenital absence, occlusion, or narrowing of the ear canal

0.00

0.0

3.3

—

60.88

—

Benign lipomatous neoplasm of intrathoracic organs

0.00

0.0

1.2

—

61.67

—

Injury of blood vessels at shoulder and upper arm level

0.00

0.0

1.8

—

53.75

—

Injury of muscle and tendon at shoulder and upper arm level

243

2430

1.00

-0.00

1.3

62.96

63.81

mmol/l

0.11

199

1918

Disorders of other digestive organs in diseases classified elsewhere

0.00

-0.00

0.0

1.4

—

86.60

—

Acquired ichthyosis

0.00

-0.00

0.0

2.0

—

56.00

—

Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere

0.00

-0.00

0.0

1.3

—

52.17

—

Digeorge syndrome

0.00

-0.00

0.0

2.2

—

89.60

—

Disorders of globe

150

1.00

-0.00

1.4

1.3

58.40

59.33

mmol/l

—

122

Mucinosis of skin

0.00

-0.00

0.0

1.7

—

75.50

—

Macular pucker, drug-induced

0.00

-0.00

0.0

1.5

—

48.17

—

Toxic encephalopathy

0.00

-0.00

0.0

1.3

—

65.67

—

Moyamoya

0.00

-0.00

0.0

1.7

—

79.17

—

Benign neoplasm: Lacrimal gland and duct

0.00

-0.00

0.0

1.3

—

57.25

—

Myopathy due to other toxic agents

0.00

-0.00

0.0

1.2

—

71.60

—

Night blindness

0.00

-0.00

0.0

1.0

—

68.40

—

Hypotony of eye

0.00

-0.00

0.0

1.6

—

48.13

—

Other and unspecified disorders of sclera

0.00

-0.00

0.0

1.8

—

69.83

—

Malignant neoplasms of independent (primary) multiple sites

0.00

-0.00

0.0

1.4

—

69.20

—

Brain mixed glioma

0.00

-0.00

0.0

1.8

—

49.20

—

Hydroxyapatite deposition disease

0.00

-0.00

0.0

2.0

—

31.60

—

Cyst of iris, ciliary body and anterior chamber

0.00

-0.00

0.0

2.0

—

49.50

—

Other and unspecified disorders of lacrimal system

0.00

-0.00

0.0

1.2

—

51.80

—

Juvenile dermatomyositis

0.00

-0.00

0.0

1.0

—

78.60

—

Disorders of muscle in diseases classified elsewhere

0.00

-0.00

0.0

3.0

—

49.60

—

Chronic postrheumatic arthropathy [Jaccoud]

0.00

-0.00

0.0

1.4

—

47.25

—

Atrophy of thyroid (acquired)

0.00

-0.00

0.0

1.7

—

60.14

—

Persistent hyperplasia of thymus

0.00

-0.00

0.0

1.0

—

66.83

—

Functional disorders of polymorphonuclear neutrophils

0.00

-0.00

0.0

1.2

—

51.00

—

Duodenal ulcer - Acute with haemorrhage, drug-induced

0.00

-0.00

0.0

1.8

—

57.25

—

Duodenal ulcer - Chronic without haemorrhage or perforation, drug-induced

0.00

-0.00

0.0

1.3

—

44.83

—

Proteinuria and renal glomerular damage; focal glomerulonephritis

0.00

-0.00

0.0

1.3

—

56.83

—

Other combined immunodeficiencies

0.00

-0.00

0.0

1.2

—

41.33

—

Unspecified drowning and submersion

0.00

-0.00

0.0

1.0

—

60.60

—

Benign neoplasm: Mesothelial tissue of other sites/unspecified

0.00

-0.00

0.0

2.0

—

50.40

—

Benign neoplasm of mesothelial tissue

0.00

-0.00

0.0

1.8

—

50.00

—

Carcinoma in situ of stomach

0.00

-0.00

0.0

1.8

—

45.11

—

Exposure to high-pressure jet

0.00

-0.00

0.0

1.7

—

72.33

—

Occupant of railway train or railway vehicle injured in transport accident

0.00

-0.00

0.0

1.6

—

66.14

—

Hereditary angioödema type 1

0.00

-0.00

0.0

1.0

—

55.60

—

General autosomal fish scale disease

0.00

-0.00

0.0

1.1

—

61.43

—

Microtia (small ears)

0.00

-0.00

0.0

2.3

—

87.56

—

Malignant neoplasm of placenta, including Hilmo

0.00

-0.00

0.0

1.2

—

91.00

—

Pectus carinatum

0.00

-0.00

0.0

5.4

—

93.00

—

Exposure to high and low air pressure and changes in air pressure

0.00

-0.00

0.0

1.6

—

69.57

—

Supernumerary ureter

0.00

-0.00

0.0

2.9

—

61.00

—

Syndactyly

0.00

-0.00

0.0

1.6

—

60.00

—

Accident to watercraft causing drowning and submersion

0.00

-0.00

0.0

2.2

—

42.60

—

Traumatic amputation of hip and thigh

0.00

-0.00

0.0

2.0

—

55.78

—

Traumatic subcutaneous emphysema

0.00

-0.00

0.0

1.2

—

75.67

—

Fracture of upper limb, level unspecified

0.00

-0.00

0.0

1.3

—

76.71

—

Merkel cell carcinoma of skin

0.00

-0.00

0.0

1.3

—

53.17

—

Mosquito-borne viral encephalitis

0.00

-0.00

0.0

1.2

—

53.40

—

Postprocedural disorders of ear and mastoid process, not elsewhere classified

1.02

-0.00

1.2

1.4

69.80

64.27

mmol/l

—

Abnormalities of ear ossicles

0.00

-0.00

0.0

1.6

—

62.44

—

Crushing injury of shoulder and upper arm

0.00

-0.00

0.0

1.8

—

64.40

—

Indeterminate sex and pseudohermaphroditism

0.00

-0.00

0.0

1.4

—

86.86

—

Acute necrotizing ulcerative gingivitis

0.00

-0.00

0.0

1.0

—

69.60

—

Pupillary membranes and other adhesions and disruptions of iris and ciliary body

0.00

-0.00

0.0

1.0

—

53.11

—

Knuckle pads

0.00

-0.00

0.0

1.2

—

55.67

—

Unspecified hairloss

0.00

-0.00

0.0

1.6

—

66.22

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Sodium [Moles/volume] in Urine

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS